TARGET USI,Gender,Race,Ethnicity,Age at Diagnosis in Days,First Event,Event Free Survival Time in Days,Vital Status,Overall Survival Time in Days,Year of Diagnosis,Year of Last Follow Up,Protocol,WBC at Diagnosis,Bone marrow leukemic blast percentage (%),Peripheral blasts (%),CNS disease,Chloroma,FAB Category,t(6;9),t(8;21),t(3;5)(q25;q34),t(6;11)(q27;q23),t(9;11)(p22;q23),t(10;11)(p11.2;q23),t(11:19)(q23:p13.1),inv(16),del5q,del7q,del9q,monosomy 5,monosomy 7,trisomy 8,trisomy 21,MLL,Minus Y,Minus X,Cytogenetic Code Other,Cytogenetic Complexity,Primary Cytogenetic Code,ISCN,FLT3/ITD positive?,FLT3/ITD allelic ratio,FLT3 PM,NPM mutation,CEBPA mutation,WT1 mutation,c-Kit Mutation Exon 8,c-Kit Mutation Exon 17,MRD at end of course 1,MRD % at end of course 1,MRD at end of course 2,MRD % at end of course 2,CR status at end of course 1,CR status at end of course 2,Risk group,SCT in 1st CR,Bone Marrow Site of Relapse/Induction Failure,CNS Site of Relapse/Induction Failure,Chloroma Site of Relapse/Induction Failure,Cytogenetic Site of Relapse/Induction Failure,Other Site of Relapse/Induction Failure,Gene Fusion,Gemtuzumab ozogamicin treatment,Refractory Timepoint sent for Induction Failure Project,Comment
TARGET-20-PAVWUU,Male,Asian,Not Hispanic or Latino,441,Relapse,276,Dead,662,2013,2015,AAML1031,6.1,18,0,Yes,Yes,,No,No,No,No,Yes,No,No,No,No,No,Yes,No,No,No,No,Yes,No,No,"+der(9)t(9;11),del(9q)",3,MLL,"46,XY,del(9)(q13q22),t(9;11)(p22;q23)[7]/47,idem,+der(9)t(9;11)(p22;q23)[18]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVGAM,Female,White,Not Hispanic or Latino,445,Relapse,336,Dead,776,2012,2014,AAML1031,6.9,20,0,Yes,Yes,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,der(3)t(1;3)(q24;p25),3,MLL,"46,XX,t(9;11)(p21;q23),add(17)(p13)[8]/46,idem,der(3)t(1;3)(q24;p25)[5]/46,XX[8]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,Yes,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAVNFA,Female,White,Hispanic or Latino,5160,Relapse,629,Alive,1976,2013,2018,AAML1031,35.2,25,0,Yes,Yes,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,15,2,t(8;21),"46,XX,t(8;21)(q22;q22)[6]/47,idem,+15[8]/46,XX[8]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWCGM,Male,White,Not Hispanic or Latino,648,Relapse,468,Alive,1674,2013,2018,AAML1031,5.9,27,0,Yes,Yes,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(9;11)(p22;q23)[18]/46,XY[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,No,Yes,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAWRPX,Male,White,Not Hispanic or Latino,348,Induction failure,61,Alive,1601,2014,2019,AAML1031,38.9,30,0,Yes,Yes,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(11;19)(q23;p13.1)[11]/46,XY[9]",No,N/A,,No,No,,,,No,0,Yes,,CR,not in CR,Standard Risk,No,Yes,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVBVP,Female,White,Hispanic or Latino,6308,Censored,2085,Alive,2085,2012,2018,AAML1031,5.4,44,0,Yes,Yes,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,der(2)t(1;2)(q31.2;q37.1),2,Other,"47,XX,der(2)t(1;2)(q31.2;q37.1),+8[8]/46,XX[12]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXIAZ,Male,Unknown,Hispanic or Latino,767,Relapse,94,Dead,206,2015,2016,AAML1031,55.6,85,0,Yes,Yes,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(9;11)(p22;q23)[17]/46,XY[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,No,Yes,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVHML,Female,White,Not Hispanic or Latino,492,Censored,0,Alive,3,2012,2012,AAML1031,12.7,2,0,Yes,Yes,,No,No,No,No,No,Yes,No,No,No,No,No,No,No,Yes,No,Yes,No,No,"+13,+18",>6,MLL,"50,XX,+8,+8,+8,der(10)(10pter->10q22:?:10q22->10q26::11q23-11qter),der(11)t(10;11)(q26;q13),+13,ins(19;11)(p13.1;q13q23)[2]/51,idem,+18[2]/46,XX[17]",No,N/A,,No,No,,,,,,,,unevaluable,unevaluable,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAXALR,Male,White,Not Hispanic or Latino,5291,Relapse,232,Dead,310,2015,2016,AAML1031,17.6,58,1,Yes,Yes,,No,No,No,No,No,No,Yes,No,No,No,Yes,No,No,No,No,Yes,No,No,"t(X;16)(q22;q13),del(9)(p22),+der(19)t(11;19)",4,MLL,"47,XY,t(11;19)(q23;p13.3),+der(19)t(11;19)(q23;p13.3)[8]/47,idem,t(X;16)(q22;q13),del(9)(p22)[15]",No,N/A,,No,No,,,,No,0,,,CR,unevaluable,Standard Risk,Unknown,No,No,Yes,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVPKA,Male,White,Not Hispanic or Latino,603,Relapse,217,Dead,1090,2013,2016,AAML1031,61.6,63,2,Yes,Yes,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,21,1,Other,"47,XX,+21[15]/46,XX[5]",No,N/A,,No,No,,,,No,0.04,No,,not in CR,CR,Standard Risk,No,Yes,No,Yes,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAVLTF,Male,Black or African American,Not Hispanic or Latino,1822,Induction failure,33,Alive,1870,2013,2018,AAML1031,19.9,10,4,Yes,Yes,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,2,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,,,,,not in CR,not in CR,Low Risk,No,No,Yes,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWRUF,Female,White,Hispanic or Latino,528,Censored,1264,Alive,1264,2014,2018,AAML1031,8.9,20,10,Yes,Yes,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XX,t(5;11)(q31;p15)[13]/46,XX[7]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAUYEV,Male,Unknown,Not Hispanic or Latino,2184,Relapse,338,Dead,1080,2012,2015,AAML1031,2.6,41,21,Yes,Yes,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,2,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[22]/46,XY[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAXGGF,Female,White,Not Hispanic or Latino,179,Induction failure,64,Alive,1137,2015,2018,AAML1031,7.3,59,22,Yes,Yes,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,Yes,No,Yes,No,No,"dup(5)(q31q35),del(7)(q32),+8",5,MLL,"47,XX,dup(5)(q31q35),del(7)(q32),+8,t(11;19)(q23;p13.1)[4]/48,idem,+8[7]/46,XX[7]",No,N/A,,No,No,,,,No,0,No,0,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXFIG,Male,White,Not Hispanic or Latino,1555,Censored,1033,Alive,1033,2015,2018,AAML1031,17.4,27,25,Yes,Yes,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,2,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[19]/46,XY[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWBSJ,Male,Asian,Not Hispanic or Latino,4905,Relapse,308,Dead,629,2013,2015,AAML1031,8.1,42,34,Yes,Yes,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,loss of Y,2,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[19]/46,XY[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWLRX,Male,Black or African American,Not Hispanic or Latino,5568,Induction failure,14,Dead,74,2014,2014,AAML1031,31.5,65,36,Yes,Yes,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,"-Y,add(10)(p13),-1,-8,-9,-10,-11,-14,-16,-18,-18,-22,-Y,-2,-3,+9,-13",>6,Other,"45,X,-Y[4]/45,idem,add(10)(p13)[2]/81<4n>XXY,-Y,-1,-8,-9,-10,-11,-14,-16,-18,-18,-22[8]/78,idem,-Y,-2,-3,+9,-13[22]/46,XY[3]",No,N/A,,No,No,,,,,,,,not in CR,not in CR,Standard Risk,No,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAVGIV,Male,Black or African American,Not Hispanic or Latino,2513,Censored,2283,Alive,2283,2012,2019,AAML1031,56.6,40,40,Yes,Yes,,No,No,No,No,No,No,No,Yes,No,Yes,No,No,No,No,No,No,No,No,,2,inv(16),"46,XY,inv(16)(p13.1q22)[9]/46,idem,del(7)(q32)[7]/46,XY[4]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWXIA,Female,Black or African American,Not Hispanic or Latino,771,Relapse,207,Dead,339,2015,2016,AAML1031,49.7,79,40,Yes,Yes,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,dup(8)(q11.2q24),1,Other,"46,XX,dup(8)(q11.2q24)[2]/46,XX[18]",No,N/A,,No,No,,,,No,0.04,No,0,CR,CR,Standard Risk,Unknown,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAWCIL,Female,Black or African American,Not Hispanic or Latino,2074,Induction failure,49,Alive,1684,2013,2018,AAML1031,39,31,55,Yes,Yes,,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,del(9q),2,t(8;21),"46,XX,t(8;21)(q22;q22)[4]/46,idem,del(9)(q21.13q21.33)[15]/46,XX[1]",No,N/A,,No,No,,,,Yes,0.1,,,not in CR,not in CR,Low Risk,No,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAVCTY,Male,Unknown,Hispanic or Latino,2436,Censored,2388,Alive,2388,2012,2019,AAML1031,16.5,22,59,Yes,Yes,,No,Yes,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,,2,t(8;21),"46,XY,del(7)(q32q34),t(8;21)(q22;q22)[18]/46,XY[4]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWWCW,Male,White,Not Hispanic or Latino,3,Relapse,473,Alive,1224,2015,2018,AAML1031,25.9,,60,Yes,Yes,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,inv(14)(q11.2q32.1),2,MLL,"46,XY,add(3)(q21),der(10)t(3;10)(q23;p26)ins(10;11) (p12;q23q13.3),del(10)(q26.2),inv(14)(q11.2q32.1)[19]/46,XY[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,Yes,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVNBL,Male,White,Not Hispanic or Latino,6854,Censored,1983,Alive,1983,2013,2018,AAML1031,8.8,44,61,Yes,Yes,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,minus Y,2,t(8;21),"46,XY,t(8;21)(q22;q22)[8]/45,idem,-Y[11]/46,XY[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVZJX,Female,Unknown,Not Hispanic or Latino,2376,Censored,1593,Alive,1593,2013,2018,AAML1031,9.6,43,66,Yes,Yes,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,-X,2,t(8;21),"45,X,-X,t(8;21)(q22;q22)[10]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAXAFN,Male,Unknown,Not Hispanic or Latino,756,Censored,1121,Alive,1121,2015,2018,AAML1031,36.8,57,67,Yes,Yes,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(3;11)(p21;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAWRPD,Male,White,Unknown,1371,Censored,1480,Alive,1480,2014,2018,AAML1031,8.4,52,68,Yes,Yes,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XY,t(8;21)(q22;q22)[17]/46,XY[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAUSKR,Male,Asian,Not Hispanic or Latino,290,Induction failure,63,Dead,93,2012,2012,AAML1031,173,79,70,Yes,Yes,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,2,MLL,"46,XY,t(9;11)(p22;q23),add(10)(p15)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,not in CR,Standard Risk,No,No,Yes,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVLKG,Female,Asian,Not Hispanic or Latino,646,Censored,2023,Alive,2023,2013,2018,AAML1031,139.1,49,76,Yes,Yes,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,Yes,No,Yes,No,No,+6 and see notes above,3,MLL,"48,XX,+6,+8,t(11;19)(q23;p13.3)[18]/46,XX[2}",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAVXZL,Male,White,Not Hispanic or Latino,339,Relapse,324,Dead,717,2013,2015,AAML1031,70.6,88,88,Yes,Yes,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,4,Other,"47,XY,t(7;12)(q36;p13),+19[17]/47,idem,dup(2)(q13q33)[6]/47,idem,del(11)(q14q25)[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAUPDK,Male,Unknown,Hispanic or Latino,1507,Death without remission,1,Dead,1,2011,2011,AAML1031,444.7,,93,Yes,Yes,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,add(17)(q25),3,Other,"46,XY,t(2;11)(q31;p15),add(12)(p13),add(17)(q25)[20]",No,N/A,,No,No,,,,,,,,death,death,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVLKB,Female,White,Hispanic or Latino,2404,Censored,1985,Alive,1985,2013,2018,AAML1031,8.4,22,20,Yes,Yes,,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,del(9)(q21q32) -X,3,t(8;21),"46,XX,t(8;21)(q22;q22),del(9)(q21q32)[12]/45,idem,-X[8]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVAYH,Female,White,Not Hispanic or Latino,1004,Death without remission,1,Dead,1,2012,2012,AAML1031,60.5,54,15,Yes,Yes,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,Yes,No,No,+der(9),5,MLL,"47,XX,+1,der(1)t(1;9)(p34;p13)t(9;11)(p22;q23)x2,+8,der(9)t(9;11)(p22;q23),-10[20]",No,N/A,,No,No,,,,,,,,death,death,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVBAY,Male,Unknown,Hispanic or Latino,1909,Censored,2234,Alive,2234,2012,2018,AAML1031,36.3,59,75,Yes,Yes,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,2,t(8;21),"46,XY,t(8;21)(q22;q22)[15]/92,idemx2[4]/46,XY[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAUSBA,Male,Black or African American,Not Hispanic or Latino,290,Censored,2539,Alive,2539,2012,2018,AAML1031,35.5,69,46,Yes,Yes,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,Yes,No,Yes,No,No,,2,MLL,"46,XY,t(11;19)(q23;p13.1)[2]/47,idem,+8[18]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWMLN,Male,White,Not Hispanic or Latino,396,Induction failure,65,Dead,102,2014,2014,AAML1031,238.8,65,89,Yes,Yes,,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,"der(2)t(2;16)(p21;p13.3),add(7)(p15),del(9)(p21), der(16)inv(16)(p13.2;q24)t(2;16),psu dic(19;21)(p11.2;p13.3)dup(19)(p11.1p13.1),t(11;12)(p15.5;q15) [11p15 did not split NUP and it was not checked for that reason]",6,Other,"45,XY,der(2)t(2;16)(p21;p13.3),add(7)(p15),del(9)(p21),der(16)inv(16)(p13.2;q24)t(2;16)(p21;p13.3),psu dic(19;21)(p11.2;p13.3)dup(19)(p11.1p13.1)[13]/46,idem,t(11;12)(p15.5;q15),-psu dic(19),+19,+21[5]/46,XY[10]",No,N/A,,No,No,,,,Yes,0.7,,,CR,not in CR,Standard Risk,No,No,No,No,No,Yes,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAXMKT,Female,White,Not Hispanic or Latino,514,Relapse,320,Alive,854,2016,2018,AAML1031,172,35,32,Yes,Yes,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XX,inv(16)(p13.1q22)[19]/46,XX[1]",Yes,0.02,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAVYKS,Female,White,Hispanic or Latino,50,Censored,0,Alive,5,2013,2013,AAML1031,,,,Unknown,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,t(8;16)(p11.2;p13.3),1,Other,"46,XX,t(8;16)(p11.2;p13.3)[3]/46,XX[17]",No,N/A,,No,No,,,,,,,,unevaluable,unevaluable,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Other
TARGET-20-PAVBIH,Male,Black or African American,Not Hispanic or Latino,511,Censored,814,Alive,2292,2012,2018,AAML1031,6.7,0,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,,No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWJKD,Female,Black or African American,Not Hispanic or Latino,3367,Death without remission,44,Dead,44,2014,2014,AAML1031,4,1,0,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,Yes,No,No,No,No,Yes,No,No,"dic(7;13)(p10;q10),-10 [the del(9q) of the der(9)t(9;11) was not counted as an extra abnormality]",3,MLL,"44,XX,dic(7;13)(p10;q10),der(9)del(9)(q13q22)t(9;11)(p22;q23),-10,der(11)t(9;11)(p22;q23)[16]",No,N/A,,No,No,,,,Yes,0.3,,,death,death,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVKAU,Female,White,Not Hispanic or Latino,163,Relapse,389,Dead,558,2013,2014,AAML1031,2.9,2,0,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,Yes,Yes,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAXLVU,Male,White,Hispanic or Latino,3014,Censored,876,Alive,876,2015,2018,AAML1031,2.5,6,0,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,del 9q,2,t(8;21),"46,XY,t(8;21)(q22;q22),del(9)(q22q34)[15]/46,XY[5]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWERK,Female,White,Not Hispanic or Latino,2858,Relapse,366,Dead,546,2014,2015,AAML1031,1,19,0,Yes,Unknown,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(11;19)(q23;p13.3)[14]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,Yes,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXDGH,Female,Unknown,Not Hispanic or Latino,1114,Censored,1240,Alive,1240,2015,2018,AAML1031,118,21,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAWUNI,Male,White,Not Hispanic or Latino,2946,Induction failure,83,Alive,1220,2014,2018,AAML1031,4.3,21,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.02,,No,No,,,,Yes,26,Yes,13,CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: Acute erythroid leukemia (Erythroleukemia, erythroid/myeloid)"
TARGET-20-PAVWNG,Male,Unknown,Hispanic or Latino,909,Relapse,169,Dead,272,2013,2014,AAML1031,9.3,21,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"+der(1)t(1;22)(p13;q13),t(6;13)(q23;q12)",3,Other,"47,XY,+der(1)t(1;22)(p13;q13),t(1;22)(p13;q13),t(6;13)(q23;q12)[11]/46,XY[9]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,Yes,No,Yes,No,No,,,,WHO Classification (final: path then study entry): AML (megakaryoblastic) with  t(1;22)(p13;q13); RMB15-MKL1
TARGET-20-PAVLSY,Male,White,Not Hispanic or Latino,9982,Censored,0,Alive,4,2013,2013,AAML1031,3.8,21,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.06,,No,No,,,,,,,,unevaluable,unevaluable,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAUYSN,Male,White,Not Hispanic or Latino,382,Censored,2326,Alive,2326,2012,2018,AAML1031,3.8,21,0,Yes,Unknown,,No,No,No,No,No,Yes,No,No,No,No,No,No,No,Yes,No,Yes,No,No,,2,MLL,"46,XY,t(10;11)(p12;q23)inv(11)(q13q23)[19]/47,idem,+8[2]/46,XY[51]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVRWU,Female,White,Not Hispanic or Latino,6019,Relapse,395,Dead,988,2013,2016,AAML1031,0.9,22,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,1,Other,"47,XX,+8[2]/46,XX[18]",No,N/A,,No,No,,,,Yes,2.2999999999999998,No,0,CR,CR,Standard Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: Acute erythroid leukemia (Erythroleukemia, erythroid/myeloid)"
TARGET-20-PAVIZT,Female,White,Not Hispanic or Latino,6256,Censored,2095,Alive,2095,2012,2018,AAML1031,3.4,22,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,No,7.0000000000000007E-2,,,CR,unevaluable,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAVGBH,Male,Asian,Not Hispanic or Latino,700,Censored,2333,Alive,2333,2012,2019,AAML1031,21.4,24,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,1,Other,"47,XY,+8[3]/46,XY[17]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVZIF,Female,White,Not Hispanic or Latino,7170,Death,169,Dead,169,2013,2014,AAML1031,4.8,25,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,Yes,No,,,,No,0,,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAVMNK,Male,White,Unknown,6669,Censored,2044,Alive,2044,2013,2018,AAML1031,4.6,25,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,Yes,1.7,No,,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWGVW,Female,White,Not Hispanic or Latino,9012,Censored,1606,Alive,1606,2014,2018,AAML1031,1.7,26,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX,t(2;3)(p21;p13)c[20]",No,N/A,,No,No,,,,Yes,43,Yes,,not in CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAXGIY,Female,Black or African American,Not Hispanic or Latino,711,Relapse,279,Dead,396,2015,2016,AAML1031,2.7,29,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,Yes,1.6,Yes,,not in CR,CR,Standard Risk,Unknown,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAWYGY,Female,Asian,Not Hispanic or Latino,1783,Relapse,465,Dead,620,2015,2016,AAML1031,4.5,30,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,X,t(X;11)(q24;q23)[5]/46,XX[17]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAVZFT,Female,White,Not Hispanic or Latino,4922,Death,672,Dead,672,2013,2015,AAML1031,1.1,40,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,1,Other,"47,XX,+8[3]/46,XX[30]",No,N/A,,No,No,,,,Yes,25,Yes,,not in CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: Acute erythroid leukemia (Erythroleukemia, erythroid/myeloid)"
TARGET-20-PAUVPP,Female,Unknown,Hispanic or Latino,229,Relapse,329,Alive,2478,2012,2019,AAML1031,7,44,0,Unknown,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,cryp ins(5;11)(q12;q23q23)[12]/46,XX[12]  NOte: this is a preliminary report. the laboratory was asked to do a sequential G-bands to FISH with MLL probe in order to find out the particular translocation. SCR 4-6-12. The pellet was sent to St JudÉ",No,N/A,,No,No,,,,No,0,No,0,unevaluable,CR,Standard Risk,No,No,No,Yes,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAUXUA,Female,Unknown,Not Hispanic or Latino,466,Relapse,276,Dead,468,2012,2013,AAML1031,4.6,48,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,"del(10)(q22q25),dic(8;12)(p11.2;p11.1),dic(12;17)(p11.1;p11.1)",4,MLL,"46,XX,der(10)cryp ins(10;11)(p12;q23q23)del(10)(q22q25)[4]/45,idem,dic(8;12)(p11.2;p11.1)[8]/45,idem,dic(12;17)(p11.1;p11.1)[7]/46,XX[6]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Yes,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWYZR,Male,White,Not Hispanic or Latino,785,Relapse,484,Dead,654,2015,2017,AAML1031,13.2,49,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,"+6,+21  1q gain",>6,Other,"46,XY,der(7)(t(1;7)(q32;p22)[13]/47,XY,t(4;11) (q21;p15),der(11)t(1;11)(q25;q32),+21[3]/50,XY,t(4;11) (q21;p15),+6,der(11)t(1;11) (q32;q25),+21,+21,+21[4]/46,XY[34]",No,N/A,,No,No,,,,Yes,0.3,No,0,unevaluable,CR,Standard Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAWDNM,Female,White,Not Hispanic or Latino,4703,Relapse,335,Dead,352,2014,2015,AAML1031,7.3,50,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"psu dic(7;10)(p15;q10),+der(10)del(10)(p11.2)del(10)(q10)",2,Other,"46,XX,psu dic(7;10)(p15;q10),+der(10)del(10)(p11.2)del(10)(q10)[11]/46,XX[8]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWXSX,Female,Asian,Not Hispanic or Latino,5606,Relapse,640,Dead,680,2015,2017,AAML1031,1.8,51,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,Yes,1.1000000000000001,Yes,,CR,CR,Standard Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAVSNL,Female,White,Hispanic or Latino,6190,Censored,1853,Alive,1853,2013,2018,AAML1031,15.7,52,0,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XX,t(16;16)(p13.1;q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWFEM,Male,White,Not Hispanic or Latino,553,Relapse,107,Dead,515,2014,2015,AAML1031,12.8,55,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"der(10)t(10;16)(q24;q24),der(16)inv(16)(p13.3q13)t(10;16)",2,Other,"46,XY,der(10)t(10;16)(q24;q24),der(16)inv(16)(p13.3q13)t(10;16)[8]/46,XY[14]",No,N/A,,No,No,,,,Yes,0.7,Yes,,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWECG,Female,White,Not Hispanic or Latino,260,Relapse,592,Alive,1606,2014,2018,AAML1031,5,55,0,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[16]/46,XX[4]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,No,Yes,Yes,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAWWMJ,Male,White,Not Hispanic or Latino,3155,Censored,1196,Alive,1196,2015,2018,AAML1031,1.3,56,0,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,Yes,No,No,,2,MLL,"47,XY,+8,t(9;11)(p22;q23)[15]/46,XY[5]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAUZPA,Female,White,Not Hispanic or Latino,372,Censored,2424,Alive,2424,2012,2019,AAML1031,14.7,56,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"der(1)t(1;11)(p36.1;q21),add(3)(p13),-11,der(11)t(3;11)(p13;p11.2),add(16)(p11.2),-17,+mar",>6,Other,"46,XX,der(1)t(1;11)(p36.1;q21),add(3)(p13),-11,der(11)t(3;11)(p13;p11.2),add(16)(p11.2),-17,+19,+mar[3]/46,XX[77]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAXGVS,Female,White,Not Hispanic or Latino,18,Censored,1278,Alive,1278,2015,2019,AAML1031,38.9,59,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,t(8;16)(p11.2;p13.3),1,Other,"46,XX,t(8;16)(p11.2;p13.3)[17]/46,XX[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAXJXC,Male,Unknown,Hispanic or Latino,7715,Relapse,305,Alive,1097,2015,2018,AAML1031,284.5,60,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(?6;11)(?q27;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVYNF,Male,White,Hispanic or Latino,1157,Censored,1959,Alive,1959,2013,2019,AAML1031,6.3,60,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"dic(9;22)(q11;p11.2),inv(17)(p12q21)",3,Other,"45,XY,dic(9;22)(q11;p11.2),del(13)(q12q22)[4]/ 45,idem,inv(17)(p12q21)[5]/46,XY[11]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAWPET,Male,Unknown,Not Hispanic or Latino,5332,Relapse,400,Dead,645,2014,2016,AAML1031,2.2,68,0,Yes,Unknown,,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(10;11)(p12;q23)[10]/46,XX[10]",No,N/A,,No,No,,,,No,0,,,CR,unevaluable,Standard Risk,Unknown,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVUUU,Female,White,Not Hispanic or Latino,6477,Censored,1965,Alive,1965,2013,2018,AAML1031,0.8,68,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"47,XX,+4[18]/46,XX[2]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAWWJN,Male,White,Not Hispanic or Latino,744,Relapse,300,Dead,524,2015,2016,AAML1031,1.8,72,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAXJMY,Male,White,Not Hispanic or Latino,5670,Relapse,439,Dead,653,2015,2017,AAML1031,0.7,77,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,t(14;15)(p11.2;q12),2,Other,"46,XY,del(13)(q12q22),t(14;15)(p11.2;q12)[18]/46,XY[2]",No,N/A,,No,No,,,,Yes,4.9000000000000004,No,0,CR,CR,Standard Risk,Yes,Yes,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAVAVV,Female,Black or African American,Not Hispanic or Latino,350,Induction failure,89,Dead,377,2012,2013,AAML1031,9.8,78,0,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,del(16)(p11.2),2,inv(16),"46,XX,del(16)(p11.2),der(16) cryp ins(16;16)(q22;p13.1p13.1)[21]/46,XX[4]",No,N/A,,No,No,,,,Yes,7.5,Yes,14,CR,not in CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWNGI,Female,White,Hispanic or Latino,6355,Death,272,Dead,272,2014,2015,AAML1031,13.8,83,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.04,,No,No,,,,Yes,27,No,0,not in CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXHYG,Male,White,Not Hispanic or Latino,4289,Relapse,416,Dead,455,2015,2017,AAML1031,1.4,84,0,Unknown,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,2,MLL,"47,XY.der(10)ins(10;11)(p11.2;q23q12),der(11)inv(11) (q12q23)ins(10;11)(p11.2;q12q23),+19[19]/46,XY[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVDVV,Female,Black or African American,Not Hispanic or Latino,5576,Relapse,268,Dead,276,2012,2013,AAML1031,2.1,84,0,Yes,Unknown,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(11;19)(q23;p13.3)[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVCNU,Female,Unknown,Not Hispanic or Latino,2055,Death,168,Dead,168,2012,2013,AAML1031,4.8,84,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,t(7;11)(p15;p15),2,Other,"46,XX,der(4)t(4;11)(q35;q13).t(7;11)(p15;p15)[11]/46,XX[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAUVBS,Female,White,Not Hispanic or Latino,4872,Relapse,307,Dead,625,2012,2013,AAML1031,1.2,86,0,Yes,Unknown,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(11;19)(q23;p13.3)[4]/46,XX[30]",No,N/A,,No,No,,,,Yes,4.7,No,0,not in CR,CR,Standard Risk,Yes,Yes,No,Yes,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWYNR,Female,White,Not Hispanic or Latino,320,Relapse,518,Dead,630,2015,2016,AAML1031,2.4,88,0,Unknown,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,t(4;20)(p15;p12),2,MLL,"46,XX,der(10)(12qter->12q13::11q23.3->11q23.3::10p12->10qter),der(11)( 11pter->11q23.1::10p12->10pter),der(12)(12pter->12q13::11q23.3->11qter)[7]/46,idem,t(4;20)(p15;p12)[9]/46,XX[4]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWTPD,Male,White,Not Hispanic or Latino,3348,Censored,1225,Alive,1225,2014,2018,AAML1031,0.8,90,0,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,ins(9;11)(p22;q22.3q23.3)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVDHJ,Male,White,Not Hispanic or Latino,610,Relapse,62,Dead,198,2012,2013,AAML1031,2.3,90,0,Yes,Unknown,,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,Yes,No,No,gain of 8q,3,MLL,"45,XY,der(1)t(1;8)(p36.1;q13),-10,der(11)cryp t(10;11)(p12;q23)add(11)(q23)[18]/46,XY[2]",No,N/A,,No,No,,,,No,0,,,CR,not in CR,Standard Risk,No,No,Yes,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAUYCB,Male,White,Not Hispanic or Latino,4368,Relapse,492,Dead,633,2012,2014,AAML1031,3,90,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAVTKK,Male,Black or African American,Not Hispanic or Latino,5971,Censored,1771,Alive,1771,2013,2018,AAML1031,1.1,92,0,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,Yes,No,No,,2,MLL,"47,XY,+8,t(9;11)(p22;q23)[14]/46,XY[1]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVFHT,Female,White,Not Hispanic or Latino,880,Censored,2044,Alive,2044,2012,2018,AAML1031,5.4,95,0,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVALI,Male,Black or African American,Unknown,5697,Relapse,231,Alive,1762,2012,2017,AAML1031,1.9,98,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,"add(8)(q24),add(11)(q24),add(12)",5,Other,"~75,XXY,add(8)(q24),add(11)(q24),add(12)(p11.2),inc[2]/103<4n>,XXYY,+X,+Y,+1,+7,add(8)(q24)x2,-9,add(11)(q24)x2),+12,add(12)(p11.2)x2,-13,+15,+16,+20,+21,+21,+21,-22,+mar,inc[7]/46,XY[12]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVYPX,Female,Unknown,Unknown,3523,Censored,1748,Alive,1748,2013,2018,AAML1031,3.7,96,0,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,2,MLL,"46,XX,add(1)(p32),t(9;11)(p22;q22)[17]/46,XX[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAXKTZ,Female,White,Hispanic or Latino,6140,Censored,886,Alive,886,2015,2018,AAML1031,11.2,0,0,Unknown,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Myeloid sarcoma
TARGET-20-PAXBIE,Male,Asian,Not Hispanic or Latino,180,Induction failure,31,Alive,1089,2015,2018,AAML1031,5.9,,0,Yes,Unknown,,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,der(10)t(10;11)(p12;q23)inv(11)(q14.1q23),der(11)t(10;11)(p12;q14.1)[20]",No,N/A,,No,No,,,,No,0,,,CR,not in CR,Standard Risk,No,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWWEI,Female,Asian,Not Hispanic or Latino,4359,Censored,1239,Alive,1239,2015,2018,AAML1031,2.5,20,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"47,XX,+11[17]/46,XX[3]",No,N/A,,No,No,,,,No,0,,,not in CR,unevaluable,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAWMUZ,Female,White,Not Hispanic or Latino,1337,Censored,1642,Alive,1642,2014,2019,AAML1031,0.6,25,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,3,Other,"48,XX,t(7;12)(q36;p13.3),+8,+19[28]/46,XX[1]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVXCF,Male,White,Not Hispanic or Latino,107,Censored,1632,Alive,1632,2013,2018,AAML1031,7.2,3,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(1;11)(p32;q23)[4]/46,XY[16]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Myeloid sarcoma
TARGET-20-PAVPCA,Male,White,Hispanic or Latino,301,Censored,1790,Alive,1790,2013,2018,AAML1031,7,85,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,+3 and confirmed with FISH with wcp3,1,Other,"47,XY,+3[3]/46,XY[17]",No,N/A,,No,No,,,,No,0.02,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAUWHF,Male,White,Not Hispanic or Latino,880,Relapse,247,Dead,371,2012,2013,AAML1031,5.3,10,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,,No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAUMIH,Male,White,Hispanic or Latino,639,Death,296,Dead,296,2011,2012,AAML1031,12.4,34,0,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY,XY[21]",No,N/A,,No,No,,,,Yes,0.2,No,0,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAVBMM,Female,White,Hispanic or Latino,473,Death without remission,2,Dead,2,2012,2012,AAML1031,37.4,58,1,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,12,2,inv(16),"46,XX,inv(16)(p13.1q22)[17]/47,idem,+12[4]",No,N/A,,No,No,,,,,,,,death,death,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWMIP,Female,White,Not Hispanic or Latino,1644,Relapse,750,Alive,1652,2014,2019,AAML1031,3.7,81,1,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAXDEL,Male,White,Not Hispanic or Latino,5049,Relapse,162,Dead,252,2015,2016,AAML1031,2.1,20,2,Yes,Unknown,,No,No,No,No,No,No,No,No,No,Yes,No,No,No,Yes,No,No,No,No,note: del 7q does not include EGFR,2,Other,"47,XY,del(7)(q32q36),+8[21]",No,N/A,,No,No,,,,Yes,0.6,Yes,,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAWNZJ,Female,White,Not Hispanic or Latino,442,Death,250,Dead,250,2014,2015,AAML1031,316.9,20,2,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,t(2;7)(p13;p22),1,Other,"46,XX,t(2;7)(p13;p22)[20]",No,N/A,,No,No,,,,No,0,,,CR,unevaluable,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWZVT,Female,White,Hispanic or Latino,1771,Relapse,372,Alive,933,2015,2017,AAML1031,5.6,21,2,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAXLDX,Female,White,Hispanic or Latino,5319,Death,181,Dead,181,2015,2016,AAML1031,5.7,27,2,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XX,t(8;21)(q22;q22)[16]/46,XX[4]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVCPM,Female,Unknown,Not Hispanic or Latino,4921,Relapse,214,Dead,506,2012,2013,AAML1031,3.5,50,2,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"+3, cryp t(11;17)(p15;p13)",2,Other,"47,XX,+3, cryp t(11;17)(p15;p13)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAVVUT,Female,Unknown,Not Hispanic or Latino,4990,Censored,1717,Alive,1717,2013,2018,AAML1031,0.8,75,2,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"del(1)(p34p36.1),+4, cryp t(7;21)(p22;q22)",3,Other,"46,XX,del(1)(p34p36.1),cryp t(7;21)(p22;q22)[10]/46,idem,+4[6]/46,XX[7]. ish RUNX1 sep",No,N/A,,No,No,,,,Yes,5.3,No,0,not in CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAVDMY,Male,White,Not Hispanic or Latino,2296,Induction failure,72,Alive,2330,2012,2019,AAML1031,1.8,79,2,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"47,XY,+9[2]/46,XY[20]",No,N/A,,No,No,,,,Yes,85,Yes,75,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWMKU,Male,White,Not Hispanic or Latino,2965,Censored,1391,Alive,1391,2014,2018,AAML1031,7,29,3,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAUNTD,Male,White,Not Hispanic or Latino,465,Relapse,271,Dead,340,2011,2012,AAML1031,22,31,3,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"add(19)(q13.3),add(20)(p11.2)",2,Other,"46,XY,add(19)(q13.3),add(20)(p11.2)[19]/46,XY[2]",No,N/A,,No,No,,,,Yes,0.2,No,,not in CR,CR,Standard Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAWJIM,Male,Black or African American,Not Hispanic or Latino,618,Censored,1680,Alive,1680,2014,2019,AAML1031,3.2,36,3,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,t(13;17)(q22;q25),1,Other,"46,XY,t(13;17)(q22;q25)[6]/46,XY[14]",No,N/A,,No,No,,,,Yes,3.2,No,0,not in CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAWPLE,Male,White,Not Hispanic or Latino,444,Censored,1622,Alive,1622,2014,2019,AAML1031,7.6,60,3,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,t(7;12) but with breakpoint at 7q32 rather than 7q36  (momlecular confirmation would be helpful).,3,Other,"45,XY,t(7;12)(q32;p13),-13,add(19)(p13.1),der(22)t(13;22) (q21;p11.2)[12]/46,XY[8]",No,N/A,,No,No,,,,Yes,0.1,No,0,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAVHWK,Female,White,Not Hispanic or Latino,3072,Censored,2030,Alive,2030,2012,2018,AAML1031,6.7,62,3,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,Yes,No,No,No,No,,2,inv(16),"47,XX,+8,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAVDRG,Female,White,Not Hispanic or Latino,2985,Censored,1679,Alive,1679,2012,2017,AAML1031,320,67,3,Yes,Unknown,,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XX,t(6;9)(p23;q34)[18]/46,XX[2]",Yes,0.61,,No,No,,,,No,0,No,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(6;9)(p23;q34); DEK-NUP214
TARGET-20-PAXBEF,Male,White,Not Hispanic or Latino,372,Censored,1113,Alive,1113,2015,2018,AAML1031,8,80,3,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,Y,ins(11;X)(q23;q24q28)[17]/46,XY[3]",No,N/A,,No,No,,,,Yes,4.5,No,0,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWMII,Male,White,Not Hispanic or Latino,1324,Censored,1600,Alive,1600,2014,2018,AAML1031,4.8,86,3,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,"+19,der(19)t(1;19)(q21;q13.3) Gain of MLL but no gain of 11; not apparent by G-banding, only  by FISH",6,Other,"48,XY,+8,-9.+2 mar[7]/48,idem,-8,+19,der(19)t(1;19)(q21;q13.3) [10]/46,XY[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWSKR,Male,White,Not Hispanic or Latino,558,Death,415,Dead,415,2014,2015,AAML1031,13.2,90,3,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAXAKF,Female,White,Not Hispanic or Latino,5694,Censored,1332,Alive,1332,2015,2018,AAML1031,2,39,3,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,N/A,Other,"47,XX,+mar c[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAXBLJ,Female,Black or African American,Not Hispanic or Latino,618,Relapse,278,Dead,309,2015,2016,AAML1031,17.9,6,4,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,2,Other,"46,XX,t(1;22)(p13;q13)[1]/47,idem,+19[2]/96,idem x2,+der(1)t(1;22)(p13;q13)x2,+19,+19[1]/46,XX[29]",No,N/A,,No,No,,,,No,0,No,,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML (megakaryoblastic) with  t(1;22)(p13;q13); RMB15-MKL1
TARGET-20-PAWEDY,Male,Unknown,Not Hispanic or Latino,668,Censored,1834,Alive,1834,2014,2019,AAML1031,6.1,25,4,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,21,2,Other,"48,XY,+8,+21[7]/46,XY[13]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAULTY,Male,White,Not Hispanic or Latino,4542,Relapse,209,Dead,355,2011,2012,AAML1031,16.7,52,4,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,gain of 1q via a der(12)t(1;12)(q24;q24),2,Other,"47XY,+8,der(12)t(1;12)(q24q24)[2]/46,XY[18]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAWCII,Male,Black or African American,Not Hispanic or Latino,353,Censored,1594,Alive,1594,2013,2018,AAML1031,9.5,96,4,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,der(10)del(10)(p11.2p12.2) cryp ins(10;11)(q11.2;q23q23)[20]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXJZX,Female,White,Not Hispanic or Latino,2905,Relapse,159,Dead,313,2015,2016,AAML1031,4.4,22,5,Yes,Unknown,,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,deletion of 5q loss of 17p amplification of MLL loss of chromosome 18,4,Other,"44,XX,der(5;17)(q10;q10),-18[6]/44,idem,der(11)(11pter-- q23::q23-->q13::q13-->q23::q23-->11pter)[14]  amp KMT2A",No,N/A,,No,No,,,,Yes,3.1,Yes,,not in CR,CR,High Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVWRV,Male,White,Not Hispanic or Latino,719,Censored,1889,Alive,1889,2013,2018,AAML1031,11.2,50,5,Unknown,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAWAWL,Male,Unknown,Unknown,3267,Censored,624,Alive,624,2013,2015,AAML1031,25.9,63,5,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[10]/46,XY[10]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAVMES,Male,White,Not Hispanic or Latino,5013,Relapse,95,Dead,166,2013,2013,AAML1031,2.2,73,5,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,4,MLL,"46,XY,+5,der(1;5)(q10;p10),ins(10;11)(p12;q21q23)[17]/45,idem,add(2)(p11.2),-15[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWKXH,Female,White,Hispanic or Latino,1756,Relapse,530,Alive,1645,2014,2019,AAML1031,2.1,78,5,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"der(2)t(2;4)(q31;q28),del(6)(q25),t(16;21)(p11.2;q22.3)",3,Other,"46,XX,der(2)t(2;4)(q31;q28),t(16;21)(p11.2;q22.3)[17]/46,idem,del(6)(q25)[2]/46,XX[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVMNA,Female,White,Not Hispanic or Latino,6396,Relapse,1133,Dead,1206,2013,2016,AAML1031,16,79,5,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,1,Other,"47,XX,+8[20]",Yes,0.94,,No,No,,,,No,0,,,CR,CR,High Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXFDN,Female,Black or African American,Not Hispanic or Latino,692,Censored,1188,Alive,1188,2015,2018,AAML1031,6.4,84,5,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,hyper-Triploid with additional gain and loss of chromosomes,>6,Other,"79<3n>,XXX,+2,+3,+5,7,+14,+14,+14,+16,+17,18,+19,+20,+21,+22[10]/46,XX[12]",No,N/A,,No,No,,,,Yes,1.5,No,0,not in CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWGKS,Male,White,Not Hispanic or Latino,484,Relapse,233,Dead,473,2014,2015,AAML1031,25.9,95,5,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,Yes,2.5,Yes,1,CR,CR,Standard Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAWRYC,Male,White,Not Hispanic or Latino,533,Relapse,252,Alive,292,2014,2015,AAML1031,6.8,11,6,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"complex with +6, +20, del 13q",>6,Other,"48,XY,+6,del(8)(q24.2),add(12(p13),del(13)(q12q14),+21[1]/ 48,idem,-del(13)[6]/47,idem,-21[2]/46,idem,-6,add(12) (q22),-21[2]/50,idem,+20,+21[1]/46,XY[5] 3 nonclonal nonspecified",No,N/A,,No,No,,,,Yes,2.2999999999999998,No,0,not in CR,CR,Standard Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAXCNV,Female,Black or African American,Not Hispanic or Latino,695,Censored,1248,Alive,1248,2015,2018,AAML1031,17.7,30,6,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,t(11;17)(q13;q23),1,Other,"46,XX,t(11;17)(q13;q23)[18]/46,XX[2]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAXDXW,Female,White,Hispanic or Latino,838,Relapse,365,Dead,1221,2015,2018,AAML1031,7.8,32,6,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,"dic(1;5)(5pter->5q13::5q31->5q13:?:1p13->1qter),add(5)(q13), +10,der(17)t(5;17)(q13;q22),+X,+8,+15",6,Other,"46,XX,dic(1;5)(5pter->5q13::5q31->5q13:?:1p13->1qter),add(5)(q13),+10,der(17)t(5;17)(q13;q22)[4]/49,idem,+X,+8,+15[7]/46,XX[8]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVUPS,Male,White,Not Hispanic or Latino,3007,Censored,2021,Alive,2021,2013,2019,AAML1031,20,55,6,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,22,2,inv(16),"46,XY,inv(16)(p13.1q22)[22]/47,idem,+22[8]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAVXEB,Female,White,Not Hispanic or Latino,2526,Relapse,577,Dead,920,2013,2016,AAML1031,46.5,58,6,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,Yes,0.1,No,0,not in CR,CR,Standard Risk,Unknown,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAXCWZ,Female,Unknown,Hispanic or Latino,391,Induction failure,73,Dead,171,2015,2015,AAML1031,5.1,28,6,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,near triploid with gain of der(11) der(1;16)(q10;p10) resulting in gain of 1q,3,MLL,"63,XX, +der(1;16)(q10;p10),+2,+3,+4,+6,+6,+7,+8,t(9;11) (p22;q23),+der(11)t(9;11),+12,+13,+14,+15,+17,+18,+19,+22[8 ]/46.XX[12]",No,N/A,,No,No,,,,No,0,,,CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAWYJH,Male,White,Not Hispanic or Latino,1109,Relapse,101,Dead,172,2015,2015,AAML1031,6.6,14,7,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,Yes,No,No,No,No,Yes,No,No,"i(1)(q10),del(9)(q13q22)",3,MLL,"47,XY,+1,i(1)(q10),del(9)(q13q22),t(9;11)(p22;q23)[15]/46,XY[5]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWTRR,Female,White,Not Hispanic or Latino,4285,Censored,1175,Alive,1175,2014,2018,AAML1031,12.2,23,7,Yes,Unknown,,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,,1,Other,"46,XY,del(7)(q32q34)[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAWVLB,Female,White,Not Hispanic or Latino,231,Relapse,106,Dead,120,2015,2015,AAML1031,17.4,25,7,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,gain of 1q x2,4,t(8;21),"46,XY,add(1)(q21), der(8)ins(8;21)(q22;q22q22)inv(8) (p.11.2q24.1)inv(8)(?;?),der(20)t(1;20) (q21;q13.3),der(21)t(1;21)(q21;q22)[16]/46,idem.add(6)(q27)",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Low Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAVFEM,Female,White,Not Hispanic or Latino,1988,Relapse,74,Dead,759,2012,2014,AAML1031,23.9,28,7,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[21]",No,N/A,,No,No,,,,No,0,No,0,CR,not in CR,Standard Risk,No,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAWDDC,Female,Unknown,Hispanic or Latino,5587,Censored,1425,Alive,1425,2014,2017,AAML1031,7,29,7,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XX,t(8;21)(q22;q22)[19]/46,XX[1]",No,N/A,,No,No,,,,No,0.01,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAUSFM,Male,American Indian or Alaska Native,Hispanic or Latino,1645,Censored,2372,Alive,2372,2012,2018,AAML1031,6.5,30,7,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,cryp add(11)(q23).nuc ish MLL sep (del 3'MLL)",Yes,0.03,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAXCEV,Female,Black or African American,Not Hispanic or Latino,3512,Censored,1301,Alive,1301,2015,2018,AAML1031,3.9,41,7,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XX,t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAUYZY,Male,White,Not Hispanic or Latino,466,Relapse,251,Dead,308,2012,2013,AAML1031,6.1,90,7,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,2,Other,"46,XY,del(11)(q21q24),der(11)ins(11;11)(p15;q21q23)[11]/46,XX[9]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAXDBF,Female,White,Not Hispanic or Latino,7271,Censored,1071,Alive,1071,2015,2018,AAML1031,1.6,94,7,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,der(16)t(11;16)(q13.4;q24)t(11;17)(q23;q12);der(2)t(2;11)(q37;q13.4)t(11;17)(q23;q12),3,MLL,"46,XX,t(11;17)(q23;q12)[4]/46,idem,der(16)t(11;16)(q13.4;q24)t(11;17)(q23;q12)[15]/46,idem,der(2)t(2;11)(q37;q13.4)t(11;17)(q23;q12)[5]",No,N/A,,No,No,,,,Yes,53,No,0,not in CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWMSW,Female,White,Not Hispanic or Latino,749,Relapse,507,Alive,1516,2014,2018,AAML1031,6.1,69,7,Yes,Unknown,,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,Yes,No,No,"t(2;9)(q13;p22),+19",3,MLL,"47,XX,t(2;9)(q13;p22),t(10;11)(q22;q23),+19[18]/46,XX[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVUJA,Female,Black or African American,Not Hispanic or Latino,492,Relapse,390,Dead,550,2013,2014,AAML1031,4.9,15,8,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,del(6)(q21q25),1,Other,"46,XX,del(6)(q21q25)[9]/46,XX[11]",No,N/A,,No,No,,,,Yes,0.3,,,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAXMAY,Male,Black or African American,Not Hispanic or Latino,4202,Induction failure,76,Alive,837,2016,2018,AAML1031,1.1,21,8,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[30]",No,N/A,,No,No,,,,Yes,32,Yes,15,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAXBPF,Female,White,Not Hispanic or Latino,7598,Censored,1244,Alive,1244,2015,2018,AAML1031,10.5,23,8,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XX,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(6;9)(p23;q34); DEK-NUP214
TARGET-20-PAVYLW,Female,Unknown,Unknown,546,Relapse,333,Dead,365,2013,2014,AAML1031,8.4,27,8,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,Yes,2.2999999999999998,No,0,not in CR,CR,Standard Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAWKLB,Male,White,Not Hispanic or Latino,992,Relapse,346,Alive,1677,2014,2019,AAML1031,20.2,41,8,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,Yes,Yes,No,No,No,"[+Y,+14,+21,+22)]",6,inv(16),"48,XY,inv(16)(p13.1q22),+21,+22[21]/51,idem,+Y,+8,+14[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAVENG,Male,Asian,Not Hispanic or Latino,2433,Censored,1291,Alive,1291,2012,2016,AAML1031,6.1,45,8,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,,3,t(8;21),"45,X,-Y,inv(1)(p36.1q32),t(8;21)(q22;q22)[10]/46,XY[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAUVWV,Female,White,Not Hispanic or Latino,119,Censored,2159,Alive,2159,2012,2018,AAML1031,12.8,70,8,Yes,Unknown,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(11;19)(q23;p13.3)[17]/46,XX[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAUSLS,Male,Black or African American,Not Hispanic or Latino,6455,Censored,1680,Alive,1680,2012,2016,AAML1031,5.2,98,8,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,-10,2,MLL,"45,XY,-10, der(11) ins(11;?10)(q23;p12p14)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWEYY,Female,White,Not Hispanic or Latino,114,Relapse,74,Dead,435,2014,2015,AAML1031,13.6,100,8,Yes,Unknown,,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,der(10)ins(10;11)(p12;q23q23)t(10;11)(q24;q23),der(11)del(11)(q23q23)t(10;11)(q24;q23)[20]/46,XX[1]",No,N/A,,No,No,,,,Yes,0.1,No,0,CR,not in CR,Standard Risk,No,No,Yes,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWUKE,Female,White,Not Hispanic or Latino,4946,Death,85,Dead,85,2014,2015,AAML1031,22.6,53,8,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[21]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: Acute erythroid leukemia (Erythroleukemia, erythroid/myeloid)"
TARGET-20-PAWWYV,Female,Unknown,Hispanic or Latino,8397,Censored,114,Alive,114,2015,2015,AAML1031,3.6,24,9,Yes,Unknown,,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"45,XX,t(6;9)(p22;q34),der(13;14)(q10;q10)?C[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(6;9)(p23;q34); DEK-NUP214
TARGET-20-PAWEKU,Male,White,Not Hispanic or Latino,739,Censored,1653,Alive,1653,2014,2018,AAML1031,10.2,34,9,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"t(5;12;7)(p15.2;p12.3;q31.3),del(13)(q12q14) Note: t(7;12) was not marked because ETV6 is not rearranged.",2,Other,"46,XY,t(5;12;7)(p15.2;p12.3;q31.3),del(13)(q12q14)[17]/46,XY[3].cryp nuc ish del(5p15.1)(D5S23,D5S721)x1",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: Acute erythroid leukemia (Erythroleukemia, erythroid/myeloid)"
TARGET-20-PAVYFM,Female,Unknown,Hispanic or Latino,5884,Censored,1634,Alive,1634,2013,2018,AAML1031,60.6,43,9,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"t(1;4)(p34;q25),del(5)(p13),add(10)(q22),inv(16)(p13.1q13)",5,t(8;21),"46,XX,t(1;4)(p34;q25),del(5)(p13),t(8;21)(q22;q22),add(10)(q22),inv(16)(p13.1q13)[19]/46,XX[1]",No,N/A,,No,No,,,,No,0,,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAXIEP,Male,White,Not Hispanic or Latino,5855,Censored,1107,Alive,1107,2015,2018,AAML1031,9.5,74,9,Unknown,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAXJGA,Female,White,Not Hispanic or Latino,1206,Relapse,377,Alive,1129,2015,2018,AAML1031,9.3,19,10,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,22,2,inv(16),"47,XX,inv(16)(p13.1q22),+22[19]/46,XX[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAVDZI,Male,White,Hispanic or Latino,5875,Relapse,278,Alive,2394,2012,2019,AAML1031,16,21,10,Yes,Unknown,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(11;19)(q23;p13.1)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAWTLZ,Male,White,Not Hispanic or Latino,208,Censored,1134,Alive,1134,2014,2018,AAML1031,21,39,10,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,variant of the t(X;6)(p11.2;q23),1,Other,"46,Y,der(X)inv(X)(p11.2p21)t(X;6)(p11.2;q23),der(6)t(X;6) (p11.2;q23)[6]/46,XY[14]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAVGKS,Female,White,Not Hispanic or Latino,6907,Relapse,134,Dead,352,2012,2013,AAML1031,2.6,45,10,Yes,Unknown,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(11;19)(q23;p13.1)[12]/46,XX[11]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAWVLI,Male,White,Not Hispanic or Latino,4576,Censored,1225,Alive,1225,2015,2018,AAML1031,0.6,79,10,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,"-Y, i(1)(q10)",3,t(8;21),"45,X,add(8)(q22),der(14)(14p11.2->14q32::8q24.3->8q22::21q22->21q22->8q22->?),add(21)(q22)[15]/45,idem,i(1)(q10)[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVYUD,Female,Black or African American,Not Hispanic or Latino,1377,Censored,1925,Alive,1925,2013,2019,AAML1031,5.9,86,10,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[19]/46,XX[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAUZSY,Female,White,Not Hispanic or Latino,1390,Relapse,1034,Alive,2379,2012,2018,AAML1031,3.3,90,10,Yes,Unknown,,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,i(7)(p10),4,Other,"46,XX,del(7)(q31q36)[2]/46,XX,i(7)(p10)[15]/46,XX,t(4;16)(q23;q12.1),del(7)(q11.1q36)[21]/46,XX[5]",Yes,0.26,,No,No,,,,Yes,0.8,No,0,CR,CR,Standard Risk,Yes,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAUYIB,Male,White,Hispanic or Latino,746,Relapse,511,Alive,2324,2012,2018,AAML1031,4.6,91,10,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,ins(9;11)(p22;q14q23)[15]/46,XY[5]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVHWT,Male,White,Not Hispanic or Latino,467,Censored,1935,Alive,1935,2012,2018,AAML1031,17.1,93,10,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,ins(10;11)(p12;q23q13)[18]/46,XY[2]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAWLGJ,Male,Black or African American,Not Hispanic or Latino,393,Censored,1448,Alive,1448,2014,2018,AAML1031,119.3,18,11,Yes,Unknown,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,,N/A,Unknown,,No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAXECE,Male,American Indian or Alaska Native,Not Hispanic or Latino,2884,Censored,1286,Alive,1286,2015,2019,AAML1031,6.1,25,11,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,,1,Other,"46,XY,r(7)(p11.2q11.2)[6]/45,XY,-7[3]",No,N/A,,No,No,,,,,,No,0,unevaluable,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAWBAS,Male,Native Hawaiian or other Pacific Islander,Not Hispanic or Latino,7321,Relapse,680,Alive,785,2013,2016,AAML1031,6.5,25,11,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,1,Other,"47,XY,+8[19]/46,XY[1]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,Unknown,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAVSLI,Male,Asian,Not Hispanic or Latino,943,Induction failure,76,Dead,213,2013,2013,AAML1031,13.5,43,11,Yes,Unknown,,No,No,No,No,Yes,No,No,No,Yes,No,No,No,No,No,Yes,Yes,No,No,"+3,del(5)(q31q35),+6,+13,add(17)(p13),+19,+21,+22",>6,Other,"52,XY,+3,+6,t(9;11)(p22;q23),+13,add(17)(p13),+19,+21,+22[cp8]/52,idem,del(5)(q31q35)[3]/46,XY[4]",No,N/A,,No,No,,,,Yes,1,Yes,33,not in CR,not in CR,High Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAUUZT,Female,White,Hispanic or Latino,4934,Relapse,609,Alive,2218,2012,2018,AAML1031,11.1,63,11,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,del(9q),2,t(8;21),"46,XX,t(8;21)(q22;q22),del(9)(q13q22)[17]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVCCG,Female,Asian,Not Hispanic or Latino,1405,Relapse,104,Dead,482,2012,2013,AAML1031,2.3,76,11,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,t(2;10)(p13;p11.2),1,Other,"46,XX,t(2;10)(p13;p11.2)[15]/46,XX[5]",No,N/A,,No,No,,,,No,0,,,CR,unevaluable,Standard Risk,No,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXFMH,Male,White,Not Hispanic or Latino,5800,Censored,1223,Alive,1223,2015,2018,AAML1031,53.1,68,11,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAWIWJ,Female,White,Not Hispanic or Latino,6433,Censored,469,Alive,469,2014,2015,AAML1031,1.5,62,12,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAWEEB,Male,White,Not Hispanic or Latino,4664,Censored,1660,Alive,1660,2014,2018,AAML1031,20.7,65,12,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[24]",No,N/A,,No,No,,,,Yes,6.7,No,0,not in CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAVNUJ,Female,Asian,Hispanic or Latino,922,Death,164,Dead,164,2013,2013,AAML1031,7.5,26,13,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,,2,Other,"45,XX,-7,t(11;17)(q23;q21)[12]/46,XX[8]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAXETX,Female,Black or African American,Not Hispanic or Latino,10799,Censored,1149,Alive,1149,2015,2018,AAML1031,9.4,28,13,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[50]",Yes,0.01,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAVSCL,Male,White,Not Hispanic or Latino,4708,Censored,2003,Alive,2003,2013,2018,AAML1031,36.7,32,13,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XY,t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,No,0,,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAXFSI,Male,White,Not Hispanic or Latino,718,Censored,1235,Alive,1235,2015,2019,AAML1031,9.7,67,13,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XY,t(5;11)(q31;p15.5)[15]/46,XY[5]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAXBLW,Male,White,Not Hispanic or Latino,471,Relapse,205,Alive,1149,2015,2018,AAML1031,125.6,95,13,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,psu dic(3;1)(q29;p13) As a consequence of the dicentric there is gain of 1q and small DNA from 1p. Subtelomeric loss of 3q.,1,Other,"46,XY,+1,psu dic(3;1)(q29;p13)[14]/46,XY[6]",No,N/A,,No,No,,,,No,0,,,CR,unevaluable,Standard Risk,No,No,No,Yes,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXMPF,Female,White,Hispanic or Latino,4071,Death,103,Dead,103,2016,2016,AAML1031,3.2,40,13,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,1,Other,"47,XX,+8[20]",No,N/A,,No,No,,,,Yes,0.7,,,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAWCBZ,Female,Black or African American,Not Hispanic or Latino,5361,Relapse,444,Alive,1658,2013,2018,AAML1031,28.3,28,13,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,del(9q),2,t(8;21),"46,XX,t(8;21)(q22;q22),del(9)(q21q34)[20]",No,N/A,,No,No,,,,No,0.05,,,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAUVCB,Male,White,Not Hispanic or Latino,4599,Relapse,282,Dead,383,2012,2013,AAML1031,35.7,25,14,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,t(3;17)(p13;q25),2,t(8;21),"46,XY,t(2;21;8)(q37;q22;q22),t(3;17)(p13;q25)[20]",No,N/A,,No,No,,,,,,,,not in CR,CR,Low Risk,No,Yes,Yes,Yes,No,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVSHX,Male,White,Not Hispanic or Latino,6152,Relapse,476,Dead,623,2013,2015,AAML1031,1.8,96,14,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(9;11)(p22;q23)[9]/46,XY[12]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,Yes,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAXLLI,Female,White,Not Hispanic or Latino,312,Censored,1161,Alive,1161,2015,2019,AAML1031,31.3,20,15,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"+7,+14,+19.+22",>6,Other,"50-51,XX,t(2;8;7)(q11.2;q22;p15),t(5;15) (q35;q22),+der(7)t(2;8;7),+der(8)t(2;8;7),ins(12;8) (q22;q21.1q11.2),+14,der(15)t(5;15)?dup(15) (q15q22),+19.+22[cp9]/46,XX[11]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAWNYK,Female,White,Not Hispanic or Latino,606,Induction failure,13,Alive,1603,2014,2019,AAML1031,9.2,22,15,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XX,t(7;12)(q36;p13)[7]/46,XX[13]",No,N/A,,No,No,,,,,,,,not in CR,not in CR,Standard Risk,No,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWWMZ,Female,White,Not Hispanic or Latino,5567,Censored,1257,Alive,1467,2015,2019,AAML1031,53.7,33,15,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAUUMZ,Male,White,Not Hispanic or Latino,10355,Censored,1784,Alive,1784,2012,2017,AAML1031,17,37,15,Unknown,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,Yes,No,No,No,No,21,3,inv(16),"46,XY,inv(16)(p13.1q22)[7]/48,idem,+8,+21[11]/46,XY[8]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAVTFI,Female,White,Hispanic or Latino,666,Relapse,388,Dead,780,2013,2015,AAML1031,6.9,70,15,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"hyperdiploid, +14,+17,+19,+21",4,Other,"50,XX,+14,+17,+19,+21[12]/46,XX[8]",No,N/A,,No,No,,,,No,0.05,No,0,CR,CR,Standard Risk,No,Yes,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAWAMB,Female,White,Not Hispanic or Latino,763,Relapse,189,Dead,451,2013,2015,AAML1031,77.3,23,16,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,del 9q,1,Other,"46,XX,del(9)(q21.11q22.3)[20]",Yes,0.02,,No,No,,,,No,0,No,0,unevaluable,CR,Standard Risk,No,Yes,Yes,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAXKSZ,Female,White,Not Hispanic or Latino,6950,Censored,896,Alive,896,2015,2018,AAML1031,1.4,72,16,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,,No,N/A,,Yes,No,,,,No,0,No,0,not in CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: Acute erythroid leukemia (Erythroleukemia, erythroid/myeloid)"
TARGET-20-PAWMKF,Male,White,Not Hispanic or Latino,2126,Censored,1290,Alive,1290,2014,2018,AAML1031,19.2,72,16,Yes,Unknown,,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XY,t(6;9)(p22;q34)[18]/46,XY[2]",Yes,0.38,,No,No,,,,Yes,0.8,No,0,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(6;9)(p23;q34); DEK-NUP214
TARGET-20-PAVNPN,Female,Black or African American,Not Hispanic or Latino,516,Relapse,212,Dead,392,2013,2014,AAML1031,28,76,16,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,Yes,1.7,,,not in CR,unevaluable,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAWRSU,Female,White,Not Hispanic or Latino,6154,Censored,83,Alive,83,2014,2015,AAML1031,9.2,94,16,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,Yes,No,No,,2,MLL,"47,XX,+8,cryp ins(10;11)(p?11.2;q23q23)[18]/46,XX[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWZAU,Female,White,Not Hispanic or Latino,3407,Relapse,563,Alive,1295,2015,2018,AAML1031,20.9,76,16,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XX,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWNYM,Male,White,Not Hispanic or Latino,6028,Induction failure,178,Dead,232,2014,2015,AAML1031,1.5,38,17,Yes,Unknown,,No,No,No,No,No,No,No,No,No,Yes,No,No,No,Yes,No,No,No,No,"r(7)(p11.2q11.2),+8",2,Other,"46,XY,r(7)(p11.2q11.2)[11]/47,XY,+8[3]/46,XY[6]",No,N/A,,No,No,,,,Yes,0.1,Yes,,CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAVXSH,Male,Unknown,Not Hispanic or Latino,533,Censored,1754,Alive,1754,2013,2018,AAML1031,24.2,58,17,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,"del(5)(p13),i(7q),-13,-18,+21,+mar",6,Other,"47,XY,del(5)(p13),i(7)(q10),-13,+21,+mar[13]/46,idem,-18[3]/46,XY[4]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAXACP,Female,White,Not Hispanic or Latino,4306,Censored,1194,Alive,1194,2015,2018,AAML1031,6.4,73,17,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,2,Other,"47,+8,t(12;22)(p13;q12)[19]/46,XX[1]",No,N/A,,No,No,,,,Yes,56,,,not in CR,unevaluable,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAVCWT,Male,White,Not Hispanic or Latino,5803,Induction failure,72,Alive,2332,2012,2019,AAML1031,1.2,75,17,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,6p deletion  Gain of X could be constitutional. lab will f/u with peripheral blood study,2,Other,"47,XY,+X,del(6)(p21.3p25)[18]/46,XY[2]",No,N/A,,No,No,,,,Yes,12,Yes,38,not in CR,not in CR,Standard Risk,No,Yes,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAUTIK,Female,Unknown,Not Hispanic or Latino,2726,Censored,2358,Alive,2358,2012,2018,AAML1031,27.4,75,17,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XX,t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWNKT,Female,Black or African American,Not Hispanic or Latino,7521,Censored,1339,Alive,1339,2014,2018,AAML1031,4.4,39,17,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,1,Other,"47,XX,+8[1]/46,XX[19]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAXEWG,Male,White,Not Hispanic or Latino,6478,Censored,96,Alive,96,2015,2015,AAML1031,5.5,33,18,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,Yes,No,,,,No,0,,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAWLER,Male,Black or African American,Not Hispanic or Latino,7464,Censored,1260,Alive,1260,2014,2017,AAML1031,3,60,18,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"+4,+13",2,Other,"48,XY,+4,+13[5]/46,XY[15]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAWTJU,Female,Asian,Not Hispanic or Latino,6736,Censored,1209,Alive,1209,2014,2018,AAML1031,3.3,71,18,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,-X,2,t(8;21),"45,X,-X,t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,Yes,0.1,,,CR,unevaluable,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWNIX,Male,White,Not Hispanic or Latino,957,Relapse,259,Dead,805,2014,2016,AAML1031,6.9,91,18,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,"del(1)(p13p22),dic(11;17)(p11.2;p11.2)",3,inv(16),"46,XY,inv(16)(p13.1q22)[1]/45,idem,del(1)(p13p22), dic(11;17)(p11.2;p11.2)[9]",No,N/A,,No,No,,,,Yes,0.1,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAVPUY,Male,White,Not Hispanic or Latino,399,Censored,2162,Alive,2162,2013,2019,AAML1031,11.2,62,18,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,2,Other,"47,XY,t(7;12)(q36;p13),+19[20]",No,N/A,,No,No,,,,No,0,,,CR,unevaluable,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWXWC,Male,Asian,Not Hispanic or Latino,2583,Censored,1221,Alive,1221,2015,2018,AAML1031,5.3,24,19,Yes,Unknown,,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XY,t(6;9)(p22;q34)[18]/46,XY[1]",Yes,7.0000000000000007E-2,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(6;9)(p23;q34); DEK-NUP214
TARGET-20-PAXMCG,Female,White,Hispanic or Latino,3275,Relapse,308,Dead,483,2016,2017,AAML1031,2,34,19,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,del(9)(q21.1q22.3),1,Other,"46,XX,del(9)(q21.1q22.3)[8]/46,XX[14]",Yes,0.14000000000000001,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAWZHY,Male,White,Not Hispanic or Latino,579,Censored,1217,Alive,1217,2015,2018,AAML1031,62,39,19,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,22,2,inv(16),"46,XY,inv(16)(p13.1q22)[4]/47,idem,+22[16]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAXMAD,Male,Black or African American,Not Hispanic or Latino,3126,Relapse,386,Alive,932,2016,2018,AAML1031,90.4,56,19,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,Yes,No,No,No,Yes,No,No,No,No,"[+22,i(22)(q10)]",5,inv(16),"46,XY,inv(16)(p13.1q22)[1]/47,idem,+22[8]/46,idem,i(22)(q10)[6]/46,idem,del(7)(q32)[2]/47,idem,del(7)(q32),+8[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,Yes,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAWYJF,Female,White,Not Hispanic or Latino,6394,Censored,1333,Alive,1333,2015,2018,AAML1031,1.7,66,19,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XX,t(8;21)(q22;q22)[11]/46,XX[4]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVACZ,Female,White,Not Hispanic or Latino,2844,Relapse,300,Dead,311,2012,2013,AAML1031,39,93,19,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[30]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAWIZG,Male,Unknown,Hispanic or Latino,6522,Censored,1755,Alive,1755,2014,2019,AAML1031,30.4,27,20,Yes,Unknown,,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XY,t(6;9)(p22;q34)[20]",No,N/A,,No,No,,,,Yes,0.1,No,0,not in CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(6;9)(p23;q34); DEK-NUP214
TARGET-20-PAVNGY,Male,Unknown,Unknown,4831,Censored,1952,Alive,1968,2013,2018,AAML1031,6.7,30,20,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAWYEP,Female,White,Not Hispanic or Latino,6974,Censored,1457,Alive,1457,2015,2019,AAML1031,8.1,37,20,Yes,Unknown,,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XX,t(6;9)(p22;q34)[19]/46,XX[1]",Yes,0.36,,No,No,,,,,,,,CR,unevaluable,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(6;9)(p23;q34); DEK-NUP214
TARGET-20-PAVLDU,Female,Unknown,Unknown,6092,Relapse,195,Alive,2032,2013,2018,AAML1031,16.6,58,20,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,Unknown,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAVCCX,Male,White,Not Hispanic or Latino,603,Relapse,185,Alive,2254,2012,2018,AAML1031,5,61,20,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,2,MLL,"46,XY,t(7;20)(p22;q11.2),t(9;11)(p22;q23)[20]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,No,Yes,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAXLDI,Female,Unknown,Not Hispanic or Latino,381,Censored,915,Alive,915,2015,2018,AAML1031,14.5,93,20,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,6,2,MLL,"46,X,t(X;11)(q24;q23)[18]/47,idem,+6[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAVUHF,Female,Unknown,Unknown,5294,Censored,1655,Alive,1655,2013,2018,AAML1031,3.9,95,20,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[15]/92,XXXX[5]",No,N/A,,No,No,,,,Yes,2.8,No,0,CR,unevaluable,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAWHJP,Female,White,Not Hispanic or Latino,4087,Relapse,188,Dead,505,2014,2015,AAML1031,5.4,,20,Yes,Unknown,,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,~4n [other abnormalities could not be ruled-out],2,Other,"~4n,XXXX,del(7)(q32)x2,inc[cp20].nuc ish CBFBx5-6,RUNX1x3",No,N/A,,No,No,,,,Yes,0.6,No,0,CR,CR,Standard Risk,Yes,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAXBCW,Female,White,Not Hispanic or Latino,2077,Censored,1205,Alive,1205,2015,2018,AAML1031,9.5,35,21,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,deletion 9q (lab had as marker),3,t(8;21),"variant complex t(8;21)   46,XX,der(3)t(3;4)(p21;q31.1)cryp ins(3;8) (p21;q21.3q21.3),der94)t(3;4)(p21;q31.1),der(8)t(8;21) (q22;q22),del(9)(q13q22),der(21)t(8;21)cryp del(21)(q22q22) [18]/46,XX[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWVVJ,Female,Asian,Not Hispanic or Latino,651,Censored,1314,Alive,1314,2015,2018,AAML1031,9.4,39,21,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,Yes,No,No,No,hyperdiploid del 6q,>6,Other,"59,XX,+1,+2,+4,+add(6)(q13),+7,+add(8) (q22),+10,+13,+14,der(17)t(5;17) (p14;q22),+18,+19,+21,+22[11]/46,XX[11]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAVXLY,Female,White,Not Hispanic or Latino,5319,Relapse,218,Dead,296,2013,2014,AAML1031,97.9,47,21,Yes,Unknown,,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(6;11)(q27;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,No,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXHDA,Male,Black or African American,Not Hispanic or Latino,6734,Censored,950,Alive,950,2015,2018,AAML1031,6.8,60,21,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,Yes,No,No,No,No,No,No,No,No,,2,inv(16),"46,XY,add(7)(q31),inv(16)(p13.1q22)[10]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAVGUM,Female,Black or African American,Not Hispanic or Latino,3653,Censored,1999,Alive,1999,2012,2018,AAML1031,22.3,68,21,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWRVC,Male,White,Not Hispanic or Latino,3560,Relapse,504,Alive,1289,2014,2018,AAML1031,63.5,79,21,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(9;11)(p22;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVDZL,Female,White,Not Hispanic or Latino,4781,Induction failure,97,Dead,238,2012,2013,AAML1031,80.3,20,22,Yes,Unknown,,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,,1,Other,"46,XX,del(5)(q15q35.3)[20]",No,N/A,,No,No,,,,Yes,36,,,not in CR,not in CR,High Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVNYE,Female,White,Not Hispanic or Latino,5117,Censored,707,Alive,707,2013,2015,AAML1031,24.3,42,22,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,Yes,No,No,No,No,del 9q,3,t(8;21),"46,XX,t(2;21;8)(q21;q22;q22[2]/46,idem,del(9)(q13q22)[15]/47,idem,+8[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAXIYA,Male,Black or African American,Not Hispanic or Latino,2598,Relapse,333,Alive,1110,2015,2018,AAML1031,42.5,60,22,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,,1,Other,"45,XY,-7[20]",No,N/A,,No,No,,,,Yes,21,Yes,35,not in CR,CR,High Risk,Unknown,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVXPB,Male,White,Not Hispanic or Latino,744,Relapse,334,Alive,1901,2013,2018,AAML1031,9.9,68,22,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"+6, +19  Follow up FISH with probe to ETV6 confirmed t(7;12)  48% interphase cells had rearrangement of ETV6 SCR checked t(7;12) above 4-9-14.",4,Other,"49,XY,+6,t(7;12)(q36;p13),+16,+19[20]",No,N/A,,No,No,,,,No,0.03,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,Yes,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAXJTM,Female,White,Hispanic or Latino,2130,Censored,1136,Alive,1136,2015,2018,AAML1031,137.8,74,22,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,Yes,No,No,No,No,deletion of 7q35-7q36,3,inv(16),"47,XX,del(7)(q35q36.2),+8,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWIUT,Male,White,Not Hispanic or Latino,5519,Censored,1614,Alive,1614,2014,2018,AAML1031,3.8,52,22,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAVKZH,Female,White,Unknown,6468,Death,124,Dead,124,2013,2013,AAML1031,6.3,24,23,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XX,t(8;21)(q22;q22)[17]/46,XX[3]",No,N/A,,No,No,,,,,,,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAUSTM,Female,Asian,Not Hispanic or Latino,3126,Censored,2350,Alive,2350,2012,2018,AAML1031,21.6,43,23,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,,2,t(8;21),"45,X,-X,cryp ins(8;21)(q22;q22)[20]/46,XX.ish  ins(8;21)(q22;q22q22)(RUNX1T1+,RUNX1+;RUNX1+;RUNX1T1-)",No,N/A,,No,No,,,,No,0,,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAXGHE,Female,White,Not Hispanic or Latino,314,Relapse,216,Dead,1004,2015,2018,AAML1031,11.6,90,23,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[19]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,Unknown,No,Yes,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVPJM,Male,White,Not Hispanic or Latino,3527,Censored,1946,Alive,1946,2013,2018,AAML1031,36.5,83,24,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,Yes,No,No,No,No,"+14,+21",4,inv(16),"49,XY,+8,+14,inv(16)(p13.1q22),+21[18]/46,XY[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAUPNN,Female,White,Not Hispanic or Latino,5591,Relapse,448,Alive,2590,2011,2019,AAML1031,7.4,17,25,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,del(9)(q13q22),2,t(8;21),"46,XX,t(8;21)(q22;q22),del(9)(q13q22)[15]/46,XX[5]",No,N/A,,No,No,,,,No,0,,,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWNMU,Female,White,Not Hispanic or Latino,873,Relapse,501,Dead,712,2014,2016,AAML1031,36.9,25,25,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,"+6,+19,+22  del 9q",5,MLL,"49,XX,+6,t(8;11;10)(q22;q23;q22),del(9) (p21),+19,+22[15]/46,XX[5]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAWBSE,Male,Black or African American,Not Hispanic or Latino,6528,Relapse,393,Alive,1653,2013,2018,AAML1031,127,38,25,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,Unknown,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAVXZS,Female,White,Not Hispanic or Latino,2997,Death,207,Dead,207,2013,2014,AAML1031,5,43,25,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,"+6,-X",3,t(8;21),"45,X,-X,t(8;12;21)(q22;p12;q22){2]/46,idem,+6[16]/46,XX[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAUWYG,Male,Unknown,Not Hispanic or Latino,3034,Censored,2149,Alive,2149,2012,2018,AAML1031,44.6,45,25,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[5]/46,XY[11]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAVTDU,Female,White,Not Hispanic or Latino,4243,Relapse,434,Alive,2053,2013,2019,AAML1031,29,50,25,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XX,der(8)inv(8)(p22q24.2)inv(8)(q12q22)inv(8)(q21.3q24.2)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWXSL,Female,White,Not Hispanic or Latino,1337,Censored,507,Alive,507,2015,2016,AAML1031,5.6,97,25,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.43,,Yes,No,,,,Yes,1,No,,CR,CR,High Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAWMEZ,Male,Asian,Not Hispanic or Latino,7266,Censored,1395,Alive,1395,2014,2018,AAML1031,3.1,35,26,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,Yes,19,Yes,,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVMFT,Female,White,Not Hispanic or Latino,4489,Death,96,Dead,96,2013,2013,AAML1031,10.2,62,26,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XX,t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWTGF,Male,White,Not Hispanic or Latino,4521,Censored,1259,Alive,1259,2014,2018,AAML1031,92,66,26,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAUVEF,Male,Black or African American,Hispanic or Latino,6720,Relapse,253,Dead,257,2012,2012,AAML1031,80.4,88,26,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,2.11,,No,No,,,,Yes,54,Yes,,not in CR,CR,High Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAWLII,Male,White,Hispanic or Latino,4448,Censored,1622,Alive,1622,2014,2018,AAML1031,46.2,22,27,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,t(16;16)(p13.1;q22)[19]/46,XY[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWHAB,Female,Unknown,Unknown,5274,Censored,1661,Alive,1661,2014,2018,AAML1031,4.7,58,27,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,Yes,"del 9q, -X",3,t(8;21),"45,X,-X,t(8;17;21)(q22;q25;q22)[8]/45,sl,del(9)(q21q22) [8]/46,sdl1,+X[3]/46,XX[1]   * one cell in this clone is tetraploid",No,N/A,,No,No,,,,No,0,,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVELC,Female,White,Not Hispanic or Latino,7106,Relapse,108,Dead,861,2012,2015,AAML1031,2.6,76,27,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,,2,Other,"45,XX,t(3;3)(q21;q26.2),-7[19]/46,XX[1]",No,N/A,,No,No,,,,Yes,42,Yes,,not in CR,CR,High Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVDGM,Male,White,Not Hispanic or Latino,5971,Relapse,578,Alive,2182,2012,2018,AAML1031,2.7,22,28,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[29]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAUMMR,Male,White,Not Hispanic or Latino,7180,Censored,1311,Alive,1311,2011,2015,AAML1031,47.2,56,28,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[30]",Yes,0.12,,No,No,,,,Yes,16,,,not in CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAWXYG,Female,Native Hawaiian or other Pacific Islander,Not Hispanic or Latino,4634,Relapse,105,Alive,1269,2015,2018,AAML1031,21.7,67,28,Yes,Unknown,,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,"+4,+6,+der(6),+21",6,MLL,"46,XX,t(6;11)(q27;q23)[3]/50,idem,+6,+der(6)t(6;11),+19,+21[14]/50,idem,+4,+der(6)t(6;11),+19,+21[5]/46,XX[3]",No,N/A,,No,No,,,,Yes,0.1,,,CR,CR,Standard Risk,No,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAXDNA,Male,White,Not Hispanic or Latino,1261,Censored,1243,Alive,1243,2015,2018,AAML1031,14.6,42,28,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,,2,t(8;21),"46,XY,del(7)(q34q36),t(8;20;21)(q22;q13.2;q22)[17]/46,XY[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAULNJ,Male,Unknown,Not Hispanic or Latino,4771,Censored,408,Alive,408,2011,2012,AAML1031,13.1,52,29,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XY,t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVFWI,Female,Asian,Not Hispanic or Latino,6050,Censored,2326,Alive,2326,2012,2019,AAML1031,3.4,55,29,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,del(2)(q33),2,t(8;21),"46,XX,del(2)(q33),t(8;21)(q22;q22)[15]/46,XX[5]",No,N/A,,No,No,,,,No,0,No,0,unevaluable,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVLEG,Male,White,Not Hispanic or Latino,309,Induction failure,24,Dead,276,2013,2013,AAML1031,20.2,72,29,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,Yes,No,No,"add(3)(p14),der(9)add(9)(p22)add(9)(q13),add(11)(q23),der(16)(3pter->3p14::11q23->11q23::16p13.3->16qter),del(9)(q12q22)",5,MLL,"46,XY,add(3)(p14),der(9)add(9)(p22)add(9)(q13),add(11)(q23),der(16)(3pter->3p14::11q23->11q23::16p13.3->16qter)[9]/46,idem,add(12)(p11.2)[7]/46,idem,del(9)(q12q22)[2]/46,XY[1]",No,N/A,,No,No,,,,,,,,not in CR,not in CR,Standard Risk,No,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWNSL,Female,White,Hispanic or Latino,7648,Censored,1322,Alive,1322,2014,2018,AAML1031,78.9,20,30,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,-X,2,t(8;21),"45,X,-X,t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,No,0.06,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWEFT,Male,White,Not Hispanic or Latino,2379,Relapse,1624,Alive,1672,2014,2018,AAML1031,2.5,32,30,Yes,Unknown,,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,"r(7)(p14q21),+21",2,Other,"47,XY,r(7)(p14q21),+21[9]/46,XY[1]",No,N/A,,No,No,,,,Yes,2,Yes,,not in CR,CR,Standard Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWABG,Female,White,Not Hispanic or Latino,4811,Censored,1953,Alive,1953,2013,2019,AAML1031,9.4,36,30,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XX,t(8;21)(q22;q22)[17]/46,XX[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVCFR,Female,White,Not Hispanic or Latino,5073,Censored,2329,Alive,2329,2012,2018,AAML1031,116.4,70,30,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XX,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAUYXM,Male,White,Not Hispanic or Latino,2840,Censored,2366,Alive,2366,2012,2018,AAML1031,3.2,78,30,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,5,Other,"46,XY,t(5;12)(p13;p13),add(8)(q24),-9,+10[14]/47,idem,+9[2]/93,(idem x 2)[14]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAUUXA,Female,White,Not Hispanic or Latino,4617,Censored,2394,Alive,2394,2012,2018,AAML1031,1.2,80,30,Yes,Unknown,,No,No,No,No,No,No,No,No,Yes,No,No,No,No,Yes,No,No,No,No,,5,Other,"47,XX,t(2;11)(q37;q23),add(5)(q11.2),+8,del(12)(p11.2),del(13)(q12q14)[18]/46,XX[2]",No,N/A,,No,No,,,,No,0.05,No,0,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAUHFI,Female,Black or African American,Not Hispanic or Latino,722,Relapse,257,Dead,276,2011,2012,AAML1031,29.8,83,30,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[20]",No,N/A,,No,No,,,,Yes,1.7,No,0,CR,CR,Standard Risk,Yes,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAWXCK,Female,Unknown,Not Hispanic or Latino,3207,Censored,1299,Alive,1299,2015,2018,AAML1031,2.9,84,30,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,X,t(X;11)(q24;q23.3)[17]/46,XX[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAVMCA,Female,White,Not Hispanic or Latino,6542,Censored,1990,Alive,1990,2013,2018,AAML1031,136.8,,30,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XX,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWUCF,Male,White,Hispanic or Latino,1632,Induction failure,69,Dead,163,2014,2015,AAML1031,155,28,31,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,Yes,68,Yes,45,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWHUE,Male,White,Hispanic or Latino,9119,Relapse,313,Dead,817,2014,2016,AAML1031,8.3,50,31,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWNHW,Male,Asian,Not Hispanic or Latino,5151,Relapse,205,Dead,247,2014,2015,AAML1031,16.6,76,31,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,polyploid,>6,MLL,"85,XXYY,r(7)(p15.2q34),-9,-10,-10,-11,-11,add(11)q23,-12,-13,del(17)(p11.2)[cp17]/46,XY[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAXMLI,Male,White,Not Hispanic or Latino,6271,Relapse,802,Dead,1016,2016,2018,AAML1031,10.1,,31,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,Yes,No,"-Y, t(8;18)(p11.2;p11.2),del(12)(p12p13) [unknown if the t(8;18) is constitutional or not]",4,MLL,"45,X,-Y, t(8;18)(p11.2;p11.2),ins(10;11)(p13;q13q23),del(12)(p12p13)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVXDS,Female,White,Not Hispanic or Latino,7773,Death,129,Dead,129,2013,2014,AAML1031,1.3,62,31,Yes,Unknown,,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,del 9p resulting in biallelic loss of CDKN2A,>6,Other,"46,XX,del(4)(q25q34),i(6)(p10),r(7)(?p13?q21),del(9) (p13p24)[1]/83,slx2,-5,-i(6)(p10),+7,- r(7),-8,-11,-12,-14,-15,-18,-22[13],46,XX[13]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAUVXT,Male,White,Not Hispanic or Latino,4761,Relapse,145,Dead,251,2012,2012,AAML1031,219.4,,31,Unknown,Unknown,,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(6;11)(q27;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVPLI,Female,Unknown,Not Hispanic or Latino,7001,Censored,2175,Alive,2175,2013,2019,AAML1031,5.9,39,32,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,Yes,-X,5,t(8;21),"46,XX,t(8;21)(q22;q22)[12]/45,idem,-X[5]/49,XX,+4,+8,+8[3]/46,XX[1]",No,N/A,,No,No,,,,Yes,1.7,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAUNVN,Female,White,Not Hispanic or Latino,7284,Censored,2341,Alive,2341,2011,2018,AAML1031,15.3,60,32,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.33,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAVKFD,Female,Unknown,Not Hispanic or Latino,1638,Censored,2163,Alive,2163,2013,2018,AAML1031,6.1,61,32,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,"inv(7)(q22q36),del(9)(q22q32),+del(9)(q22q32)",4,t(8;21),"47,XX,inv(7)(q22q36),t(8;21)(q22;q22),del(9)(q22q32),+del(9)(q22q32)[18]/46,XX[2]",Yes,0.03,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAVMWJ,Male,White,Hispanic or Latino,7547,Induction failure,55,Dead,161,2013,2013,AAML1031,5,73,32,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,4,t(8;21),"47,XY,t(8;14;21)(q22;p11.2;q22),+13,add(13)(p11.2),del(17)(q22)[15]/46,XY[6]",No,N/A,,No,No,,,,Yes,93,Yes,77,not in CR,not in CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAXMBS,Female,Native Hawaiian or other Pacific Islander,Not Hispanic or Latino,4047,Censored,820,Alive,820,2016,2018,AAML1031,93.7,30,32,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,gain of 15q,2,t(8;21),"46,XX,t(8;21)(q22;q22)[15]/46,idem,der(3)t(3;15)(q29;q11.2) [5]",No,N/A,,No,No,,,,Yes,7.8,Yes,,CR,CR,Low Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWRIY,Female,Asian,Not Hispanic or Latino,5974,Death without remission,21,Dead,21,2014,2014,AAML1031,9,54,32,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,,,,,death,death,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWESF,Male,White,Not Hispanic or Latino,3628,Censored,1679,Alive,1679,2014,2018,AAML1031,5.9,21,33,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,2,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[16]/46,XY[4]",No,N/A,,No,No,,,,No,0.03,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVAFJ,Male,Black or African American,Not Hispanic or Latino,5470,Censored,2121,Alive,2121,2012,2018,AAML1031,6.5,22,33,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,2,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[12]/46,XY[8]",No,N/A,,No,No,,,,No,0,,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWGEG,Female,White,Not Hispanic or Latino,5470,Censored,1756,Alive,1756,2014,2019,AAML1031,15.1,31,33,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.16,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAVXFA,Male,Unknown,Hispanic or Latino,1767,Death,127,Dead,127,2013,2014,AAML1031,71.1,44,33,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"+6,+13,+19",4,t(8;21),"46,XY,t(8;21)(q22;q22)[18]/49,idem,+6,+13,+19[2]",No,N/A,,No,No,,,,No,0,,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVWJY,Male,Black or African American,Not Hispanic or Latino,632,Relapse,146,Dead,519,2013,2015,AAML1031,18.3,81,33,Yes,Unknown,,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,Yes,Yes,No,"-Y,add(8)(p21),der(11)t(11;*11)(p11.2;q22),der(12)t(8;12)(q11.2;p12)[10]",5,MLL,"46,XY,add(8)(p21),der(10)t(10;11)(p11.2;q23),der(11)t(11;*11)(p11.2;q22),der(11)(?->11p11.2->11q23::*11q22->11q24*::?)[5]/45,idem,-Y[4]/46,idem,der(12)t(8;12)(q11.2;p12)[10]",No,N/A,,No,No,,,,No,0,No,0,not in CR,unevaluable,Standard Risk,No,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVWPW,Male,White,Not Hispanic or Latino,383,Induction failure,77,Dead,279,2013,2014,AAML1031,8.7,32,33,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,"+6,+8,del(10)(q22),add(11)(q21),del(13) (q12q14),der(17)t(11;17)(q13;p13.3)",6,Other,"48,XY,+6,+8,del(10)(q22),add(11)(q21),del(13)(q12q14),der(17)t(11;17)(q13;p13.3)[5]/46,XY[15]",No,N/A,,No,No,,,,Yes,3.6,Yes,12,CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAVBEM,Female,White,Hispanic or Latino,1681,Censored,2090,Alive,2090,2012,2018,AAML1031,6.3,59,34,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,>6,t(8;21),"46,X,der(X)add(X)(p22.1)ins(X;?)(q22;?)t(X;14)(q22;q11.2),t(1;8)(q25;q24.1),add(4)(p16),t(8;21)(q22;q22),-10,add(14)(q11.2),+mar[19]/46,XX[4]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVANX,Female,White,Not Hispanic or Latino,1408,Censored,2216,Alive,2216,2012,2018,AAML1031,22.5,86,34,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,add(19)(q13.3),2,Other,"47,XX,+8,add(19)(q13.3)[19]/46,XX[2]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXJPP,Female,White,Not Hispanic or Latino,416,Induction failure,90,Dead,395,2015,2016,AAML1031,35.1,94,34,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,inv(7)(p13q36),1,Other,"46,XX,inv(7)(p13q36)[18]/92<4n>,idemx2[2]/46,XX[1]",No,N/A,,No,No,,,,Yes,0.1,No,,CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWWUN,Female,White,Unknown,4114,Censored,1182,Alive,1182,2015,2018,AAML1031,77.5,32,35,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,-X,2,t(8;21),"45,X,-X,t(8;21)(q22;q22)[18]/46,XX[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWSRG,Male,Black or African American,Not Hispanic or Latino,343,Relapse,372,Alive,1502,2014,2018,AAML1031,54,45,35,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(q13q22) cryp ins(16)(q22p13.1p13.1)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,Yes,No,No,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAUURD,Male,White,Not Hispanic or Latino,1543,Censored,2521,Alive,2521,2012,2019,AAML1031,88.6,45,35,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAXMCV,Male,Black or African American,Not Hispanic or Latino,3668,Censored,898,Alive,898,2016,2018,AAML1031,4.1,78,35,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,2,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[20]  [RUNX1T1 loss]",No,N/A,,No,No,,,,Yes,1.8,Yes,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAXMNR,Male,White,Not Hispanic or Latino,721,Relapse,168,Dead,454,2016,2017,AAML1031,36.9,66,36,Yes,Unknown,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(11;19)(q23;p13.3)[20]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,No,Yes,Yes,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVANT,Female,White,Not Hispanic or Latino,6512,Death,149,Dead,149,2012,2012,AAML1031,8.8,70,36,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,Yes,,,,No,0,,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWMRJ,Female,White,Not Hispanic or Latino,5161,Censored,1637,Alive,1637,2014,2019,AAML1031,51.8,73,36,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[25]",No,N/A,,Yes,No,,,,Yes,0.4,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVVTF,Male,White,Hispanic or Latino,3713,Censored,1652,Alive,1652,2013,2018,AAML1031,21.5,76,36,Yes,Unknown,,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,4,2,MLL,"46,XY,t(6;11)(q27;q23)[11]/47,idem,+4[9]",No,N/A,,No,No,,,,Yes,0.7,No,0,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXHZL,Female,White,Not Hispanic or Latino,6777,Relapse,888,Alive,1159,2015,2018,AAML1031,2.6,77,36,Yes,Unknown,,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,add(10)(p14),2,Other,"46,XX,del(5)(q31.1q31.3),add(10)(p14)[5]/46,XX[15]",No,N/A,,No,No,,,,No,0,,,CR,unevaluable,High Risk,Yes,No,No,Yes,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAUWCF,Male,White,Not Hispanic or Latino,492,Relapse,2037,Alive,2294,2012,2018,AAML1031,151.8,95,36,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,t(2;7)(p15;p22),1,Other,"46,XY,t(2;7)(p15;p22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAXKAH,Female,Black or African American,Not Hispanic or Latino,3301,Censored,905,Alive,905,2015,2018,AAML1031,104.1,33,37,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,,1,Other,"45,XX,inv(2)(p21q21)c,-7[20]",No,N/A,,No,No,,,,,,,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVWFA,Female,White,Not Hispanic or Latino,4662,Relapse,272,Alive,1941,2013,2018,AAML1031,6.4,38,37,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,2,t(8;21),"46,XX,t(8;21)(q22;q22)[14]/45,idem,-X[6]",No,N/A,,No,No,,,,No,0.01,,,CR,CR,Low Risk,No,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWHFV,Male,White,Not Hispanic or Latino,208,Censored,1573,Alive,1573,2014,2018,AAML1031,4.1,58,37,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,Y,cryp ins(X;11)(q24;q23.3q23.3)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXLXI,Male,White,Not Hispanic or Latino,6036,Relapse,918,Alive,922,2015,2018,AAML1031,20.2,84,37,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAVXNZ,Male,White,Not Hispanic or Latino,821,Censored,122,Alive,122,2013,2014,AAML1031,26,39,39,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"der(1)t(1;1)(p13;q25)t(1;13)(q23;q14),inv(1)(p13p31),t(7;13)(q31;q21),der(10)(10pter->10q26::1p11->1q23::13q13->13qter), der(13)t(1;13)(p12;q12),del(13)(q12.3q14.3),",6,Other,"46,XY,der(1)t(1;1)(p13;q25)t(1;13)(q23;q14),inv(1)(p13p31),t(7;13)(q31;q21),der(10)(10pter->10q26::1p11->1q23::13q13->13qter),der(13)t(1;13)(p12;q12),del(13)(q12.3q14.3),del(17)(p11.2p13)[9]",No,N/A,,No,No,,,,Yes,1.2,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAWDTR,Female,White,Hispanic or Latino,6241,Induction failure,76,Dead,214,2014,2014,AAML1031,46.8,41,40,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,Yes,No,No,No,"+7,+10,+12,+21,+21,+22",>6,Other,"50,XX,+8,+10,+21,+21[4]/53,XX,+7,+8,+10,+12,+21,+21,+22[1]/46,XX[15]",No,N/A,,No,No,,,,Yes,38,,,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAWWID,Male,White,Not Hispanic or Latino,1570,Censored,1135,Alive,1135,2015,2018,AAML1031,33,58,40,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,Yes,Yes,No,No,No,No,21,3,Other,"45,XY,-7[18]/47,idem,+8,+21[2]",No,N/A,,No,No,,,,Yes,17,Yes,,not in CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAUYRR,Male,White,Not Hispanic or Latino,5657,Relapse,544,Alive,2248,2012,2018,AAML1031,56.9,67,40,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,Unknown,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAVINA,Male,White,Not Hispanic or Latino,1244,Censored,1956,Alive,1956,2012,2018,AAML1031,9.9,72,40,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,del 9q,2,t(8;21),"46,XY,t(8;21)(q22;q22)[12]/46,idem,del(9)(q22q34)[2]/46,XY[6]",Yes,0.08,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVSEJ,Male,White,Not Hispanic or Latino,4360,Censored,1917,Alive,1917,2013,2018,AAML1031,31.3,52,41,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XX,inv(16)(p13.1q22.1)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAVGDM,Female,White,Not Hispanic or Latino,4029,Relapse,853,Alive,1954,2012,2018,AAML1031,36.5,75,41,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[11]/46,XX,cryp del(15)(q24q24)[8]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAVCRM,Female,White,Not Hispanic or Latino,1150,Censored,2297,Alive,2297,2012,2018,AAML1031,15.9,73,42,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,,No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAVXRM,Male,White,Not Hispanic or Latino,2599,Induction failure,82,Dead,325,2013,2014,AAML1031,30.4,55,43,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,6,1,Other,"47,XY,+6[9]/46,XY[11]",Yes,0.09,,No,No,,,,Yes,3.2,Yes,18,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWCCR,Male,Asian,Not Hispanic or Latino,7238,Relapse,521,Alive,1677,2013,2018,AAML1031,8.9,75,43,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,"del(9q),der(15)t(11;15)(q12;p11.2)",2,Other,"46,XY,der(15)t(11;15)(q12;p11.2)[5]/46,idem,del(9)(q13q22)[14]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,No,Yes,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVNAN,Male,White,Hispanic or Latino,4723,Censored,1937,Alive,1937,2013,2018,AAML1031,14.7,62,43,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,1,Other,"46,XY[19]/47,XY,+8[1]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAVBCV,Female,White,Hispanic or Latino,454,Relapse,105,Dead,178,2012,2013,AAML1031,99.8,49,44,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,,1,Other,"45,XX,-7[20]",No,N/A,,No,No,,,,Yes,0.4,,,CR,CR,High Risk,No,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVELT,Female,White,Not Hispanic or Latino,5320,Relapse,703,Alive,2282,2012,2018,AAML1031,22.9,58,44,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,Yes,No,No,No,No,21,3,inv(16),"46,XX,inv(16)(p13.1q22)[13]/47,idem,+21[1]/48,idem,+8,+21[4]/46,XX[2]",No,N/A,,No,No,,,,No,0,,,CR,unevaluable,Low Risk,No,Yes,No,No,No,Yes,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWCXR,Male,White,Hispanic or Latino,5120,Censored,1589,Alive,1589,2014,2018,AAML1031,5.7,73,44,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,11,3,MLL,"47,XY,t(7;9;11)(q32;p22;q23),+11,del(14)(q21q31)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVANE,Male,White,Not Hispanic or Latino,6241,Death,453,Dead,453,2012,2013,AAML1031,27.9,85,44,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,1,Other,"47,XY,+8[20]",Yes,0.85,,No,No,,,,No,0,,,CR,unevaluable,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXDMP,Female,White,Not Hispanic or Latino,1529,Censored,1156,Alive,1156,2015,2018,AAML1031,8.2,46,44,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,del 7p,1,Other,"46,XX,del(7)(p12p15)[2]/46,XX[18]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAWEKL,Male,White,Hispanic or Latino,4855,Relapse,699,Alive,1586,2014,2018,AAML1031,11.2,36,45,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XY,t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,Yes,0.1,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAUMMG,Female,Black or African American,Not Hispanic or Latino,4999,Censored,490,Alive,490,2011,2013,AAML1031,2.4,60,45,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,Yes,"-X,del(9)(q22q34)",3,t(8;21),"45,X,-X,t(8;21)(q22;q22),del(9)(q22q34)[18]/46,XX[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWVUX,Female,White,Not Hispanic or Latino,4832,Censored,1163,Alive,1163,2015,2018,AAML1031,126.8,72,45,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,Yes,No,No,No,No,t(1;12)(q25;p12),3,inv(16),"46,XX,inv(16)(p13.1q22)[7]/46,idem,t(1;12)(q25;p12)[10]/46,idem,+8[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWVPZ,Male,White,Hispanic or Latino,4435,Censored,1211,Alive,1211,2015,2018,AAML1031,8.5,,45,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,Yes,No,-Y,3,t(8;21),"46,XY,t(8;21)(q22;q22)[5]/45,idem,- Y[8]/47,idem,+8[6]/46,XY[1]",Yes,0.03,,No,No,,,,No,0,No,0,not in CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWIUZ,Female,Asian,Not Hispanic or Latino,4219,Death without remission,64,Dead,64,2014,2014,AAML1031,50.2,73,45,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[30]",Yes,0.88,,Yes,No,,,,,,,,CR,death,High Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAWHTL,Male,White,Hispanic or Latino,4730,Relapse,259,Dead,635,2014,2016,AAML1031,16.9,76,45,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,2,Other,"47,XX,+8,del(16)(q22)[20]  could be  47,XX,+8,der(16)cryp inv(16)(p13.1q22)del(q22q24)",No,N/A,,No,No,,,,No,0.02,No,0,CR,unevaluable,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWHCT,Male,White,Not Hispanic or Latino,3669,Relapse,953,Alive,1730,2014,2019,AAML1031,2.8,79,45,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,i(11)(q10)    This karyotype has two normal #11's and one i(11)(q10) resulting in 4 copies of 11q,2,Other,"47,XX,+11,i(11)(q10)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,No,No,Yes,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAVPWB,Male,White,Not Hispanic or Latino,6651,Censored,2160,Alive,2160,2013,2019,AAML1031,8.3,22,45,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,2,t(8;21),"46,XY,t(7;21;8)(p15;q22;q22)[6]/45,idem,-Y[11]/46,XY[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVJIT,Male,White,Not Hispanic or Latino,2026,Relapse,394,Alive,1932,2012,2018,AAML1031,16.6,50,46,Yes,Unknown,,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XY,t(6;9)(p23;q34)[17]",No,N/A,,No,No,,,,No,0.06,No,0,CR,CR,Standard Risk,No,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with t(6;9)(p23;q34); DEK-NUP214
TARGET-20-PAWMHE,Female,White,Not Hispanic or Latino,559,Relapse,195,Dead,499,2014,2015,AAML1031,21,61,46,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,gain of 1q     der(1)t(1;1)(p36.3;q21),2,MLL,"46,XX,t(9;11)(p22;q23)[19]/46,idem,der(1)t(1;1)(p36.1;q21)[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,No,No,Yes,Yes,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAXELP,Male,White,Not Hispanic or Latino,6007,Relapse,312,Dead,1045,2015,2018,AAML1031,9.4,78,46,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,del(9)(q12q31),2,t(8;21),"46,XY,t(8;21)(q22;q22),del(9)(q12q31)[19]/46,XY[1]",No,N/A,,No,No,,,,Yes,1.4,No,,CR,CR,Low Risk,No,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVTDW,Male,White,Not Hispanic or Latino,963,Relapse,459,Alive,462,2013,2014,AAML1031,106.4,95,46,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,+der(9)t(9;11),2,MLL,"46,XY,t(9;11)(p22;q23)[14]/47,idem,+der(9)t(9;11)[4]/46,XY[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVDNF,Male,Unknown,Not Hispanic or Latino,1990,Induction failure,92,Dead,428,2012,2013,AAML1031,7.8,82,46,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.24,,No,No,,,,Yes,54,Yes,26,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAXKWG,Female,White,Hispanic or Latino,3979,Relapse,437,Alive,871,2015,2018,AAML1031,18.6,63,47,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,Yes,"4N,-X,del(9)(q13q22),-5",5,t(8;21),"46,XX,t(8;21)(q22;q22)[14]/90<4n>,slx2,-X,-X,del(9)(q13q22)x2[3]/89<4n>,sdl1,-5[3]/46,XX[2]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Low Risk,No,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVPMH,Male,White,Not Hispanic or Latino,6422,Censored,1211,Alive,1211,2013,2016,AAML1031,10.4,80,47,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,2,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[16]/46,XY[4]",No,N/A,,No,No,,,,No,0,,,not in CR,unevaluable,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAUSBP,Male,White,Not Hispanic or Latino,4223,Relapse,235,Dead,474,2012,2013,AAML1031,100,88,47,Yes,Unknown,,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(6;11)(q27;q23)[18]/46,XY[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXDSN,Female,White,Not Hispanic or Latino,258,Relapse,569,Alive,1248,2015,2018,AAML1031,110.9,89,47,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,No,No,No,Yes,Yes,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAWGEM,Male,White,Hispanic or Latino,4646,Censored,1709,Alive,1709,2014,2018,AAML1031,9.3,50,47,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,Yes,,,,No,0.06,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAWILD,Male,White,Not Hispanic or Latino,8590,Censored,1552,Alive,1552,2014,2018,AAML1031,30.4,31,48,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.55000000000000004,,No,No,,,,,,No,,CR,CR,High Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAUWPW,Male,White,Not Hispanic or Latino,661,Induction failure,32,Alive,2378,2012,2018,AAML1031,119.9,58,48,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[19]/46,XY[1]",No,N/A,,No,No,,,,No,0,,,not in CR,not in CR,Low Risk,No,No,Yes,No,No,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAUKDH,Female,White,Hispanic or Latino,4783,Censored,2425,Alive,2425,2011,2018,AAML1031,11,68,48,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,2,t(8;21),"46,XX,der(8)ins(21;8)(q22;q22q21.2),der(21)inv(21)(q21q22)ins(21;8)(q22q22q21.2)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWDBB,Female,White,Not Hispanic or Latino,5303,Censored,1804,Alive,1804,2014,2018,AAML1031,7.4,70,48,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XX,t(16;16)(p13.1;q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAUZTM,Male,White,Not Hispanic or Latino,6153,Censored,1161,Alive,1161,2012,2015,AAML1031,181.4,49,49,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.02,,No,No,,,,Yes,0.7,No,0,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAXKRR,Female,White,Not Hispanic or Latino,6066,Censored,889,Alive,889,2015,2018,AAML1031,5,51,49,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAXMBP,Male,Unknown,Unknown,5250,Censored,924,Alive,924,2016,2018,AAML1031,6.6,79,49,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAVKEY,Male,White,Not Hispanic or Latino,5303,Censored,1896,Alive,1896,2013,2018,AAML1031,25.6,82,49,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,Yes,No,No,,2,MLL,"47,XY,+8,t(9;11)(p22;q23)[13]/46,XY[7]",No,N/A,,No,No,,,,No,0,,,CR,unevaluable,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVSIZ,Female,White,Not Hispanic or Latino,5657,Censored,1793,Alive,1793,2013,2018,AAML1031,21.7,83,49,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XX,t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAUKEZ,Female,White,Not Hispanic or Latino,6521,Censored,771,Alive,771,2011,2013,AAML1031,44.1,,49,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,Yes,No,No,No,No,22,3,inv(16),"48,XX,+8,inv(16)(p13.1q22),+22[20]",No,N/A,,No,No,,,,No,0,,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWWTP,Female,White,Not Hispanic or Latino,3782,Censored,1162,Alive,1162,2015,2018,AAML1031,7.2,44,50,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,Yes,,,,No,0,,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAWYEM,Male,White,Hispanic or Latino,373,Relapse,729,Alive,1133,2015,2018,AAML1031,47.3,45,50,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[8]/46,XY[12]",No,N/A,,No,No,,,,No,0,,,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAVTWF,Male,Unknown,Not Hispanic or Latino,8664,Relapse,455,Alive,587,2013,2015,AAML1031,6.6,49,50,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,Yes,0.1,Yes,,CR,CR,Standard Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVHCV,Male,Black or African American,Not Hispanic or Latino,1530,Censored,1973,Alive,1973,2012,2018,AAML1031,104.4,50,50,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAXHZD,Female,White,Not Hispanic or Latino,2941,Relapse,884,Alive,966,2015,2018,AAML1031,13,52,50,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,-X,2,t(8;21),"45,X,-X,t(8;21)(q22;q22)[8]/46,XX[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,No,No,Yes,No,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVUAD,Male,White,Not Hispanic or Latino,4396,Censored,2001,Alive,2001,2013,2018,AAML1031,55.7,57,50,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,Yes,0.3,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAXJFL,Female,Unknown,Unknown,5447,Death without remission,26,Dead,26,2015,2015,AAML1031,68.2,68,50,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.67,,Yes,No,,,,,,,,death,death,High Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAWCKI,Male,White,Not Hispanic or Latino,2565,Relapse,256,Dead,383,2013,2015,AAML1031,30.7,73,50,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,"t(Y;9)(q12;p22),dic(1;13)(p31;p11.1),+3,t(5;19;8)(q13;q13.3;q21.2),+8,del(18)(q11.2)",6,Other,"47,X,t(Y;9)(q12;p22),dic(1;13)(p31;p11.1),+3,t(5;19;8)(q15;q13.3;q21.2),+8,del(18)(q11.2)[14]/46,XY[6]",No,N/A,,No,No,,,,Yes,0.7,No,0,CR,CR,Standard Risk,No,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVLLR,Male,White,Not Hispanic or Latino,669,Censored,2005,Alive,2005,2013,2018,AAML1031,43,77,50,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,-Y,2,inv(16),"46,XY,inv(16)(p13.1q22)[15]/45,idem,-Y[5]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWNPU,Male,White,Not Hispanic or Latino,5469,Relapse,523,Alive,938,2014,2017,AAML1031,110.9,93,50,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,cryp ins(X:11)(q24;q23q23)",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,Yes,Yes,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAXKEZ,Male,Asian,Not Hispanic or Latino,5121,Relapse,184,Dead,384,2015,2016,AAML1031,2.9,31,50,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.15,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAVXUC,Female,White,Hispanic or Latino,5969,Relapse,302,Dead,428,2013,2014,AAML1031,64.1,,50,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.88,,No,No,,,,Yes,9,Yes,,CR,CR,High Risk,Unknown,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAULRS,Male,White,Not Hispanic or Latino,6387,Censored,2122,Alive,2122,2011,2017,AAML1031,24.9,27,51,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,Yes,No,-Y,3,t(8;21),"46,XY,del(7)(q32q34),t(8;21)(q22;q22)[5]/45,idem,-Y[14]",No,N/A,,No,No,,,,Yes,2.2999999999999998,Yes,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWLKP,Male,White,Not Hispanic or Latino,5962,Censored,1574,Alive,1574,2014,2018,AAML1031,9.5,57,51,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,1,Other,"47,XY,+8[7]/46,XY[13]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAVJXG,Male,White,Not Hispanic or Latino,5689,Relapse,517,Alive,706,2013,2014,AAML1031,1.7,95,51,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,21,2,MLL,"46,XY,t(9;11)(p22;q23)[14]/47,idem,+21[6]",No,N/A,,No,No,,,,,,No,0,not in CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAWSCV,Male,White,Not Hispanic or Latino,5275,Censored,1482,Alive,1482,2014,2018,AAML1031,65.5,70,52,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,Yes,No,No,No,No,21,3,inv(16),"46,XY,inv(16)(p13.1q22)[11]/48,idem,+8,+21[9]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAWFRK,Female,Unknown,Hispanic or Latino,2968,Relapse,584,Alive,1627,2014,2018,AAML1031,21.3,70,52,Yes,Unknown,,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,,2,Other,"47,XX,+X[10/47,idem,add(7)(q11.2)[10]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,Yes,Yes,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAWEBC,Male,Black or African American,Not Hispanic or Latino,7231,Death,175,Dead,175,2014,2014,AAML1031,11.1,26,52,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,2,t(8;21),"47,XY,+8,t(8;21)(q22;q22)[cp20]",No,N/A,,No,No,,,,No,0.05,No,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAXGKH,Female,American Indian or Alaska Native,Not Hispanic or Latino,3578,Censored,909,Alive,909,2015,2018,AAML1031,2.2,75,53,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[21]",Yes,0.55000000000000004,,Yes,No,,,,,,No,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAWNXH,Male,Black or African American,Not Hispanic or Latino,1488,Censored,1162,Alive,1162,2014,2017,AAML1031,18.3,95,53,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,"del(9)(q13q22),t(15;19)(q11.2;p13.3)",2,Other,"46,XY,del(9)(q13q22),t(15;19)(q11.2;p13.3)[20]/46,XY[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAXLWH,Male,White,Unknown,1202,Relapse,587,Alive,1077,2015,2018,AAML1031,164,72,53,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"del(2)(q34q37.3), cryp t(5;11)(q35;p15.4)",2,Other,"46,XY,del(2)(q34q37.3), cryp t(5;11)(q35;p15.4)[14]/46,XY[6]",Yes,0.49,,No,No,,,,No,0,No,,CR,CR,High Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWDBS,Male,Black or African American,Not Hispanic or Latino,362,Relapse,225,Alive,1587,2014,2018,AAML1031,59.7,53,53,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,der(6)t(1;6)(q21;p21.3),2,Other,"46,XY,del(3)(q21q25)[2]/46,idem,der(6)t(1;6)(q21;p21.3)[16]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,No,No,Yes,No,Yes,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAVDFC,Female,White,Hispanic or Latino,5386,Censored,2329,Alive,2329,2012,2019,AAML1031,12.6,82,53,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[25]",Yes,0.64,,No,No,,,,No,0,,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWHRR,Male,White,Hispanic or Latino,2599,Relapse,241,Dead,1128,2014,2017,AAML1031,14.2,49,54,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,2,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[19]/46,XY[1]",No,N/A,,No,No,,,,Yes,43,No,0,not in CR,CR,Low Risk,Unknown,No,No,Yes,No,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWUBZ,Female,Unknown,Not Hispanic or Latino,4810,Relapse,413,Alive,1519,2014,2019,AAML1031,99.6,,54,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XX,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,Unknown,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWTYT,Male,Asian,Not Hispanic or Latino,5208,Induction failure,84,Dead,376,2014,2015,AAML1031,284.4,44,55,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,1,Other,"47,XY,+8[1]/46,XY[29] [FISH 3% +8]",Yes,7.0000000000000007E-2,,No,No,,,,Yes,69,Yes,12,not in CR,not in CR,Standard Risk,No,Yes,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAURVI,Male,Black or African American,Not Hispanic or Latino,4676,Censored,1870,Alive,1870,2011,2017,AAML1031,13.7,48,55,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,2,t(8;21),"46,XY,t(8;21)(q22;q22)[17]/45,idem,-Y[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAXMGU,Female,White,Not Hispanic or Latino,5083,Death,213,Dead,213,2016,2016,AAML1031,15.1,50,55,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,i(17)(q10) has a deletion of the p arm of chromosome 17.,1,Other,"46,XX,i(17)(q10)[13]/46,XX[7]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAWRSP,Male,White,Not Hispanic or Latino,5206,Censored,1370,Alive,1370,2014,2018,AAML1031,9.3,50,55,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.54,,No,No,,,,Yes,6.9,Yes,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWWZL,Male,White,Not Hispanic or Latino,2481,Relapse,219,Alive,1242,2015,2018,AAML1031,11.1,63,55,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,,2,t(8;21),"46,XY,del(7)(q22q34),t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,Unknown,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVUGM,Male,White,Not Hispanic or Latino,8597,Relapse,151,Dead,529,2013,2014,AAML1031,6.9,74,55,Yes,Unknown,,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XY,t(6;9)(p23;q34)[20]",Yes,3.85,,No,No,,,,Yes,2.8,,,CR,CR,High Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(6;9)(p23;q34); DEK-NUP214
TARGET-20-PAWWPA,Female,White,Not Hispanic or Latino,2977,Death,247,Dead,247,2015,2015,AAML1031,23.1,82,55,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,Yes,No,No,+mar,3,MLL,"46,XX,t(9;11)(p22;q23)[14]/47,idem,+8[2]/47,idem,+mar[2]/46,XX[1]",No,N/A,,No,No,,,,Yes,0.1,No,0,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAWAMF,Female,Unknown,Not Hispanic or Latino,6585,Censored,1585,Alive,1585,2013,2018,AAML1031,13.9,29,56,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,Yes,del 9q loss of X,3,t(8;21),"45,X,-X,t(8;21)(q22;q22)[19]/45,idem,del(9)(q22q32)[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAXICE,Male,White,Unknown,498,Relapse,345,Alive,893,2015,2018,AAML1031,41.9,48,56,Yes,Unknown,,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,der(10)t(10;11)(p11.2;q23)inv(11) (q13q23),der(11)t(10;11)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWZZN,Female,White,Not Hispanic or Latino,3863,Relapse,567,Alive,1304,2015,2018,AAML1031,43.9,80,56,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAXIKL,Female,Black or African American,Not Hispanic or Latino,2086,Censored,908,Alive,1186,2015,2019,AAML1031,20.2,45,57,Yes,Unknown,,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,a consequence of the der(7)t(7;13) is the del(7q) and extra 13q material.,1,Other,"46,XX,der(7)t(7;13)(q22;q21.1)[20]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAXCPM,Female,Unknown,Unknown,4678,Induction failure,100,Dead,244,2015,2016,AAML1031,32.4,82,58,Yes,Unknown,,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,Yes,No,No,add(16)(p13.3),2,MLL,"46,XX,t(10;11)(p12;q23)[17]/46,idem,add(16)(p13.3)[4]",No,N/A,,No,No,,,,Yes,75,Yes,14,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAUYHB,Male,White,Not Hispanic or Latino,6237,Censored,2069,Alive,2069,2012,2018,AAML1031,12,87,58,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAWMFH,Male,White,Not Hispanic or Latino,8885,Censored,1532,Alive,1532,2014,2018,AAML1031,78.2,71,59,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,"add(9p11),+22",3,inv(16),"46,XY,inv(16)(p13.1q22)[14]/46,idem,add(9)(p11)[2]/47,idem,+22[4]",No,N/A,,No,No,,,,No,0,No,0,CR,unevaluable,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAXIKD,Female,Black or African American,Not Hispanic or Latino,10671,Censored,1138,Alive,1138,2015,2018,AAML1031,9.5,75,59,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,-X,2,t(8;21),"45,X,-X,cryp ins(8;21)(q22;q22q22)[19]/46,XX[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAUUPR,Male,Asian,Not Hispanic or Latino,2080,Relapse,783,Alive,2324,2012,2018,AAML1031,6.5,77,59,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAXAAA,Male,White,Not Hispanic or Latino,2375,Induction failure,82,Dead,481,2015,2016,AAML1031,362.2,90,59,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,extra X,2,Other,"48,XY,+X,+8[20]",Yes,0.39,,No,No,,,,Yes,48,Yes,57,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVKEX,Male,White,Not Hispanic or Latino,3785,Relapse,262,Dead,1013,2013,2015,AAML1031,32.5,97,59,Yes,Unknown,,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(6;11)(q27;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVKXE,Male,Unknown,Not Hispanic or Latino,3444,Censored,1940,Alive,1940,2013,2018,AAML1031,301,,59,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[21]",Yes,0.67,,No,No,,,,No,0,No,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAUTAG,Male,Unknown,Hispanic or Latino,6419,Censored,1219,Alive,1219,2012,2015,AAML1031,1.9,76,59,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,"+4, del(9)(q12q22)",2,Other,"47,XY,+4,del(9)(q12q22)[3]/46,XY[17]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAUNVJ,Female,Unknown,Hispanic or Latino,6258,Relapse,438,Alive,1870,2011,2016,AAML1031,167.4,31,60,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,unevaluable,Low Risk,Unknown,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAUTYK,Female,White,Not Hispanic or Latino,5506,Censored,2506,Alive,2506,2012,2019,AAML1031,8.6,38,60,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,Yes,,,,Yes,0.4,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVGXC,Male,White,Not Hispanic or Latino,8798,Relapse,315,Dead,611,2012,2014,AAML1031,114.1,44,60,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[20]",Yes,0.04,,No,No,,,,No,0,,,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAWEBG,Male,White,Not Hispanic or Latino,3662,Relapse,334,Dead,347,2014,2015,AAML1031,14.6,89,60,Yes,Unknown,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(11;19)(q23;p13.3)[20]",No,N/A,,No,No,,,,Yes,2.1,No,0,CR,CR,Standard Risk,Yes,Yes,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAXGXR,Female,White,Not Hispanic or Latino,6519,Censored,995,Alive,995,2015,2018,AAML1031,28,90,60,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.82,,No,No,,,,No,0,No,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWREX,Female,White,Not Hispanic or Latino,5014,Censored,1417,Alive,1417,2014,2018,AAML1031,202.1,43,61,Yes,Unknown,,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(6;11)(q27;q23)[20]",Yes,0.36,,No,No,,,,Yes,2,No,0,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAVSWX,Male,White,Not Hispanic or Latino,9192,Induction failure,87,Alive,263,2013,2014,AAML1031,67,49,61,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[27]",Yes,0.56000000000000005,,No,No,,,,Yes,6.7,Yes,,not in CR,not in CR,High Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAXLEE,Female,Unknown,Hispanic or Latino,3647,Relapse,294,Dead,402,2015,2017,AAML1031,23.2,80,61,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,1,Other,"47,XX,+8[16]/46,XX[4]",Yes,0.57999999999999996,,No,No,,,,No,0,Yes,,not in CR,CR,High Risk,Unknown,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXBAP,Male,White,Not Hispanic or Latino,6271,Censored,1178,Alive,1178,2015,2018,AAML1031,40.4,84,61,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[21]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAXGPE,Male,White,Hispanic or Latino,933,Censored,1245,Alive,1245,2015,2019,AAML1031,33.2,90,61,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,5q35 translocation with rearrangement of NPM1,1,Other,"46,XY,t(5;6)(q35;q23)[20]",Yes,0.18,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAUVER,Female,White,Not Hispanic or Latino,508,Relapse,516,Alive,2480,2012,2018,AAML1031,38.6,,61,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,jumping translocation of 1q; 5 different partner chromosomes,6,MLL,"46,XY,t(9;11)(p22;q23)[1]/46,idem,der(16)t(1;16)(q12;q24)[10],46,idem,der(14)t (1;14)[q12;q32)]6]/46,idem,der(3)t(1;13)(q12;p25)[1]/46,idem,der(9)t(1;9)(q12; q34)[1]/46,idem,der(11)t(1;11)(q12;q23)[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAUYWJ,Female,White,Hispanic or Latino,2293,Censored,2397,Alive,2397,2012,2018,AAML1031,61.8,40,62,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XX,t(8;21)(q22;q22)[18]/46,XX[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAUZVW,Male,Black or African American,Not Hispanic or Latino,4088,Censored,2111,Alive,2111,2012,2018,AAML1031,145,49,62,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAUPNA,Male,White,Not Hispanic or Latino,4733,Censored,980,Alive,980,2011,2014,AAML1031,23.6,73,62,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,,1,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[19]/46,XY[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVTIP,Male,Asian,Not Hispanic or Latino,6126,Censored,415,Alive,415,2013,2014,AAML1031,7,75,62,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[31]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAVKBW,Male,White,Not Hispanic or Latino,6794,Censored,2034,Alive,2034,2013,2018,AAML1031,83.9,81,62,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,Yes,No,No,No,No,No,No,No,No,,2,inv(16),"46,XY,inv(16)(p13.1q22)[2]/46,idem,del(7)(q31)[18]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAXJYU,Male,Black or African American,Not Hispanic or Latino,6060,Censored,1185,Alive,1185,2015,2019,AAML1031,68.9,58,63,Yes,Unknown,,No,No,No,No,No,No,No,No,No,Yes,No,No,No,Yes,No,No,No,No,add(7)(q32) because the add(7q) results in del of the terminal region of 7q. Add(16q24),3,Other,"47,XY,add(7)(q32),+8,add(16)(q24)[11]/46,XY[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAUSBK,Male,White,Not Hispanic or Latino,382,Relapse,98,Dead,424,2012,2013,AAML1031,47.9,65,63,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,3,MLL,"46,XY,der(7)(7pter->7q11.2::10p12->10p15::11q23->11qter),der(10)(10pter->10p15::10p11.2->10qter),der(11)(11pter->11q23::10p12->10p11.2::11q23->11q23::7q11.2->7qter)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,No,Yes,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAXARX,Female,White,Not Hispanic or Latino,1473,Censored,1018,Alive,1018,2015,2018,AAML1031,77.8,88,63,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,13,2,inv(16),"46,XX,inv(16)(p13.1q22)[15]/46,idem,+13[5]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAXGVH,Female,White,Not Hispanic or Latino,308,Death,362,Dead,362,2015,2016,AAML1031,90.7,97,63,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,Yes,0.9,No,,not in CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAVEMX,Female,Unknown,Hispanic or Latino,3769,Censored,2362,Alive,2362,2012,2019,AAML1031,20.6,56,64,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XX,t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVAKA,Male,Asian,Not Hispanic or Latino,1320,Censored,2331,Alive,2331,2012,2018,AAML1031,65,80,64,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[18]/46,XY[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAVTMY,Female,White,Not Hispanic or Latino,4677,Death,133,Dead,133,2013,2013,AAML1031,34.6,83,64,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XX,t(8;21)(q22;q22)[16]/46,XX[5]",Yes,0.52,,No,No,,,,Yes,3.2,Yes,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAXEMU,Female,Asian,Not Hispanic or Latino,3221,Censored,1117,Alive,1117,2015,2018,AAML1031,47.7,90,64,Yes,Unknown,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,,2,MLL,"46,XX,t(11;19)(q23;p13.1)[15]/46,idem,del(3)(q21)[5]",Yes,0.8,,No,No,,,,,,,,unevaluable,unevaluable,High Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAWITY,Female,White,Not Hispanic or Latino,1820,Censored,1516,Alive,1516,2014,2018,AAML1031,69.6,,64,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,"+22,+9,add(7q22)",4,inv(16),"47,XX,inv(16)(p13.1q22),+22[14]/48,idem,+9[2]/46,XX,add(7)(q22),inv(16)(p13.1q22)[7]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAURKG,Female,White,Hispanic or Latino,6299,Censored,2462,Alive,2462,2011,2018,AAML1031,62.4,42,65,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,Yes,No,No,No,No,,2,inv(16),"46,XX,inv(16)(p13.1q22)[19]/47,idem,+8[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAVWRI,Male,White,Not Hispanic or Latino,2987,Censored,2026,Alive,2026,2013,2019,AAML1031,10.2,71,65,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,Yes,No,-Y,3,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[12]/45,idem,del(7)(q22q32)[8]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAUMAR,Male,White,Not Hispanic or Latino,5192,Censored,2402,Alive,2402,2011,2018,AAML1031,4.8,76,65,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,Yes,No,,,,,,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAXJFT,Male,Asian,Not Hispanic or Latino,5299,Relapse,133,Alive,1209,2015,2019,AAML1031,71.8,78,66,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.57999999999999996,,No,No,,,,Yes,5.3,,,not in CR,CR,High Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAXBSE,Female,White,Not Hispanic or Latino,5091,Censored,1108,Alive,1108,2015,2018,AAML1031,6.5,84,66,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.83,,No,Yes,,,,No,0,No,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAWTEI,Female,Unknown,Hispanic or Latino,1273,Censored,1519,Alive,1519,2014,2019,AAML1031,19.9,65,66,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XX,t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,Yes,1.8,No,0,not in CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWVUA,Female,White,Hispanic or Latino,2712,Censored,1149,Alive,1149,2015,2018,AAML1031,22.5,53,67,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XX,t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAURUT,Female,White,Not Hispanic or Latino,2735,Relapse,300,Alive,2505,2011,2018,AAML1031,150,70,67,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAWRKX,Male,White,Not Hispanic or Latino,5123,Death,314,Dead,314,2014,2015,AAML1031,87.8,82,67,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.55000000000000004,,No,No,,,,Yes,1.4,,,not in CR,unevaluable,High Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAXACY,Male,White,Not Hispanic or Latino,5283,Censored,456,Alive,456,2015,2016,AAML1031,7.7,82,68,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.66,,Yes,No,,,,No,0,No,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWHML,Male,White,Not Hispanic or Latino,5636,Relapse,369,Alive,1754,2014,2019,AAML1031,30.3,61,69,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWZIX,Female,Unknown,Not Hispanic or Latino,4898,Relapse,634,Alive,1250,2015,2018,AAML1031,68.6,67,69,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAWNAP,Male,White,Not Hispanic or Latino,5950,Censored,123,Alive,123,2014,2014,AAML1031,106.6,85,69,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.53,,Yes,No,,,,,,No,,CR,CR,High Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAUWRZ,Male,White,Not Hispanic or Latino,4969,Censored,2375,Alive,2375,2012,2018,AAML1031,210.4,100,69,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,der(7)t(7;11)(q37;q22),2,inv(16),"46,XY,der(7)t(7;11)(q37;q22),inv(16)(p13.3q22)[20]",No,N/A,,No,No,,,,No,0,,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWPGW,Female,White,Hispanic or Latino,4871,Induction failure,95,Dead,255,2014,2015,AAML1031,191.1,,69,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.96,,No,No,,,,Yes,36,Yes,,not in CR,not in CR,High Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWWFF,Female,White,Not Hispanic or Latino,4974,Censored,1421,Alive,1421,2015,2018,AAML1031,134.2,51,70,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[21]",Yes,1.98,,Yes,No,,,,No,0,No,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAWZNG,Male,Black or African American,Not Hispanic or Latino,6672,Censored,1240,Alive,1240,2015,2018,AAML1031,12.6,80,70,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.96,,Yes,No,,,,No,0,No,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAXGDG,Male,White,Hispanic or Latino,2077,Relapse,540,Alive,1180,2015,2018,AAML1031,117.4,95,70,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(13.1q22)[8]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWKRF,Male,White,Not Hispanic or Latino,1883,Censored,1517,Alive,1517,2014,2018,AAML1031,11.8,85,70,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,+4 add(6)(p22),2,Other,"47,XY,+4,add(6)(p22),t(17;19)[22]/46,XY[5]",Yes,0.86,,No,No,,,,No,0,,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVSJN,Male,White,Hispanic or Latino,1467,Relapse,157,Dead,172,2013,2013,AAML1031,345.8,68,71,Yes,Unknown,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(11;19)(q23;p13.3)[20]",No,N/A,,No,No,,,,Yes,38,No,0,not in CR,CR,Standard Risk,Yes,No,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXLMS,Male,Asian,Not Hispanic or Latino,5153,Censored,930,Alive,930,2015,2018,AAML1031,17,72,71,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,2,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[19]/46,XY[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVKEM,Female,White,Hispanic or Latino,5529,Censored,1824,Alive,1824,2013,2018,AAML1031,82.3,72,71,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,22,2,inv(16),"47,XX,inv(16)(p13.1q22),+22[21]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWNHH,Female,White,Not Hispanic or Latino,536,Censored,1476,Alive,1476,2014,2018,AAML1031,44.4,76,71,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,2,Other,"47,XX,t(7;12)(q36;p13),+19[20]",No,N/A,,No,No,,,,Yes,0.2,No,,not in CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAUMCV,Female,White,Not Hispanic or Latino,377,Censored,2705,Alive,2705,2011,2019,AAML1031,71.4,,71,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,3,Other,"47,XX,ider(13)(q10)del(13)(q12q14),+i(21)(q10)[20]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: Acute erythroid leukemia (Erythroleukemia, erythroid/myeloid)"
TARGET-20-PAURWH,Male,White,Hispanic or Latino,3655,Relapse,414,Alive,2310,2012,2018,AAML1031,231,60,72,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAVRJP,Male,White,Not Hispanic or Latino,7775,Relapse,347,Dead,824,2013,2015,AAML1031,7,78,72,Yes,Unknown,,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,Yes,Yes,No,loss of Y,2,MLL,"45,X,-Y,t(10;11)(p12;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAUMUZ,Female,White,Not Hispanic or Latino,4329,Relapse,210,Dead,298,2011,2012,AAML1031,29.8,83,72,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,"+X,+6,+i(q10)",5,Other,"51,XX,+X,i(1)(q10),+6,+8,+13[cp17]/46,XX[3]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,No,Yes,Yes,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAWIHN,Female,Asian,Not Hispanic or Latino,6501,Censored,1670,Alive,1670,2014,2018,AAML1031,5.2,85,72,Yes,Unknown,,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,"i(7)(p10)resulting in loss of 7q  did not do MLL, CBFB, or RUNX1T1-RUNX1",1,Other,"46,XX,i(7)(p10)[13]/46,XX[7]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAUYAE,Female,White,Unknown,5652,Censored,2427,Alive,2427,2012,2019,AAML1031,19.9,86,72,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.73,,Yes,No,,,,No,0,No,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAWLKE,Male,White,Not Hispanic or Latino,6550,Relapse,508,Alive,1614,2014,2018,AAML1031,44.9,91,72,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,Yes,No,No,"+6,+14,+18,+19 in addition to the +8",>6,MLL,"52,XY,+6,+8,t(11;17)(q23;q25),+14,+18,+19,+20[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAUMGZ,Female,White,Not Hispanic or Latino,3273,Censored,1153,Alive,1153,2011,2014,AAML1031,82.5,92,72,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[22]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAVDDA,Male,White,Not Hispanic or Latino,6160,Relapse,261,Dead,555,2012,2014,AAML1031,43.4,65,73,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,2,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,Yes,4.0999999999999996,No,,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWZUZ,Male,Unknown,Not Hispanic or Latino,3070,Relapse,300,Alive,1112,2015,2018,AAML1031,146.9,66,73,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,Yes,No,No,No,No,No,No,No,No,,2,inv(16),"46,XY,inv(16)(p13.1q22)[17]/46,idem,dup(7)(q32q36)[5]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAUUCG,Female,White,Not Hispanic or Latino,3851,Induction failure,108,Dead,230,2012,2012,AAML1031,4.7,79,73,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"inv(11)(p15q24), add(17p)",2,Other,"46,XX,inv(11)(p15q24),add(17)(p11.2)[18]/46,XX[14]",No,N/A,,No,No,,,,Yes,41,Yes,,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAVBNV,Male,Asian,Not Hispanic or Latino,5258,Relapse,1543,Alive,2418,2012,2019,AAML1031,7.6,89,73,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"del(15)(q15q22),+11,+12,+20",4,Other,"46,XY,del(15)(q15q22)[9]/49,idem,+11,+12,+20[7]/46,XY[4]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAXCCW,Female,White,Not Hispanic or Latino,4695,Censored,1325,Alive,1325,2015,2019,AAML1031,18.5,76,74,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,6,1,Other,"47,XX,+6[20]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAXDVZ,Male,White,Hispanic or Latino,7344,Death without remission,3,Dead,3,2015,2015,AAML1031,346.6,85,74,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,,,,,death,death,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWPCN,Male,Unknown,Hispanic or Latino,349,Censored,1540,Alive,1540,2014,2018,AAML1031,66.2,88,74,Yes,Unknown,,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,der(10)t(10;11)(p12;q23)inv(11)(q14q23),der(11) t(10;11)(p12;q14)[20]",No,N/A,,No,No,,,,Yes,0.1,No,0,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXBAV,Male,Asian,Not Hispanic or Latino,3037,Death,206,Dead,206,2015,2015,AAML1031,58.9,78,74,Yes,Unknown,,No,No,No,No,No,No,No,No,No,Yes,Yes,No,No,Yes,No,No,No,No,+21 del(9q),4,Other,"46,XY,add(7)(q31),del(9)(q22q34) [6]/47,idem,+8[9]/47,idem,+21[4]/46,XY[1]",No,N/A,,No,No,,,,Yes,5.5,No,0,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWUCG,Male,White,Not Hispanic or Latino,3352,Censored,1391,Alive,1391,2014,2018,AAML1031,110.7,86,75,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,+der(1;5)(q10;p10),2,MLL,"46,XY,ins(10;11*)(p12;q23q21),del(11*) (q21q25),der(18)ins(18;11*) (q21;q23q24)add(18)(q21)[13]/47,idem,+der(1;5)(q10;p10) [6]/46,XY[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVJRF,Male,Unknown,Hispanic or Latino,2137,Relapse,321,Dead,848,2012,2015,AAML1031,42.2,87,75,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,2,Other,"46,XY,t(2;18)(q31;q21),t(17;19)(q23;q13.3)[17]/46,XY[3]",No,N/A,,No,No,,,,Yes,0.2,No,0,CR,CR,Standard Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWFBA,Male,Black or African American,Not Hispanic or Latino,3458,Relapse,61,Dead,188,2014,2014,AAML1031,41.7,90,75,Yes,Unknown,,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,"add(9)(q22),der(11)(11qter->11q21::11p11.2->11qter), der(17)t(9;17)(q13;p11.2",4,Other,"46,XY,del(7)(q32q36),add(9)(q22),der(11)(11qter->11q21::11p11.2->11qter),der(17)t(9;17)(q13;p11.2)[29]/46,XY[1]",No,N/A,,No,No,,,,Yes,68,Yes,,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVWRR,Female,Black or African American,Not Hispanic or Latino,766,Induction failure,68,Dead,158,2013,2014,AAML1031,43.1,,75,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,Yes,No,No,No,"+19,+21,+der(22)t(1;22)(q21;q13),+8,+10",5,Other,"49,XX,+19,+21,+der(22)t(1;22)(q21;q13)[8]/51,idem,+8,+10[12]",No,N/A,,No,No,,,,Yes,70,Yes,27,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAUKTH,Female,White,Hispanic or Latino,6057,Death,195,Dead,195,2011,2012,AAML1031,42.9,65,76,Yes,Unknown,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,,N/A,Unknown,,No,N/A,,No,No,,,,Yes,0.6,No,0,CR,CR,,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAVNVA,Male,Black or African American,Not Hispanic or Latino,3938,Death,189,Dead,189,2013,2013,AAML1031,25,89,76,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XY,t(8;21)(q22;q22)[7]/46,XY[5]",No,N/A,,No,No,,,,Yes,1.1000000000000001,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAUZXK,Male,White,Not Hispanic or Latino,4356,Relapse,208,Dead,221,2012,2013,AAML1031,194.8,,76,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,,Yes,0.63,,No,No,,,,,,,,unevaluable,unevaluable,High Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAURMW,Female,White,Not Hispanic or Latino,726,Censored,1599,Alive,1599,2011,2016,AAML1031,138.4,,76,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,idic(21q),1,Other,"46,XX,idic(21)(q22.3)[20]/46,XX[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAUNSV,Male,Black or African American,Not Hispanic or Latino,4907,Relapse,462,Alive,1881,2011,2017,AAML1031,160,73,77,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[72]",Yes,0.02,,No,Yes,,,,No,0,No,0,not in CR,CR,Low Risk,No,Yes,Yes,No,No,No,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAWVNC,Male,White,Not Hispanic or Latino,3895,Relapse,576,Alive,1222,2015,2018,AAML1031,7.4,90,77,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[21]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAVPDN,Female,White,Not Hispanic or Latino,6551,Induction failure,16,Alive,1896,2013,2018,AAML1031,75.7,42,77,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XX,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,,,,,not in CR,not in CR,Low Risk,No,No,Yes,No,No,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWVGN,Male,Unknown,Unknown,2235,Relapse,290,Dead,889,2015,2017,AAML1031,53.4,86,78,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,cryp ins(10;11)(p12.3;q23.3q23.3)",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Yes,No,No,No,Yes,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWHFW,Male,White,Not Hispanic or Latino,5454,Relapse,190,Dead,285,2014,2015,AAML1031,51.5,91,78,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,1.1299999999999999,,No,No,,,,Yes,7.4,Yes,,not in CR,CR,High Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVBZM,Female,White,Not Hispanic or Latino,3873,Censored,2047,Alive,2047,2012,2018,AAML1031,115.5,93,78,Yes,Unknown,,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XX,t(6;9)(p23;q34)[20]",Yes,4.47,,No,No,,,,Yes,23,,,not in CR,unevaluable,High Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(6;9)(p23;q34); DEK-NUP214
TARGET-20-PAWSYM,Male,White,Not Hispanic or Latino,6300,Censored,1384,Alive,1384,2014,2018,AAML1031,197.4,,78,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,22,2,inv(16),"46,XY,inv(16)(p13.1q22)[17]/47,idem,+22[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAVBFN,Male,White,Not Hispanic or Latino,1786,Relapse,419,Alive,2041,2012,2018,AAML1031,27.9,89,79,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[30]",Yes,0.43,,Yes,No,,,,No,0,No,,CR,CR,High Risk,Unknown,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAWTSD,Male,White,Not Hispanic or Latino,1186,Relapse,629,Alive,1280,2014,2018,AAML1031,198.5,96,79,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(9;11)(p22;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAWAFT,Female,Black or African American,Not Hispanic or Latino,4561,Death,270,Dead,270,2013,2014,AAML1031,280.1,,79,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.77,,No,No,,,,No,0,No,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAVXEL,Male,White,Not Hispanic or Latino,845,Relapse,189,Alive,1772,2013,2018,AAML1031,241.6,,79,Unknown,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(9;11)(p22;q23)[20]",No,N/A,,No,No,,,,No,0,,,CR,unevaluable,Standard Risk,No,Yes,Yes,No,No,Yes,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAWWXU,Male,White,Not Hispanic or Latino,3524,Relapse,338,Dead,442,2015,2016,AAML1031,10.3,55,80,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,Yes,No,No,Yes,No,"del(9q),dup(1p)",4,t(8;21),"46,XY,t(8;21)(q22;q22)[8]/46,idem,del(9)(q13q22)[4]/46,idem,dup(1)(p31p36.3),del(9)[4]/45,idem,-Y[3]/45,idem,-Y,del(9)[5]",No,N/A,,No,No,,,,Yes,29,No,0,not in CR,CR,Low Risk,No,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWYNC,Female,White,Not Hispanic or Latino,5642,Censored,1251,Alive,1251,2015,2018,AAML1031,21.8,75,80,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[28]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWKYG,Female,White,Not Hispanic or Latino,1966,Induction failure,70,Alive,662,2014,2016,AAML1031,53,91,80,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"cryp t(?;9)(?;q34.1)c, CBFBx1",2,Other,"46,XX, cryp t(?;9)(?;q34.1)[37]. ish NUP214 sep, CBFBx1",No,N/A,,No,No,,,,Yes,36,Yes,67,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAVEDT,Male,White,Not Hispanic or Latino,2164,Relapse,494,Alive,2075,2012,2018,AAML1031,8.6,92,80,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,+Y,1,Other,"47,XY,+Y[14]/46,XY[6]",No,N/A,,Yes,No,,,,Yes,4.8,,,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAUVIB,Male,White,Not Hispanic or Latino,6588,Death,175,Dead,175,2012,2012,AAML1031,64.7,36,81,Yes,Unknown,,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(6;11)(q27;q23)[20]",No,N/A,,No,No,,,,Yes,55,No,0,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWHXI,Female,White,Not Hispanic or Latino,4372,Censored,1698,Alive,1698,2014,2018,AAML1031,8.3,71,81,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,Yes,0.2,No,0,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWLFB,Female,White,Not Hispanic or Latino,5930,Censored,1682,Alive,1682,2014,2019,AAML1031,35.2,39,82,Unknown,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,add(9)(p22),1,Other,"46,XX,add(9)(p22)[3]/46,XX[17]",Yes,0.02,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAUXCD,Male,White,Not Hispanic or Latino,5400,Relapse,233,Alive,2297,2012,2018,AAML1031,80.3,61,82,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[13]/46,XY[7]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,Yes,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWHJI,Female,Unknown,Hispanic or Latino,520,Relapse,183,Dead,225,2014,2014,AAML1031,56.4,81,82,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[20]",No,N/A,,No,No,,,,Yes,29,Yes,,not in CR,CR,Standard Risk,Unknown,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVHLI,Female,White,Not Hispanic or Latino,9731,Relapse,341,Alive,2275,2012,2019,AAML1031,211.7,83,82,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XX,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAXLMN,Male,White,Not Hispanic or Latino,2604,Censored,965,Alive,965,2015,2018,AAML1031,239,85,82,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[17]",No,N/A,,Yes,No,,,,No,0,No,0,not in CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWPVX,Female,Unknown,Hispanic or Latino,5930,Relapse,863,Alive,1276,2014,2018,AAML1031,11.5,90,82,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,t(5;12)(p13;p13),1,Other,"46,XX,t(5;12)(p13;p13)[20]",No,N/A,,No,No,,,,No,0.03,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAXJGS,Male,White,Not Hispanic or Latino,5840,Relapse,140,Dead,272,2015,2016,AAML1031,91.4,64,83,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,"+6,+18",3,MLL,"46,XY,ins(10;11)(p12;q23q12)[8]/48,idem,+6,+18[10]/46,XY[2]",No,N/A,,No,No,,,,No,0,Yes,,CR,CR,Standard Risk,No,No,No,No,No,Yes,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXBXI,Female,White,Hispanic or Latino,5948,Censored,1195,Alive,1195,2015,2018,AAML1031,195,81,83,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,1,Other,"47,XX,+8[17]/46,XX[3]",Yes,0.62,,No,No,,,,No,0,,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXISI,Male,White,Not Hispanic or Latino,6472,Relapse,316,Alive,1171,2015,2019,AAML1031,59.1,82,83,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.25,,No,Yes,,,,No,0,No,0,not in CR,CR,Low Risk,No,Yes,Yes,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAWYEK,Female,White,Not Hispanic or Latino,2071,Relapse,226,Dead,295,2015,2015,AAML1031,48.4,91,83,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,3,1,Other,"47,XX,+3[9]/46,XX[11]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,Yes,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXHWI,Female,White,Not Hispanic or Latino,5942,Death without remission,4,Dead,4,2015,2015,AAML1031,24,95,83,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.35,,Yes,No,,,,,,,,death,death,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAUMAD,Female,Black or African American,Not Hispanic or Latino,6605,Death,319,Dead,319,2011,2012,AAML1031,7.5,85,83,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"dup(1)(q21q44),t(2;8)(q21;q21.2),r(11)(p15q23),del(16)(q13),+22",5,Other,"47,XX,dup(1)(q21q44),t(2;8)(q21;q21.2),r(11)(p15q21),del(16)(q13),+22[21]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAVAAM,Female,White,Not Hispanic or Latino,1703,Death without remission,24,Dead,24,2012,2012,AAML1031,139.4,93,83,Yes,Unknown,,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(6;11)(q27;q23)[20]",No,N/A,,No,No,,,,,,,,death,death,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVEZN,Female,White,Not Hispanic or Latino,7090,Censored,2047,Alive,2047,2012,2018,AAML1031,39.9,73,84,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,del(9)(q12q32),1,Other,"46,XX,del(9)(q12q32)[10]/46,XX[15]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAWYTW,Female,White,Not Hispanic or Latino,6115,Censored,1270,Alive,1270,2015,2018,AAML1031,165.2,80,84,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XX,cryp ins(16;16)(p13.1;q22q22)[?]",No,N/A,,No,No,,,,No,0,,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAVTLN,Female,White,Not Hispanic or Latino,5440,Relapse,496,Dead,635,2013,2015,AAML1031,174.2,90,84,Yes,Unknown,,No,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,t(3;5)(q25.3;q35.1),1,Other,"46,XX,t(3;5)(q25.3;q35.1)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAUPIY,Male,Black or African American,Not Hispanic or Latino,3505,Relapse,122,Dead,191,2011,2012,AAML1031,394,94,84,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.83,,No,No,,,,Yes,13,No,,CR,CR,High Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAXHGR,Female,White,Not Hispanic or Latino,170,Induction failure,33,Alive,112,2015,2016,AAML1031,64,,84,Unknown,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,2,Other,"47,XX,t(7;12)(q36;p13),+19[20]",No,N/A,,No,No,,,,Yes,0.7,,,not in CR,not in CR,Standard Risk,No,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAUPSS,Female,Unknown,Hispanic or Latino,1845,Relapse,333,Dead,1133,2011,2015,AAML1031,45,77,85,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,del(9)(q12q22),2,t(8;21),"46,XX,t(8;21)(q22;q22),del(9)(q12q22)[20]",No,N/A,,No,No,,,,No,0.02,No,0,CR,CR,Low Risk,No,Yes,No,No,No,Yes,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVAGA,Female,White,Not Hispanic or Latino,5672,Censored,2356,Alive,2356,2012,2018,AAML1031,117.5,85,85,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.72,,No,No,,,,Yes,2.6,,,not in CR,unevaluable,High Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWPKR,Female,White,Hispanic or Latino,1585,Relapse,134,Dead,331,2014,2015,AAML1031,346.4,,85,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23) [20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAUVXU,Female,White,Not Hispanic or Latino,455,Relapse,227,Dead,660,2012,2014,AAML1031,281.6,,85,Unknown,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[19]/46,XX[1]",No,N/A,,No,No,,,,No,0,,,CR,unevaluable,Standard Risk,No,Yes,Yes,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAXCVU,Male,White,Not Hispanic or Latino,3881,Censored,999,Alive,999,2015,2018,AAML1031,133.6,75,86,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.66,,No,No,,,,Yes,5.2,,,not in CR,unevaluable,High Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAVFHK,Male,White,Not Hispanic or Latino,6960,Relapse,248,Dead,466,2012,2014,AAML1031,134.5,82,86,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.26,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAXKAI,Female,White,Unknown,7087,Censored,863,Alive,863,2015,2018,AAML1031,45.7,85,86,Yes,Unknown,,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,,4,Other,"46,XX,add(4)(q31.3),add(17)(q25),add(8)(p21),del(7)(q22q36) [15]/46,XX[5]",No,N/A,,No,No,,,,Yes,50,No,0,not in CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVUVI,Male,White,Hispanic or Latino,1335,Censored,1897,Alive,1897,2013,2018,AAML1031,199.1,91,86,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVNZB,Female,White,Not Hispanic or Latino,5790,Induction failure,44,Dead,354,2013,2014,AAML1031,143.1,,86,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.71,,No,No,,,,Yes,14,Yes,,not in CR,not in CR,High Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXFBN,Male,Unknown,Not Hispanic or Latino,647,Censored,1174,Alive,1174,2015,2018,AAML1031,185.8,,86,Unknown,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(9;11)(p22;q23)[20]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAWWRG,Male,White,Hispanic or Latino,5921,Relapse,463,Alive,1268,2015,2018,AAML1031,8.6,58,87,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: Acute erythroid leukemia (Erythroleukemia, erythroid/myeloid)"
TARGET-20-PAXFWY,Male,White,Not Hispanic or Latino,4478,Censored,983,Alive,983,2015,2018,AAML1031,144,82,87,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,Yes,65,Yes,,not in CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWRNZ,Female,Unknown,Hispanic or Latino,6068,Relapse,546,Dead,1057,2014,2017,AAML1031,20.5,86,87,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,t(16;21)(p11.2;q22) with gain of 1q,2,Other,"46,XX,der(16)t(16;21)(p11.2;q22)t(1;16) (q12;q12.1),der(21)t(16;21)(p11.2;q22)[19]/46,XX[1]",No,N/A,,No,No,,,,Yes,68,No,,not in CR,CR,Standard Risk,Yes,No,No,Yes,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWFFJ,Female,Black or African American,Not Hispanic or Latino,1095,Induction failure,63,Dead,103,2014,2014,AAML1031,247.2,88,87,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,"t(1;7)(q25.2;p15),del(17)(q23),+der(8)del(8)(p12)del(8)(q11.2q21.3)",4,MLL,"46,XX,t(1;7)(q25.2;p15),t(9;11)(p22;q23)[8]/47,idem,del(17)(q23),+der(8)del(8)(p12)del(8)(q11.2q21.3)[12]",No,N/A,,No,No,,,,No,0,,,CR,not in CR,Standard Risk,No,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWWEE,Female,White,Not Hispanic or Latino,2069,Relapse,192,Dead,296,2015,2015,AAML1031,142.1,82,88,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,mar,2,t(8;21),"46,XX, cryp ins(21;8)(q22;q22q22)[15]/47,idem,+mar[5]",No,N/A,,No,No,,,,No,0.02,No,,CR,CR,Low Risk,No,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWYRT,Male,White,Not Hispanic or Latino,6230,Induction failure,83,Dead,243,2015,2015,AAML1031,87.9,90,88,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,"del(9)(q13q34),-9",2,Other,"46,XY,del(9)(q13q34)[15]/45,XY,-9[4]/46,XY[1]",Yes,0.78,,No,No,,,,Yes,28,Yes,,not in CR,not in CR,High Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAUXLK,Male,White,Not Hispanic or Latino,6208,Relapse,906,Alive,2233,2012,2018,AAML1031,164,84,88,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAVZIB,Male,White,Not Hispanic or Latino,5137,Relapse,269,Dead,724,2013,2015,AAML1031,103.8,91,89,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,"del(9)(q13q33),+21",2,Other,"46,XY,del(9)(q13q33)[9]/46,idem,+21[9]/46,XY[2]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAXBVX,Female,Black or African American,Not Hispanic or Latino,30,Death without remission,16,Dead,16,2015,2015,AAML1031,274.8,72,89,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,t(8;14;16)(p11.2;q32;p13.3),1,Other,"46,XX,t(8;14;16)(p11.2;q32;p13.3)[22]/46,XX[1]",No,N/A,,No,No,,,,,,,,death,death,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVZBG,Male,White,Not Hispanic or Latino,2851,Relapse,538,Dead,1671,2013,2018,AAML1031,191.6,80,90,Yes,Unknown,,No,No,No,No,No,No,No,No,Yes,No,Yes,No,No,No,No,No,No,No,del 9q,2,Other,"46,XY,del(5)(q22q33),del(9)(q13q22)[cp7]",No,N/A,,No,No,,,,,,,,not in CR,unevaluable,High Risk,No,No,No,Yes,No,Yes,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVRTN,Male,White,Not Hispanic or Latino,3514,Relapse,173,Dead,250,2013,2014,AAML1031,55.4,83,90,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,Yes,No,del 9q,3,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[14]/45,idem,del(9)(q21q22)[3]/46,XY[3]",No,N/A,,No,No,,,,Yes,0.6,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAUZPD,Female,White,Not Hispanic or Latino,3154,Censored,2243,Alive,2243,2012,2018,AAML1031,140.7,90,90,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.6,,Yes,No,,,,No,0,No,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAVSVU,Female,Black or African American,Not Hispanic or Latino,6634,Relapse,337,Alive,2125,2013,2019,AAML1031,11.6,93,90,Yes,Unknown,,No,No,No,No,No,No,No,No,No,Yes,No,No,No,Yes,No,No,No,No,"add(7q),del(7q),add(14q),+4,+8,+10,",>6,Other,"49,XX,+4,+8,+8[14]/49,idem,add(7)(q31),-8,+10[7]/49,idem, del(7)(q22q36),add(14)(q32)[2]/46,XX[1]",No,N/A,,No,No,,,,No,0.09,Yes,,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAWBDK,Female,White,Not Hispanic or Latino,3724,Censored,1558,Alive,1558,2013,2018,AAML1031,143.1,97,90,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWSED,Male,White,Not Hispanic or Latino,5101,Relapse,400,Dead,530,2014,2016,AAML1031,94.8,,90,Unknown,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,22,2,inv(16),"47,XY,inv(16)(p13.1q22),+22[20]",Yes,0.18,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWJDM,Male,White,Not Hispanic or Latino,8122,Death,946,Dead,946,2014,2016,AAML1031,171.1,,90,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,deletion 7q,1,Other,"46,XY,del(7)(q22)[20]",No,N/A,,No,No,,,,Yes,0.7,No,0,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAVBYN,Female,White,Not Hispanic or Latino,6912,Relapse,887,Alive,2171,2012,2018,AAML1031,41.3,78,90,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,Yes,,,,No,0,No,0,not in CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAXEWD,Male,Black or African American,Not Hispanic or Latino,3798,Relapse,221,Alive,265,2015,2016,AAML1031,280.5,80,91,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,Yes,,,,Yes,0.4,Yes,,not in CR,CR,Low Risk,No,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAVWRN,Female,White,Not Hispanic or Latino,4647,Relapse,239,Dead,597,2013,2015,AAML1031,115.8,94,91,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,Yes,23,Yes,,not in CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAUNBR,Male,Asian,Not Hispanic or Latino,5503,Relapse,313,Dead,579,2011,2013,AAML1031,200.9,95,91,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,3,MLL,"47,XY,t(1;3)(p34;q27),t(2;9;11)(q21;p22;q23),+8,t(8;9)(p23;p22)[21]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVKAH,Female,White,Not Hispanic or Latino,5191,Censored,681,Alive,681,2013,2014,AAML1031,87.3,80,91,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAVEYP,Female,White,Not Hispanic or Latino,3187,Relapse,355,Alive,2363,2012,2019,AAML1031,59.3,78,91,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[30]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAWWLI,Male,White,Not Hispanic or Latino,5437,Relapse,176,Dead,211,2015,2015,AAML1031,93,85,92,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,Yes,No,No,,2,MLL,"46,XY,ins(10;11)(p12;q23q14)[22]/46,idem,der(10) dic[8;ins(10;11)](q11.2;p15)[15]",No,N/A,,No,No,,,,Yes,0.9,No,0,CR,CR,Standard Risk,Yes,Yes,No,Yes,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVIXV,Female,White,Not Hispanic or Latino,5669,Censored,2081,Alive,2081,2012,2018,AAML1031,17.8,92,92,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,2,Other,"48,XX,+4,+21[4]/46,XX[16]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAUZAM,Male,White,Not Hispanic or Latino,3630,Death without remission,42,Dead,42,2012,2012,AAML1031,153.7,95,92,Yes,Unknown,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,+der(19)t(11;19),2,MLL,"47,XY,t(11;19)(q23;p13.3),+der(19)t(11;19)(q23;p13.3)[20]/46,XY[1]",No,N/A,,No,No,,,,No,0,,,death,death,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXCYJ,Female,White,Not Hispanic or Latino,5274,Relapse,92,Dead,214,2015,2016,AAML1031,173.7,,92,Yes,Unknown,,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,Yes,No,No,"t(10;11)(p12;q14),der(1)t(1;11)(p36.3;q13),add(7)(p13),del(15)(q22q25),der(20)t(11;20)(q13;p11.2)",>6,MLL,"46,XX,der(1)t(1;11)(p36.3;q13),add(7)(p13),t(10;11)(p12;q14),del(12)(p12),del(13)(q12q14),del(15)(q22q25)[13]/46,idem,der(20)t(11;20)(q13;p11.2)[3]/46,XX[6]",No,N/A,,No,No,,,,Yes,5,,,CR,unevaluable,Standard Risk,Unknown,No,Yes,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVWZV,Female,White,Not Hispanic or Latino,3295,Censored,1727,Alive,1727,2013,2018,AAML1031,91.4,83,92,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.86,,Yes,No,,,,No,0,No,,not in CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAWDCZ,Male,White,Not Hispanic or Latino,4810,Censored,1398,Alive,1398,2014,2017,AAML1031,329.9,70,93,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.01,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWNBB,Male,White,Hispanic or Latino,6181,Relapse,757,Dead,1051,2014,2017,AAML1031,65,88,93,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XY,t(1;11)(q23;p15)[19]/46,XY[1]",Yes,0.05,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAVLAE,Male,White,Not Hispanic or Latino,4742,Death,489,Dead,489,2013,2014,AAML1031,195.5,95,93,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,+mar,2,MLL,"47,XY,cryp ins(10;11)(p12;q23q23),+mar[20]",No,N/A,,No,No,,,,No,0.03,No,,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAVKJV,Female,White,Hispanic or Latino,6445,Censored,1979,Alive,1979,2013,2018,AAML1031,19.7,91,94,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"+21,add(8)(p21),del(11)(q21q24)",3,Other,"47,XX,+21[4]/46,XX,add(8)(p21)[2]/46,XX,del(11)(q14q23)[2]/46,XX[14]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAXFHW,Female,White,Not Hispanic or Latino,2162,Censored,1218,Alive,1218,2015,2018,AAML1031,217.3,94,94,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,Yes,No,No,Yes,No,No,No,No,del 9q,4,Other,"47,XX,del(5)(q31q35),+8,del(9)(q11q34)[14]/46,add(2) (q21),del(9)(q11q34)[5]/46,XX[1]",No,N/A,,No,No,,,,No,0,,,CR,unevaluable,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAWEVC,Female,Unknown,Not Hispanic or Latino,5385,Censored,1093,Alive,1093,2014,2017,AAML1031,210.7,95,94,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,1,Other,"47,XX,+8[19]/46,XX[1]",Yes,0.52,,No,No,,,,Yes,0.5,Yes,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVHXU,Female,White,Not Hispanic or Latino,5597,Censored,2079,Alive,2079,2012,2018,AAML1031,29.4,93,94,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,i(8p),1,Other,"47,XX,+i(8)(p10)[20]",Yes,0.63,,Yes,No,,,,No,0,No,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAVKVT,Male,White,Not Hispanic or Latino,6081,Censored,283,Alive,283,2013,2013,AAML1031,55.1,93,95,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY,cryp del(12)(p13.1p13.2)[?]",No,N/A,,No,No,,,,Yes,3.6,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWLHJ,Male,White,Not Hispanic or Latino,5854,Death,117,Dead,117,2014,2014,AAML1031,106.4,97,95,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAUVAT,Female,White,Not Hispanic or Latino,3097,Relapse,292,Dead,420,2012,2013,AAML1031,49.4,89,95,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XX,t(10;12)(p13;q15)[18]/46,XX[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWZWN,Female,White,Not Hispanic or Latino,7165,Censored,1149,Alive,1149,2015,2018,AAML1031,49.3,87,96,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.01,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAWMNN,Male,White,Not Hispanic or Latino,1113,Censored,1425,Alive,1425,2014,2018,AAML1031,549.9,87,97,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(9;11)(p22;q23)[20]",Yes,0.59,,No,No,,,,No,0,No,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVNUW,Female,Black or African American,Not Hispanic or Latino,3801,Relapse,439,Dead,700,2013,2015,AAML1031,142.6,91,97,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAUPSX,Male,Black or African American,Not Hispanic or Latino,5218,Relapse,508,Dead,1679,2011,2016,AAML1031,439,92,97,Yes,Unknown,,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,,>6,Other,"82,XXYY,del(5)(q13q33)x2,-6,-7,-8,-9,-11,-12,-12,-15,-16,-17,-18,+mar",No,N/A,,No,No,,,,,,,,unevaluable,unevaluable,High Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAWLYM,Female,White,Not Hispanic or Latino,6136,Relapse,285,Dead,1329,2014,2018,AAML1031,117.3,90,98,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,Yes,No,,,,Yes,4.9000000000000004,No,0,CR,CR,Low Risk,No,No,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAXCLE,Female,White,Not Hispanic or Latino,1519,Induction failure,80,Dead,443,2015,2016,AAML1031,265.6,,100,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,del(9)(q12q22),1,Other,"46,XX,del(9)(q12q22)[20]",Yes,0.73,,No,No,,,,Yes,79,Yes,,not in CR,not in CR,High Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAVIYH,Female,White,Not Hispanic or Latino,1054,Censored,2233,Alive,2233,2012,2019,AAML1031,5.9,7,4,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[18]/46,XX[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAXMCH,Female,White,Not Hispanic or Latino,408,Censored,876,Alive,876,2016,2018,AAML1031,5.8,12,4,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,"[+der(1)t(1;22),+2,t(6;12)(p21;p13),+10,+13,+14,+19,+19,+20,+21,+22]",>6,Other,"56,XX,t(1;22)(p13;q13),+der(1)t(1;22),+2,t(6;12)(p21;p13),+10,+13,+14,+19,+19,+20,+21,+22[4]/46,XX[16]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML (megakaryoblastic) with  t(1;22)(p13;q13); RMB15-MKL1
TARGET-20-PAXKKC,Female,White,Hispanic or Latino,159,Censored,810,Alive,810,2015,2018,AAML1031,27.4,22,17,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(1;11)(q21;q23)[15]/46,XX[5]",No,N/A,,No,No,,,,No,0,,,not in CR,unevaluable,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAUZXP,Male,White,Hispanic or Latino,6143,Censored,2360,Alive,2360,2012,2018,AAML1031,18.5,23,,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[22]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAVUVD,Male,White,Not Hispanic or Latino,5896,Censored,1786,Alive,1786,2013,2018,AAML1031,16.9,30,14,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,22,2,inv(16),"46,XY,inv(16)(p13.1q22)[10]/47,idem,+22[10]",No,N/A,,No,No,,,,Yes,6.3,No,0,not in CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAVAWS,Male,Asian,Not Hispanic or Latino,859,Relapse,250,Dead,441,2012,2013,AAML1031,7.5,30,21,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,4,Other,"46,XY,add(10)(p11.2)[4]/48,idem,+6,del(13)(q12q22),+21[cp16]",No,N/A,,No,No,,,,Yes,0.5,No,0,CR,CR,Standard Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAVMGM,Female,White,Not Hispanic or Latino,1547,Censored,1920,Alive,1920,2013,2018,AAML1031,101.2,31,30,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XX,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAURLB,Male,Unknown,Unknown,621,Censored,2245,Alive,2245,2011,2018,AAML1031,35.7,32,,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,,1,Other,"45,XY,-7[17]/46,XY[3]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAWLAN,Female,White,Not Hispanic or Latino,2688,Censored,1056,Alive,1056,2014,2017,AAML1031,5.7,33,3,Yes,Unknown,,No,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XX,t(3;5)(q25.3;q34)",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAWTSM,Female,White,Not Hispanic or Latino,477,Censored,1484,Alive,1484,2014,2018,AAML1031,22.1,40,8,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,Yes,Yes,No,No,"other trisomies,",>6,MLL,"56,XX,+3,+6,+8,der(10)(10pter-10p13::10p11.2- 10q11.2::11q23.3::10q24-10qter),der(10*)(11pter- 11q25::10q24-10q11.2::10p11.2-10q11.2::11q23.3::10q11.2- 10qter),der(11)(11pter-11q23.3::10q11.2- 10qter),+17,+18,+19,+20,+21,+21,+22 [11]/46,XX[9]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAVVKU,Male,White,Not Hispanic or Latino,800,Relapse,177,Dead,313,2013,2014,AAML1031,9.8,41,8,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"t(X;13)(q28;q12),+2,t(4;7;8)(q31;q22;q22), add(7)(q21),del(16)(q12),add(17)(q25),+der(?)t(?;7)(?;q21)",>6,Other,"48,Y,t(X;13)(q28;q12),+2,t(4;7;8)(q31;q22;q22),add(7)(q21),del(16)(q12),add(17)(q25),+der(?)t(?;7)(?;q21)[15]/46,XY[5]",No,N/A,,No,No,,,,Yes,0.2,No,0,CR,CR,Standard Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAVUEF,Male,White,Not Hispanic or Latino,4375,Censored,2091,Alive,2091,2013,2019,AAML1031,10.5,43,31,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,21,2,t(8;21),"47,XY,t(8;21)(q22;q22)[14]/47,idem,+21[4]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWRSI,Male,White,Not Hispanic or Latino,6410,Censored,1593,Alive,1593,2014,2019,AAML1031,45,44,11,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,2,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[20]",Yes,0.01,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAXJAA,Female,Unknown,Not Hispanic or Latino,1017,Relapse,413,Alive,922,2015,2018,AAML1031,31.7,48,41,Yes,Unknown,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,,N/A,Unknown,,No,N/A,,No,No,,,,No,0,No,0,CR,CR,,Unknown,No,No,Yes,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAWDKU,Male,White,Not Hispanic or Latino,4309,Censored,374,Alive,829,2014,2016,AAML1031,3.6,50,39,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,2,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[17]/46,XY[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAUYFL,Female,White,Not Hispanic or Latino,5359,Censored,2410,Alive,2410,2012,2018,AAML1031,3.9,52,26,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[30]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAXJWS,Male,Unknown,Hispanic or Latino,3451,Induction failure,76,Dead,338,2015,2016,AAML1031,39.7,55,69,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,Yes,76,Yes,17,not in CR,not in CR,Standard Risk,No,Yes,No,Yes,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWDVC,Male,White,Not Hispanic or Latino,6558,Induction failure,77,Dead,710,2014,2016,AAML1031,7.4,60,62,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,Yes,66,Yes,61,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVLJH,Female,White,Not Hispanic or Latino,5666,Relapse,382,Alive,720,2013,2015,AAML1031,22,63,47,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XX,inv(16)(p13.1q22)[19]/46,XX[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,No,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWEAN,Female,Asian,Not Hispanic or Latino,6344,Censored,1440,Alive,1440,2014,2018,AAML1031,6.4,67,,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,-X,2,t(8;21),"45,X,-X,t(8;21)(q22;q22)[20]/46,XX[10]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVMEH,Female,White,Not Hispanic or Latino,3503,Censored,1837,Alive,1837,2013,2018,AAML1031,8.9,68,47,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAWTEB,Male,White,Hispanic or Latino,5102,Induction failure,86,Dead,148,2014,2015,AAML1031,27,70,43,Yes,Unknown,,No,No,No,No,No,No,No,No,No,Yes,No,No,No,Yes,No,No,No,No,"gain of 11q +8,+8 gain of 1q loss of 7q",4,Other,"49,XY,+1,der(1;7)(q10;p10),+8,+8,+i(11)(q10)[20]",No,N/A,,No,No,,,,,,No,0,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAWENM,Male,Unknown,Hispanic or Latino,3112,Relapse,521,Alive,1591,2014,2018,AAML1031,82.3,70,71,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,Yes,No,No,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWDNF,Female,White,Not Hispanic or Latino,2832,Relapse,841,Alive,1582,2014,2018,AAML1031,35.5,72,50,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,loss of X,2,t(8;21),"45,X,-X,t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,No,No,Yes,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWVBV,Female,Asian,Not Hispanic or Latino,4295,Death,182,Dead,182,2014,2015,AAML1031,314.6,73,64,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[23]",Yes,0.65,,Yes,No,,,,No,0,,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAWYUC,Female,White,Not Hispanic or Latino,1286,Censored,1308,Alive,1308,2015,2018,AAML1031,6.9,75,43,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,2,t(8;21),"46,XX,t(8;21)(q22;q22)[14]/46,idem,dup(X)(q13q28) [5]/46,XX[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVJDK,Male,White,Not Hispanic or Latino,6580,Relapse,384,Dead,1392,2012,2016,AAML1031,7.8,75,18,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(9;11)(p22;q23)[20]",No,N/A,,No,No,,,,Yes,0.1,No,0,CR,CR,Standard Risk,Unknown,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAXEPC,Male,Black or African American,Not Hispanic or Latino,4409,Relapse,345,Dead,720,2015,2017,AAML1031,7.9,78,,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,Yes,No,,,,Yes,6.2,Yes,,not in CR,CR,Low Risk,No,Yes,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAXLNX,Male,Black or African American,Not Hispanic or Latino,1481,Relapse,389,Dead,768,2015,2018,AAML1031,0.6,78,8,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,"4n, psu dic(6;9)(q27;p21),del(9)(p21),+22",4,Other,"90<4n>,XXYY,psu dic(6;9)(q27;p21)x2,del(9)(p21)x2[4]/91,idem,+22[4]/46,XY[7]",No,N/A,,No,No,,,,Yes,0.1,,,CR,unevaluable,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXMPG,Female,White,Not Hispanic or Latino,334,Relapse,270,Dead,743,2016,2018,AAML1031,39.6,80,80,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,An abnormal 7 that is difficult to assess ISCN. add(7)(q32) Asked for opinion and mill modify accordingly if needed.,3,Other,"47,XX,?add(7)(q32), cryp ins(7;12)(q36;p13.2p13.2),+19[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,Yes,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWKUR,Female,White,Not Hispanic or Latino,1098,Censored,1657,Alive,1657,2014,2019,AAML1031,53.7,80,53,Yes,Unknown,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,inv(12)(p13.3q13),2,inv(16),"46,XX,inv(16)(p13.1q22)[18]/46,idem,inv(12)(p13.1q13)[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWGCN,Male,White,Not Hispanic or Latino,7167,Censored,1416,Alive,1416,2014,2018,AAML1031,27.7,80,63,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,DEL(9q),2,t(8;21),"46,XY,t(8;21)(q22;q22),del(9)(q13q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVPLM,Female,White,Not Hispanic or Latino,2841,Relapse,288,Alive,1898,2013,2018,AAML1031,35.1,80,3,Yes,Unknown,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(11;19)(q23;p13.1)[20]",No,N/A,,No,No,,,,No,0,,,not in CR,CR,Standard Risk,No,Yes,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAVDGR,Male,White,Not Hispanic or Latino,4725,Induction failure,80,Alive,2030,2012,2018,AAML1031,13.6,80,3,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,del(9)(q13q22),1,Other,"46,XY,del(9)(q13q22)[15]/46,XY[5]",No,N/A,,No,No,,,,Yes,6.4,Yes,,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWHKK,Female,American Indian or Alaska Native,Hispanic or Latino,200,Relapse,295,Dead,559,2014,2015,AAML1031,145.2,81,53,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,3,MLL,"47,XX,+X,der(2)t(2;11)(q11.2;q13)inv(11) (q13q23),der(11)t(2;11)(q11.2;q13)[18]/46,XX[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXMPW,Male,White,Not Hispanic or Latino,2945,Censored,911,Alive,911,2016,2018,AAML1031,3.4,85,9,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAVNZU,Male,White,Not Hispanic or Latino,5231,Censored,1904,Alive,1904,2013,2018,AAML1031,19.8,85,93,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,2,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[13]/46,XY[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVXUR,Male,Black or African American,Not Hispanic or Latino,8306,Censored,1823,Alive,1823,2013,2018,AAML1031,128.9,87,23,Yes,Unknown,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(9;11)(p22;q23)[20]",No,N/A,,No,No,,,,Yes,0.3,No,,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAWSWR,Female,Unknown,Hispanic or Latino,5384,Censored,1240,Alive,1240,2014,2018,AAML1031,2.2,88,22,Yes,Unknown,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,-X  del 9q,3,t(8;21),"46,XX,t(8;21)(q22;q22)[12]/45,idem,-X[9],46,idem,del(9) (q13q22.3)[2]/46,XX[2]",No,N/A,,No,No,,,,Yes,1.4,Yes,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVNAZ,Female,Black or African American,Not Hispanic or Latino,5891,Censored,1994,Alive,1994,2013,2018,AAML1031,119.2,92,94,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"+3,+6,+10,+11,+15,+19",6,Other,"52,XX,+3,+6,+10,+11,+15,+19[20]",Yes,5.5,,No,No,,,,,,,,unevaluable,unevaluable,High Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVDZK,Male,White,Not Hispanic or Latino,5591,Relapse,527,Dead,1006,2012,2015,AAML1031,64.7,96,90,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"del(X)(p22.1p22.3),add(1)(q32),add(2)(p23),add(7)(p22),add(8)(q24),-11,add(11)(q24),der(16)add(16)(p13.3)del(16)(q13q24)",>6,Other,"45,Y,del(X)(p22.1p22.3),add(1)(q32),add(2)(p23),add(7)(p22),add(8)(q24),-11,add(11)(q24),del(12)(p11.2p13),del(13)(q12q21),der(16)add(16)(p13.3)del(16)(q13q24)[20]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,Yes,No,No,Yes,Yes,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAUYHR,Male,White,Not Hispanic or Latino,5509,Censored,917,Alive,917,2012,2014,AAML1031,124,98,98,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"47,XX,+19[17]/46,XY[3]",No,N/A,,No,No,,,,Yes,79,Yes,,not in CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAXLFG,Male,White,Not Hispanic or Latino,3491,Induction failure,57,Dead,110,2015,2016,AAML1031,33.1,92,23,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.03,,No,No,,,,Yes,92,Yes,27,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAXGGM,Male,White,Hispanic or Latino,4596,Relapse,200,Dead,317,2015,2016,AAML1031,225,,60,Yes,Unknown,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(11;19)(q23;p13.1)[12]/46,XY[8]",No,N/A,,No,No,,,,Yes,2.2999999999999998,,,CR,CR,Standard Risk,Unknown,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWRUK,Female,White,Hispanic or Latino,752,Censored,1260,Alive,1260,2014,2018,AAML1031,19.7,39,7,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,4,Other,"48,X,ins(5;X)(q31;q24q28),+8,+21[5]/47,idem,der(12;18) (q10;q10)[3]/46,XX[12]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAWPVR,Female,White,Not Hispanic or Latino,5605,Censored,809,Alive,809,2014,2016,AAML1031,432.2,,98,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.8,,No,No,,,,Yes,1.4,Yes,,CR,unevaluable,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWMFY,Female,White,Not Hispanic or Latino,509,Relapse,532,Alive,1398,2014,2018,AAML1031,3.3,95,,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,No,7.0000000000000007E-2,No,0,not in CR,CR,Standard Risk,Unknown,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAVDVU,Male,Black or African American,Not Hispanic or Latino,551,Relapse,68,Dead,239,2012,2013,AAML1031,175.7,71,50,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,,1,Other,"45,XY,-7[24]",No,N/A,,No,No,,,,No,0,Yes,,CR,not in CR,High Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVCJB,Male,White,Hispanic or Latino,195,Relapse,256,Dead,734,2012,2014,AAML1031,46.7,40,61,Yes,Unknown,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,"+6, +15, +21",6,Other,"51,XY,+6,t(7;12;14)(q36;p13;q32.1),+8,+15,+19,+21[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAWDPD,Female,Unknown,Not Hispanic or Latino,1274,Censored,1528,Alive,1528,2014,2018,AAML1031,7.6,0,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,Yes,No,No,No,"t(1;8)(p34;q22),+2,i(2)(q10),+6,+6,+7,+15,+20,+21,+21",>6,Other,"57,XX,t(1;8)(p34;q22),+2,i(2)(q10),+6,+6,+7,+8,+15,+19,+19,+20,+21,+21[10]/46,XX[14]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: Acute erythroid leukemia (Erythroleukemia, erythroid/myeloid)"
TARGET-20-PAWAFE,Male,Unknown,Hispanic or Latino,1556,Censored,1620,Alive,1620,2013,2018,AAML1031,3.9,0,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAVJPL,Female,White,Not Hispanic or Latino,228,Censored,2248,Alive,2248,2012,2019,AAML1031,11.4,0,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Myeloid sarcoma
TARGET-20-PAXGZA,Male,Unknown,Hispanic or Latino,684,Induction failure,73,Alive,1232,2015,2019,AAML1031,10.5,1,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[19] on orbital mass; only 19 cells available 46,XY[20] on bone marrow",No,N/A,,No,No,,,,No,0,No,0,CR,not in CR,Standard Risk,No,No,No,No,No,Yes,,,,WHO Classification (final: path then study entry): Myeloid sarcoma
TARGET-20-PAWWWL,Female,White,Not Hispanic or Latino,114,Censored,797,Alive,797,2015,2017,AAML1031,11,1,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Myeloid sarcoma
TARGET-20-PAWGFC,Female,White,Hispanic or Latino,3929,Censored,1723,Alive,1723,2014,2018,AAML1031,11.1,1,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,No,0.05,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Myeloid sarcoma
TARGET-20-PAVCZF,Female,Black or African American,Not Hispanic or Latino,370,Censored,2033,Alive,2033,2012,2018,AAML1031,11,4,0,Yes,No,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,"der(X;1)(q10;q10),+1",3,MLL,"46,X,der(X;1)(q10;q10),+1,t(11;19)(q23;p13.1)[2]/46,XX[18]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVSIX,Female,White,Not Hispanic or Latino,4809,Censored,2016,Alive,2016,2013,2018,AAML1031,5.4,6,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[29]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAWDVL,Female,White,Hispanic or Latino,6019,Censored,363,Alive,363,2014,2015,AAML1031,2.1,20,0,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,Yes,"del(9q),-X",3,t(8;21),"46,XX,t(8;21)(q22;q22),del(9)(q13q22)[2]/45,idem,-X[16]/46,XX[2]",No,N/A,,No,No,,,,No,0.04,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVNNA,Female,White,Not Hispanic or Latino,2498,Censored,1965,Alive,1965,2013,2018,AAML1031,5,20,0,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,-X,2,t(8;21),"45,X,-X,t(8;21)(q22;q22)[11]/46,XX[9]",No,N/A,,No,No,,,,No,0,,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAUPYX,Female,White,Not Hispanic or Latino,649,Relapse,432,Dead,1598,2011,2016,AAML1031,2.9,21,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,3,MLL,"46,XX,t(11;17)(q23;q12)[3]/46,idem,add(7)(q36)[2]/46,idem,+1,der(1;18)(q10;q10)[3]/46,XX[12]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,Yes,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVCJW,Female,Unknown,Hispanic or Latino,32,Censored,2359,Alive,2359,2012,2019,AAML1031,15.1,26,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XX,t(1;22)(p13;q13)[18]/46,XX[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML (megakaryoblastic) with  t(1;22)(p13;q13); RMB15-MKL1
TARGET-20-PAWGYA,Male,White,Not Hispanic or Latino,493,Relapse,505,Dead,690,2014,2016,AAML1031,8.1,30,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,Yes,1.5,No,0,not in CR,CR,Standard Risk,Yes,Yes,No,Yes,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAVMIY,Female,White,Not Hispanic or Latino,971,Censored,2009,Alive,2009,2013,2018,AAML1031,23.1,31,0,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XX,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWKMU,Male,White,Not Hispanic or Latino,4314,Censored,1641,Alive,1641,2014,2018,AAML1031,2.2,36,0,Unknown,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.32,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAVNHD,Male,Black or African American,Not Hispanic or Latino,2426,Censored,2023,Alive,2023,2013,2018,AAML1031,2.2,38,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,1,Other,"47,XY,+8[3]/46,XY[17]",No,N/A,,No,No,,,,Yes,14,,,not in CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAUZTH,Male,White,Not Hispanic or Latino,2410,Relapse,288,Dead,548,2012,2013,AAML1031,5.9,40,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(11;12;19)(q23;q13;p13.1)[17]/46,XY[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWKLE,Female,White,Not Hispanic or Latino,164,Relapse,213,Dead,225,2014,2015,AAML1031,5,45,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,t(8;18;11;10)(q13;q22;q23.1;p11.2),1,Other,"46,XX,t(8;18;11;10)(q13;q22;q23.1;p11.2)[10]/46,XX[14]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,No,No,Yes,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAUYDT,Female,White,Not Hispanic or Latino,9801,Censored,2306,Alive,2306,2012,2018,AAML1031,10.9,46,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,Yes,No,,,,No,0,,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAXHPH,Male,White,Not Hispanic or Latino,219,Censored,934,Alive,934,2015,2018,AAML1031,8,50,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XY,t(1;22)(p13;q13)[3]/46,XY[25]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML (megakaryoblastic) with  t(1;22)(p13;q13); RMB15-MKL1
TARGET-20-PAXDNI,Female,White,Not Hispanic or Latino,375,Relapse,159,Dead,311,2015,2016,AAML1031,15,50,0,Yes,No,,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(6;11)(q27;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,unevaluable,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVIGB,Female,White,Hispanic or Latino,876,Relapse,384,Dead,986,2012,2015,AAML1031,2.1,50,0,Unknown,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[19]/46,XX[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVZTJ,Female,White,Hispanic or Latino,234,Censored,1944,Alive,1944,2013,2019,AAML1031,34.3,65,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(1;11)(q21;q23)[12]/46,XX[8]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVKJD,Female,White,Hispanic or Latino,929,Relapse,699,Alive,2062,2013,2018,AAML1031,5.8,75,0,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,"der(X)t(X;11)(q26;q23),del(2)(q35),del(11)(q13q24),add(18)(q23)",>6,MLL,"47,X,der(X)t(X;11)(q26;q23),del(2)(q35),der(3)(3pter->3p22::3q21->3p22::3q21->3q25::?::11q13->11q23::3q26.1->3qter),der(9)t(9;11)(p22;q23),del(11)(q13q24),+19[16]/47,idem,add(18)(q23)[4]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAXLVV,Male,White,Not Hispanic or Latino,4003,Relapse,267,Alive,1133,2015,2019,AAML1031,30.9,78,0,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(9;11)(p22;q23)[17]/46,XY[3]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,No,Yes,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAXKTY,Male,White,Not Hispanic or Latino,4881,Censored,1089,Alive,1089,2015,2018,AAML1031,1,80,0,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(9;11)(p22;q23)[9]/46,XY[11]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAWBYK,Male,Unknown,Hispanic or Latino,1422,Induction failure,76,Alive,1611,2013,2018,AAML1031,5.4,80,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,5q rearrangement but NOT 5q31 _ FISH negative  other abnormalities not known recurrent abnormalities,3,Other,"46,XY,der(5)t(5;12)(p13;q14)der(5)t(5;17)(q33;q12),add(12) (q12),-17,+r[17]/46,XY[3]",No,N/A,,No,No,,,,No,0,No,0,CR,not in CR,Standard Risk,No,No,No,No,No,Yes,,,,WHO Classification (final: path then study entry): Myeloid sarcoma
TARGET-20-PAUWFM,Male,White,Hispanic or Latino,730,Relapse,136,Dead,592,2012,2013,AAML1031,30.2,80,0,Unknown,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"47,XY,+21[2]/46,XY[20]",No,N/A,,No,No,,,,Yes,0.9,No,,not in CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAWJGZ,Female,White,Not Hispanic or Latino,6002,Censored,1439,Alive,1439,2014,2018,AAML1031,9,84,0,Yes,No,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,Yes,No,Yes,No,No,,2,MLL,"47,XX,+8,t(11;19)(q23;p13.3)[9]/46,XX[11]",No,N/A,,No,No,,,,Yes,0.1,,,unevaluable,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXMLN,Female,White,Not Hispanic or Latino,6520,Censored,880,Alive,880,2016,2018,AAML1031,44.6,85,0,Yes,No,,No,No,No,No,No,No,No,Yes,No,Yes,No,No,No,No,No,No,No,No,,2,inv(16),"46,XX,del(7)(q31.2q34),inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAXIHA,Male,White,Not Hispanic or Latino,973,Censored,1203,Alive,1203,2015,2019,AAML1031,6.6,85,0,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(9;11;17)(p22;q23;q25)[15]/46,XY[5]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVFYL,Male,Black or African American,Not Hispanic or Latino,794,Death,381,Dead,381,2012,2013,AAML1031,7.6,86,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,21,1,Other,"47,XY,+21[7]/46,XY[13]",No,N/A,,No,No,,,,Yes,7.2,,,not in CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWDTX,Male,White,Not Hispanic or Latino,4790,Relapse,398,Dead,655,2014,2015,AAML1031,1.4,87,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.89,,No,No,,,,No,0.05,No,,CR,CR,High Risk,Yes,No,No,No,No,Yes,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAVZYI,Male,Black or African American,Not Hispanic or Latino,4618,Death without remission,4,Dead,4,2013,2013,AAML1031,14.1,88,0,Unknown,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,,,,,death,death,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXIDA,Male,White,Unknown,1929,Induction failure,79,Alive,651,2015,2017,AAML1031,4.6,90,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,Yes,No,No,Yes,No,No,No,No,"pentasomy [7x3], del(9)(p22),  many plus or minus chromosomes for pentasomy",>6,Other,"123,XXYYY,-1,-3,+6,-7,-7,+8,+8,-9,del(9)(p22)x2,+13,+14,+18,+18,+18,+19,+19,+20,+20,+22[10]/46,XY[10]",No,N/A,,No,No,,,,No,0,,,CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAXARD,Female,White,Not Hispanic or Latino,589,Censored,1257,Alive,1257,2015,2018,AAML1031,4,90,0,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,2,MLL,"46,XX,t(9;11)(p22;q23)[21]/46,idem,del(12)(p13)[11]",No,N/A,,No,No,,,,No,0,No,0,CR,unevaluable,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAWJJY,Female,White,Not Hispanic or Latino,291,Induction failure,85,Dead,232,2014,2015,AAML1031,4.1,90,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,No,0,,,not in CR,not in CR,Standard Risk,No,No,No,No,No,Yes,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVZNG,Male,White,Not Hispanic or Latino,701,Censored,1612,Alive,1612,2013,2018,AAML1031,2.6,90,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,t(7;10)(q32;q22),2,MLL,"46,XY,t(7;10)(q32;q22),crypt inv(11)(q23q23)[30]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVWXI,Male,White,Not Hispanic or Latino,5006,Censored,993,Alive,993,2013,2016,AAML1031,1,90,0,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,Yes,No,No,,2,MLL,"47,XY,+8,der(9)t(9;11)(p22;q23),der(11)inv(11)(p13q23)inv(11)(q21q23)t(9;11)(p22;q23)[19]/46,XY[1]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVSSE,Male,Asian,Not Hispanic or Latino,558,Relapse,162,Alive,1839,2013,2018,AAML1031,6.1,90,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,deletion 16q,2,MLL,"46,XX,inv(11)(q14q23),del(16)(q12.1)[20]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAUYHN,Male,White,Hispanic or Latino,267,Relapse,194,Dead,372,2012,2013,AAML1031,5.5,90,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,2,MLL,"46,XY,der(5)t(5;11)(p15.3;q23),der(9)t(9;15)(p22;21), der(11)t(11;13)(q22;q21),der(13)(13pter->13q21::11q23->11q22::9p22->9pter),der(15)t(5;15)(p15.3q21)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,Yes,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAWPDC,Female,Black or African American,Not Hispanic or Latino,1499,Censored,162,Alive,167,2014,2015,AAML1031,15.3,92,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[32]",No,N/A,,No,No,,,,Yes,3.2,Yes,,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXMKU,Male,White,Not Hispanic or Latino,2934,Censored,959,Alive,959,2016,2018,AAML1031,2.4,93,0,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,i(8)(q10)  presence of multiple i(8)(q10) yields 5-7 copies of 8q per cell,4,MLL,"47,XY,i(8)(q10),+i(8)(q10),t(9;11)(p22;q23)[18]/48,idem,+i(8)(q10) [2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVULK,Male,White,Hispanic or Latino,3680,Relapse,689,Dead,1055,2013,2016,AAML1031,97.1,97,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"+4,+6",2,Other,"48,XY,+4,+6[13]/46,XY[7]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXGIX,Female,White,Not Hispanic or Latino,128,Relapse,246,Alive,667,2015,2017,AAML1031,4.6,88,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,ins(10;11)(p11.2;q23.1q23.3)[20]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAWZIG,Female,White,Not Hispanic or Latino,1347,Censored,1447,Alive,1447,2015,2019,AAML1031,7.2,,0,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,11,2,MLL,"47,XX,t(9;11)(p22;q23),+11[1]/46,XX[14]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Myeloid sarcoma
TARGET-20-PAWMIX,Male,Black or African American,Not Hispanic or Latino,654,Relapse,765,Dead,945,2014,2017,AAML1031,8.5,,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,No,0,Yes,,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAWFIZ,Female,White,Not Hispanic or Latino,163,Relapse,559,Dead,664,2014,2015,AAML1031,4.6,72,0,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAWDYG,Male,White,Not Hispanic or Latino,274,Relapse,125,Dead,141,2014,2014,AAML1031,3.1,17,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,"add(16)(q24),add(20)(q11.2),add(22)(q11.2)",4,MLL,"46,XY,ins(10;11)(p12;q23q13),add(16)(q24), add(20)(q11.2),add(22)(q11.2)[8]/46,XY[12]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,Unknown,Yes,Yes,No,No,Yes,,,,WHO Classification (final: path then study entry): Myeloid sarcoma
TARGET-20-PAWDHA,Female,Unknown,Not Hispanic or Latino,1267,Relapse,214,Dead,440,2014,2015,AAML1031,7,4,0,Yes,No,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,,N/A,Unknown,,No,N/A,,No,No,,,,No,0,,,CR,CR,,Unknown,No,No,Yes,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: Acute erythroid leukemia (Erythroleukemia, erythroid/myeloid)"
TARGET-20-PAVTWM,Male,White,Not Hispanic or Latino,175,Relapse,389,Dead,1084,2013,2016,AAML1031,5.3,98,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,der(10)inv(10)(p12q11.2)t(10;11;17)(p12;q23;p13), der(10)t(10;11;17),der(17)t(10;11;17)[18]/46,XY[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,No,No,Yes,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVLSH,Female,White,Not Hispanic or Latino,76,Censored,1961,Alive,1961,2013,2018,AAML1031,7.4,,0,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[14]/46,XX[6]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAXCKK,Male,White,Not Hispanic or Latino,1985,Relapse,291,Dead,357,2015,2016,AAML1031,11.1,44,0,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"der(8)add(8)(p11.2)ins(8;?14)(q22;?),add(14)(q11.2), der(16)t(8;16)(p11.2;p13.3)",2,Other,"46,XY,der(8)add(8)(p11.2)ins(8;?14)(q22;?),add(14)(q11.2),der(16)t(8;16)(p11.2;p13.3)[5]/46,XY[15]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAVGEV,Female,White,Not Hispanic or Latino,1468,Relapse,155,Dead,414,2012,2013,AAML1031,12.2,6,1,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,21,3,MLL,"48,XX,t(9;11)(p22;q23),+19,+21[8]/46,XX[11]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,No,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAULCA,Female,Black or African American,Not Hispanic or Latino,192,Death without remission,69,Dead,69,2011,2011,AAML1031,17.5,90,1,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,Yes,8.9,Yes,23,CR,death,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: Acute erythroid leukemia (Pure erythroid leukemia)"
TARGET-20-PAXLYF,Male,White,Not Hispanic or Latino,3449,Induction failure,53,Dead,107,2015,2016,AAML1031,28.1,,1,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,Yes,No,No,"der(Y)t(Y;20)(q11.2;q13.3),der(4)add(4)(p16)t(4;9)(q35;q32),t(5;7)(q13;p15),+8,-9, cryp ins(?;11)(?;q23q23),del(17)(p11.2p12),der(20)(20pter->20q13.3::?::Yq11.2-Yqter)",>6,MLL,"46,X,der(Y)t(Y;20)(q11.2;q13.3),der(4)add(4)(p16)t(4;9)(q35;q32),t(5;7)(q13;p15),+8,-9, cryp ins(?;11)(?;q23q23),del(17)(p11.2p12),der(20)(20pter>20q13.3::?::Yq11.2-Yqter)[9]/46,XY[13]",No,N/A,,No,No,,,,No,0,,,CR,not in CR,Standard Risk,No,No,No,No,No,Yes,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAUWKY,Male,White,Not Hispanic or Latino,3394,Death,226,Dead,226,2012,2012,AAML1031,5.4,,1,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,t(3;8)(q27;q24),2,Other,"45,XY,t(3;8)(q27;q24),-7[13]",No,N/A,,No,No,,,,,,,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAUVZD,Female,Black or African American,Not Hispanic or Latino,364,Relapse,156,Dead,193,2012,2012,AAML1031,16.5,4,2,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,"dup(8)(q21.3q22),add(11)(p13),del(13)(q12q14),add(18)(p11.2),t(X;9;3)(q26;q32;p23),inv(15)(q15q26.1),+mar,+X,+7,+7,+21,+21",>6,Other,"46,XX,dup(8)(q21.3q22),add(11)(p13),del(13)(q12q14),add(18)(p11.2)[14]/46,sl,t(X;9;3)(q26;q32;p23),-del(13),inv(15)(q15q26.1),+18,-add(18),+mar[21]/~4n,sd1,+X,+7,+7,+21,+21[cp2]/46,XX[20]",No,N/A,,No,No,,,,Yes,2.8,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): Myeloid sarcoma
TARGET-20-PAVPIU,Female,White,Not Hispanic or Latino,5457,Censored,1995,Alive,1995,2013,2018,AAML1031,14.5,14,2,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,Yes,0.7,Yes,,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAUTVU,Female,White,Not Hispanic or Latino,267,Censored,2468,Alive,2468,2012,2018,AAML1031,14.2,22,2,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[43]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAVRAT,Male,Black or African American,Hispanic or Latino,6432,Relapse,140,Dead,181,2013,2013,AAML1031,7.2,23,2,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,Yes,Too many to describe. see the karyotype above.,>6,Other,"~72,XY,-X,+1,-4,add(4)(q35),del(6)(q13q21),+del(6)(q13q21),+7,add(7)(p11.2),+8,-9,+10,del(10)(p13),-11,i(12)(p10),+i(12)(p10),-13,add(17)(q10),+18,+19,+21,-22[cp19]/46,XY[2]",No,N/A,,No,No,,,,No,0,No,0,unevaluable,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAUZLS,Female,White,Not Hispanic or Latino,6325,Censored,2484,Alive,2484,2012,2019,AAML1031,8.1,60,2,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAUJMC,Male,White,Not Hispanic or Latino,6538,Relapse,577,Alive,2749,2011,2019,AAML1031,18.6,62,2,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,t(12;17),1,Other,"46,XY,t(12;17)(q24.2;q11.1)[19]/46,XY[1]",Yes,7.0000000000000007E-2,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAVPED,Male,White,Hispanic or Latino,4650,Censored,2006,Alive,2006,2013,2018,AAML1031,5,72,2,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,t(10;17)(p13;q21),1,Other,"46,XY,t(10;17)(p13;q21)[8]/92,idemx2[2]/46,XY[10]",No,N/A,,No,No,,,,,,,,unevaluable,unevaluable,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAUMTZ,Male,White,Not Hispanic or Latino,3639,Relapse,327,Dead,659,2011,2013,AAML1031,64.6,86,2,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY, cryp ins(10;11)(p12;q23q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAUZJJ,Female,Unknown,Not Hispanic or Latino,475,Relapse,131,Dead,382,2012,2013,AAML1031,17.8,88,2,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"47,XX,+3[18]/46,XX[2]",No,N/A,,No,No,,,,Yes,6.5,No,0,not in CR,CR,Standard Risk,No,Yes,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAUXRA,Female,White,Not Hispanic or Latino,6474,Censored,2474,Alive,2474,2012,2019,AAML1031,45.8,59,2,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXLXM,Female,White,Not Hispanic or Latino,2191,Death,30,Dead,30,2015,2016,AAML1031,2,3,3,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[19]/46,XX[2]",No,N/A,,No,No,,,,,,,,unevaluable,unevaluable,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAWTTI,Female,White,Not Hispanic or Latino,4402,Censored,1302,Alive,1302,2014,2018,AAML1031,2.3,25,3,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,1,Other,"47,XX,+8[8]/46,XX[12]",No,N/A,,No,No,,,,Yes,0.3,,,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAVLWV,Male,White,Not Hispanic or Latino,4180,Relapse,424,Alive,2052,2013,2018,AAML1031,3.3,51,3,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[25]",No,N/A,,Yes,No,,,,No,0,,,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAVIDD,Female,White,Not Hispanic or Latino,64,Censored,1943,Alive,1943,2012,2018,AAML1031,56.7,44,4,Yes,No,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,,2,MLL,"46,XX,der(2)t(2;11)(q33;q23.1)t(11;19)(q23.3;p13.3),der(11)t(2;11)(q33;q23.1),der(19)t(11;19)(q23.3;p13.3)[20]",No,N/A,,No,No,,,,No,0,,,not in CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAUNDC,Female,White,Hispanic or Latino,2836,Censored,2348,Alive,2348,2011,2018,AAML1031,104.6,63,4,Yes,No,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(11;19)(q23;p13.1)[7]/46,XX[3]",No,N/A,,No,No,,,,Yes,1.2,,,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAXCDU,Female,Black or African American,Not Hispanic or Latino,7045,Relapse,811,Alive,1109,2015,2018,AAML1031,34.6,74,4,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.71,,No,No,,,,,,,,unevaluable,unevaluable,High Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAVYTI,Female,White,Not Hispanic or Latino,7280,Censored,1993,Alive,1993,2013,2019,AAML1031,2.1,58,5,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAWMLA,Male,White,Not Hispanic or Latino,7981,Censored,1563,Alive,1563,2014,2018,AAML1031,28.1,68,5,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAVGXF,Male,White,Hispanic or Latino,205,Induction failure,64,Alive,2114,2012,2018,AAML1031,11.9,94,5,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,3,MLL,"45,XX,dic(10;11)(p12;q23)del(11)(q13q23)[6]/45,idem,t(9;14) (p22;q22)[14]",No,N/A,,No,No,,,,No,0,,,CR,not in CR,Standard Risk,No,Yes,Yes,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAXJPZ,Male,Other,Not Hispanic or Latino,553,Relapse,367,Alive,367,2015,2016,AAML1031,12,14,6,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,"[+2,+6,+7,+7,+14,+21,+21,+mar1,+mar2,+der(1)]",>6,Other,"55,XY,t(1;22)(p13;q13),+der(1)t(1;22)(p13;q13),+2,+6,+7,+7,+14,+21,+21,+mar1[5]/55,idem,add(21)(q22)[2]/55,idem,-mar1,+mar2[4]/46,XY[9]",No,N/A,,No,No,,,,No,0,No,0,CR,unevaluable,Standard Risk,Yes,No,No,No,No,Yes,,,,WHO Classification (final: path then study entry): AML (megakaryoblastic) with  t(1;22)(p13;q13); RMB15-MKL1
TARGET-20-PAUUTY,Male,White,Hispanic or Latino,622,Relapse,225,Dead,251,2012,2012,AAML1031,13.4,16,6,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XY,t(1;22)(p13;q13)[2]/46,XY[6]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML (megakaryoblastic) with  t(1;22)(p13;q13); RMB15-MKL1
TARGET-20-PAVPBC,Male,White,Not Hispanic or Latino,1135,Censored,1953,Alive,1953,2013,2018,AAML1031,77.2,67,6,Yes,No,,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(6;11)(q27;q23)[17]/46,XY[3]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAUMJB,Male,Asian,Not Hispanic or Latino,2337,Censored,1734,Alive,1734,2011,2016,AAML1031,19.9,95,6,Yes,No,,No,Yes,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,"add(7)(q32) resulting in del(7q),add(8)(q22),-11,+der(21)t(11;21)(q13;q22) SCR added del(7q) due to 7q+. [4-7-15]",5,t(8;21),"46,XY,add(7)(q32),add(8)(q22),-11,der(21)t(8;21)(q22;q22),+der(21)t(11;21)(q13;q22)[14]/46,XY[6]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWZZS,Female,White,Not Hispanic or Latino,3342,Death,432,Dead,432,2015,2016,AAML1031,2.3,67,6,Yes,No,,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,,3,Other,"46,XX,der(5)t(5;11)(q22;q21),t(7;21)(p22;q22) [11]/47,idem,+4,-der(5)t(5;11)[2]/46,XX[7]",No,N/A,,No,No,,,,Yes,0.1,No,0,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAWYDD,Male,Black or African American,Not Hispanic or Latino,458,Induction failure,35,Alive,1267,2015,2018,AAML1031,27.7,68,6,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,Yes,No,No,,2,MLL,"46,XY,der(9)t(9;11)(q34;q23)inv(11)(q24q23),der(11)t(11;20)(q13;q11.2),der(20)t(9;20)(q34;q11.2)[14]/47,sl,+8[8]/46,XY[3]",No,N/A,,No,No,,,,No,0,,,not in CR,not in CR,Standard Risk,No,No,Yes,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVWJV,Male,White,Not Hispanic or Latino,5365,Censored,1279,Alive,1279,2013,2017,AAML1031,3,28,7,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAVVAT,Female,White,Hispanic or Latino,1979,Relapse,401,Alive,1969,2013,2018,AAML1031,8.2,37,7,Yes,No,,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XX,t(2;9;6)(q23;q34;p23)[20]",Yes,0.24,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(6;9)(p23;q34); DEK-NUP214
TARGET-20-PAWNLU,Male,White,Not Hispanic or Latino,2008,Censored,1283,Alive,1283,2014,2018,AAML1031,17,50,7,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,loss of Y,2,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[19]/46,XY[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAUUKK,Female,Black or African American,Not Hispanic or Latino,557,Relapse,166,Dead,230,2012,2012,AAML1031,30.1,83,7,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,t(8;16)(p11.2;p13.3),2,Other,"47,XX,t(8;16)(p11.2;p13.3),+der(8)t(8;16)[19]/46,XX[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,No,Yes,No,Yes,Yes,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVGIX,Male,White,Not Hispanic or Latino,4676,Censored,1796,Alive,1796,2012,2017,AAML1031,2.6,95,7,Yes,No,,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,"der(9)t(9;11)(q34;?),-11",4,Other,"45,XY,der(7)(7pter->7q11.2::11q12->11q22::?),der(9)t(9;11)(q34;?),ins(10;11)(p12;q23q25),-11[21]/46,XY[4]",No,N/A,,No,No,,,,Yes,4.0999999999999996,,,CR,unevaluable,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAVKMI,Female,White,Not Hispanic or Latino,1892,Relapse,255,Dead,282,2013,2013,AAML1031,7.5,,7,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,t(8;16)(P11.2;P13.3),2,Other,"47,XX,+8,t(8;16)(p11.2;p13.3)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWKGX,Female,Black or African American,Not Hispanic or Latino,5800,Relapse,237,Dead,1140,2014,2017,AAML1031,69.4,15,8,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[30]",Yes,0.02,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,Yes,Yes,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAUHXN,Male,Black or African American,Not Hispanic or Latino,5704,Censored,1145,Alive,1145,2011,2014,AAML1031,54.4,15,8,Yes,No,,No,Yes,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,Yes,No,"-Y,add(7q) resulting in 7q deletion. SCR 4-7-15.",3,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[13]/45,idem,add(7)(q32)[5]/46,XY[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAXJIH,Female,White,Not Hispanic or Latino,2384,Censored,1004,Alive,1004,2015,2018,AAML1031,3.5,33,8,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XX,t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWKHN,Male,Unknown,Not Hispanic or Latino,266,Censored,1639,Alive,1639,2014,2018,AAML1031,23.9,40,8,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,4,Other,"48,XY,t(6;9)(p21;p13.3),t(7;8)(p15;q22.3),+8,+der(19)t(6;19) [18]/46,XY[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAWWWE,Male,Unknown,Unknown,339,Relapse,207,Dead,270,2015,2015,AAML1031,2.7,43,8,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,dup 17q,1,Other,"46,XY,dup(17)(q11.2q25)[17]/46,XY[3]",No,N/A,,No,No,,,,Yes,4.0999999999999996,No,,not in CR,CR,Standard Risk,Unknown,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAVERG,Male,Unknown,Hispanic or Latino,3939,Relapse,556,Dead,1128,2012,2015,AAML1031,1.3,54,8,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,Yes,13,Yes,,not in CR,CR,Standard Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAUJCF,Female,White,Hispanic or Latino,3976,Relapse,742,Alive,2681,2011,2018,AAML1031,88.9,83,8,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XX,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAVZBM,Female,White,Not Hispanic or Latino,540,Censored,1636,Alive,1636,2013,2018,AAML1031,54,46,8,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,cryp ins(8;11)(q?;q23q23)[29]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWCBJ,Male,White,Not Hispanic or Latino,6539,Censored,1605,Alive,1605,2013,2018,AAML1031,15,30,9,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"t(3;16)(q10;p10),t(4;6)(q25;q21)",2,Other,"46,XY,t(3;16)(q10;p10),t(4;6)(q25;q21)[10]/46,XY[10]",Yes,0.06,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAWVGF,Female,White,Not Hispanic or Latino,745,Relapse,399,Alive,1259,2015,2018,AAML1031,282.2,40,9,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XX,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Low Risk,Unknown,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAVUZN,Female,White,Not Hispanic or Latino,582,Relapse,185,Alive,1241,2013,2016,AAML1031,5.7,93,9,Yes,No,,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,Yes,No,No,gain of 1q,2,MLL,"46,XX,t(10;11)(p12;q23)[1]/46,idem,der(2)t(1;2)(q32;q37)[33]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,No,No,Yes,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWNGC,Male,White,Hispanic or Latino,1619,Censored,1506,Alive,1506,2014,2018,AAML1031,48.2,21,10,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAXGPF,Female,White,Hispanic or Latino,3222,Censored,950,Alive,950,2015,2018,AAML1031,4.1,68,10,Unknown,No,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,,N/A,Unknown,,No,N/A,,No,No,,,,No,0,No,0,CR,CR,,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWEKW,Male,White,Not Hispanic or Latino,576,Relapse,385,Dead,890,2014,2016,AAML1031,9.5,80,10,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,cryp ins(10;11)(p12;q23q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWDEG,Female,White,Not Hispanic or Latino,5485,Censored,468,Alive,468,2014,2015,AAML1031,4.4,95,11,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,Yes,47,,,not in CR,unevaluable,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWIUS,Female,White,Not Hispanic or Latino,5478,Induction failure,35,Alive,1611,2014,2018,AAML1031,35.4,48,11,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,idic(7p),2,MLL,"46,XX,t(1;11)(q21;q23)[23]/46,idem,idic(7)(p12)[4]",No,N/A,,No,No,,,,Yes,1,,,not in CR,not in CR,Standard Risk,No,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAWGYG,Female,White,Not Hispanic or Latino,1269,Relapse,114,Dead,125,2014,2014,AAML1031,17.7,11,11,Yes,No,,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,"+6,+19,+21",6,Other,"50,XX,del(1)(q21),+6,del(7)(q32),+12,+19,+21[20]/46,XX[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVHWZ,Female,White,Not Hispanic or Latino,211,Relapse,70,Dead,131,2012,2013,AAML1031,9.5,,11,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"+6,+7,+17,+19,t(19;22)(p13.3;q13),+der(19)t(19;22)(p13.3;q13),+21",>6,Other,"53,XX,t(1;22)(p13;q13),+der(1)t(1;22)(p13;q13),+6,+7,+17,+19,t(19;22) (p13.3;q13),+der(19)t(19;22)(p13.3;q13),+21[9]/46,XX[11]",No,N/A,,No,No,,,,No,0,,,not in CR,unevaluable,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML (megakaryoblastic) with  t(1;22)(p13;q13); RMB15-MKL1
TARGET-20-PAWIEJ,Female,White,Not Hispanic or Latino,6485,Censored,1769,Alive,1769,2014,2019,AAML1031,8,28,12,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,-X,2,t(8;21),"45,-X,t(8;21)(q22;q22)[19]/46,XX[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAXMRA,Female,White,Not Hispanic or Latino,8799,Relapse,223,Alive,878,2016,2018,AAML1031,13.1,37,12,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.08,,Yes,No,,,,Yes,0.2,No,0,CR,CR,Low Risk,Unknown,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVLGZ,Male,White,Not Hispanic or Latino,5353,Censored,1925,Alive,1925,2013,2018,AAML1031,4.4,60,12,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,,No,N/A,,No,No,,,,Yes,0.4,Yes,,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWNFJ,Female,White,Not Hispanic or Latino,6373,Censored,810,Alive,810,2014,2016,AAML1031,39,68,12,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.06,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAXDDY,Male,White,Hispanic or Latino,8339,Relapse,482,Alive,1074,2015,2018,AAML1031,5.1,80,12,Yes,No,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,,N/A,Unknown,,No,N/A,,No,No,,,,No,0,No,0,CR,unevaluable,,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAXKZA,Female,White,Not Hispanic or Latino,6166,Death without remission,8,Dead,8,2015,2015,AAML1031,37.4,13,13,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XX,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,,,,,death,death,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAWMAV,Male,Black or African American,Not Hispanic or Latino,585,Censored,1491,Alive,1491,2014,2018,AAML1031,364,72,13,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(11;16)(q23;q24)[18]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXJNP,Male,White,Not Hispanic or Latino,6467,Censored,1110,Alive,1110,2015,2018,AAML1031,6.4,94,13,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,,1,Other,"45,XY,-7[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAUNHG,Male,Black or African American,Not Hispanic or Latino,502,Death,732,Dead,732,2011,2013,AAML1031,7.6,25,14,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[30]",No,N/A,,No,No,,,,No,0,,,CR,unevaluable,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAVGNC,Male,White,Hispanic or Latino,5890,Censored,1239,Alive,1239,2012,2016,AAML1031,36,26,14,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XY,+dmim[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAWNIK,Female,Unknown,Unknown,3140,Censored,1659,Alive,1659,2014,2019,AAML1031,63.1,29,14,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XX,inv(16)(p13.1q22)[19]/46,XX[1]",No,N/A,,No,No,,,,No,7.0000000000000007E-2,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWLUE,Male,White,Not Hispanic or Latino,5900,Relapse,386,Alive,1493,2014,2018,AAML1031,36.3,35,15,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,der(9)t(9;11)(q34;q22)  but NOT MLL rearranged. results in  gain of MLL,3,inv(16),"46,XY,inv(16)(p13.1q22)[8]/46,idem,der(9)t(9;11)(q34;q22) [5]/47,idem,+13[7]",Yes,0.03,,No,No,,,,No,0,No,0,CR,CR,Low Risk,Unknown,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAXFEE,Male,White,Not Hispanic or Latino,632,Censored,1096,Alive,1096,2015,2018,AAML1031,14.2,93,15,Yes,No,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,,N/A,Unknown,,No,N/A,,No,No,,,,Yes,15,No,,not in CR,CR,,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAWBRP,Female,White,Not Hispanic or Latino,6426,Relapse,263,Alive,789,2013,2016,AAML1031,79.7,39,15,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"47,XX,+13[9]/46,XX[11]",No,N/A,,No,No,,,,No,0,,,CR,unevaluable,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXKTN,Female,White,Not Hispanic or Latino,2434,Censored,766,Alive,766,2015,2018,AAML1031,20.2,40,16,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,Yes,"-X, del(9)(q13q34.2)",3,t(8;21),"45,X,-X,t(8;21)(q22;q22),del(9)(q13q34.2)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVIYS,Female,White,Not Hispanic or Latino,3202,Relapse,353,Alive,1931,2012,2018,AAML1031,4.6,84,16,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,Yes,No,,,,Yes,1.7,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAWVCG,Male,Unknown,Not Hispanic or Latino,287,Relapse,268,Alive,1260,2014,2018,AAML1031,52.2,86,16,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(9;11)(p22;q23)[18]/46,XY[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,No,Yes,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAWHZX,Female,Unknown,Not Hispanic or Latino,2734,Censored,1737,Alive,1737,2014,2019,AAML1031,42.8,35,17,Yes,No,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(11;19)(q23;p13.1)[16]/46,XX[4]",No,N/A,,No,No,,,,Yes,0.2,,,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAXISV,Female,Asian,Not Hispanic or Latino,3732,Censored,386,Alive,386,2015,2016,AAML1031,6.5,40,17,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XX,t(8;21)(q22;q22)[17]/46,XX[3]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Low Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVAFA,Male,White,Not Hispanic or Latino,599,Induction failure,59,Dead,771,2012,2014,AAML1031,25.9,40,17,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"t(1;2;1)(p36.3;q11.2;p32),t(2;13)(q31;q14),add(8)(p21), t(9;12)(q34;q13)",4,Other,"46,XY,t(1;2;1)(p36.3;q11.2;p32),t(2;13)(q31;q14),add(8)(p21),t(9;12)(q34;q13)[14]/46,XY[6]",No,N/A,,No,No,,,,Yes,4,No,0,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAUWYZ,Female,White,Not Hispanic or Latino,6542,Censored,2291,Alive,2291,2012,2018,AAML1031,2.8,42,17,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWTKY,Male,White,Not Hispanic or Latino,398,Censored,640,Alive,640,2014,2016,AAML1031,37,70,17,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(5;11)(q31;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXEEY,Male,White,Not Hispanic or Latino,1060,Induction failure,64,Alive,64,2015,2015,AAML1031,8.5,35,18,Yes,No,,No,No,No,No,No,No,No,No,No,No,Yes,No,No,Yes,No,No,Yes,No,"-Y,+6,+9,del(9)(q13q22),+12,+21",>6,Other,"48,X,-Y,+6,+9,del(9)(q13q22),+12,del(13)(q12q22)[12]/49,XY,+8,+19,+21[7]/ 46,XY[4]",No,N/A,,No,No,,,,Yes,0.4,No,0,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAWIXW,Male,White,Not Hispanic or Latino,1128,Relapse,407,Dead,610,2014,2016,AAML1031,2.6,85,18,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,2,Other,"47,Y,t(X;10)(p10;p10),+8[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,Yes,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWMGT,Female,White,Not Hispanic or Latino,678,Censored,1672,Alive,1672,2014,2019,AAML1031,3.9,98,18,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAULSL,Female,White,Hispanic or Latino,646,Censored,2586,Alive,2586,2011,2018,AAML1031,11.3,81,18,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,der(9)inv(9)(p22q34)t(9;11)(p22;q23),der(11)t(9;11)(p22;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVNXC,Male,White,Not Hispanic or Latino,3781,Censored,1814,Alive,1814,2013,2018,AAML1031,6.3,36,19,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,2,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[16]/46,XY[4]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWLTG,Female,White,Not Hispanic or Latino,6218,Censored,1575,Alive,1575,2014,2018,AAML1031,3.8,44,19,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAVUBN,Male,White,Not Hispanic or Latino,5399,Relapse,335,Dead,509,2013,2014,AAML1031,1.3,80,19,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XY,t(1;2)(p36;p21)[17]/46,XY[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXEHH,Male,Black or African American,Not Hispanic or Latino,5879,Censored,1100,Alive,1100,2015,2018,AAML1031,13.9,83,19,Yes,No,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,,N/A,Unknown,,No,N/A,,No,No,,,,No,0,No,0,CR,CR,,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAVXLM,Female,Black or African American,Not Hispanic or Latino,5917,Censored,702,Alive,702,2013,2015,AAML1031,2.9,26,20,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,-X,2,t(8;21),"46,XX,ins(21;8)(q22;q23q22)[14]/45,idem,-X[5]/46,XX[1]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWEFF,Male,White,Not Hispanic or Latino,1168,Censored,1781,Alive,1781,2014,2018,AAML1031,6.1,29,20,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,3,MLL,"48,XY,t(1;11;19)(q21;q23;q13.2),+der(19)t(11;19)x2)[17]/46,XY[3]",No,N/A,,No,No,,,,Yes,0.1,No,0,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAXBDM,Male,Black or African American,Not Hispanic or Latino,4855,Relapse,650,Alive,1126,2015,2018,AAML1031,8.8,74,20,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.65,,No,No,,,,Yes,28,,,not in CR,unevaluable,High Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAVUDH,Male,White,Hispanic or Latino,1375,Relapse,166,Dead,220,2013,2014,AAML1031,4.8,20,21,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(1;11)(q21;q23)[20]",No,N/A,,No,No,,,,Yes,0.2,No,0,CR,CR,Standard Risk,Yes,No,No,No,No,Yes,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAWKIU,Female,White,Not Hispanic or Latino,984,Censored,1487,Alive,1487,2014,2018,AAML1031,17.7,40,21,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XX,t(8;21)(q22;q22)[15]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVDBT,Male,White,Not Hispanic or Latino,6095,Censored,708,Alive,708,2012,2014,AAML1031,72.1,88,21,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAWIIK,Female,White,Hispanic or Latino,6349,Censored,1589,Alive,1589,2014,2018,AAML1031,11.7,68,22,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAUNBY,Male,Unknown,Not Hispanic or Latino,1523,Relapse,188,Dead,322,2011,2012,AAML1031,37.8,83,22,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,1,Other,"47,XY,+8[19]/46,XY[1]",Yes,0.64,,No,No,,,,Yes,8.8000000000000007,,,not in CR,CR,High Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAXIJL,Female,Unknown,Unknown,6250,Censored,990,Alive,990,2015,2018,AAML1031,3.3,22,23,Yes,No,,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XX,t(6;9)(p22;q34)[17]/46,XX[3]",Yes,0.33,,No,No,,,,Yes,2.1,No,0,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(6;9)(p23;q34); DEK-NUP214
TARGET-20-PAXLGL,Male,White,Not Hispanic or Latino,7046,Relapse,629,Alive,962,2015,2018,AAML1031,6.1,39,23,Yes,No,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(11;19)(q23;p13.1)[17]/46,XY[4]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWFZT,Female,White,Hispanic or Latino,1107,Censored,1588,Alive,1588,2014,2018,AAML1031,28,70,23,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XX,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWMGH,Female,White,Not Hispanic or Latino,5433,Censored,1301,Alive,1301,2014,2018,AAML1031,31.9,72,23,Unknown,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAVRHS,Female,White,Not Hispanic or Latino,5942,Censored,1881,Alive,1881,2013,2018,AAML1031,5,,23,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XX,t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAXJVE,Female,White,Not Hispanic or Latino,833,Censored,1091,Alive,1091,2015,2018,AAML1031,71.8,23,24,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,21,2,inv(16),"46,XX,inv(16)(p13.1q22)[6]/47,idem,+21[14]",No,N/A,,No,No,,,,Yes,0.9,,,CR,unevaluable,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAVHUI,Male,White,Not Hispanic or Latino,1878,Induction failure,123,Dead,208,2012,2013,AAML1031,104.2,23,24,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,,1,Other,"45,XY,-7[20]",No,N/A,,No,No,,,,Yes,43,Yes,50,not in CR,not in CR,High Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAWZLW,Female,White,Not Hispanic or Latino,1529,Induction failure,53,Dead,263,2015,2015,AAML1031,5.5,50,24,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,,1,Other,"45,XX,-7[20]",No,N/A,,No,No,,,,Yes,46,,,not in CR,not in CR,High Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAURJK,Female,White,Not Hispanic or Latino,321,Relapse,188,Alive,2290,2011,2018,AAML1031,12.3,,24,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,Yes,No,No,"11p15, +6,+9,+16,+18, +19,+20,+22",>6,MLL,"46,XX,t(1;11)(q22;p15),t(9;11)(p22;q23),t(15;22)(q24;q13)[5]/50,idem,+6,+8,+ 18,+22[8]/52,idem,+6,+8,+9,+16,+19,+20[5]/46,XX[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAUIIB,Female,White,Not Hispanic or Latino,4395,Censored,2468,Alive,2468,2011,2018,AAML1031,7.9,69,25,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[35]",Yes,0.78,,No,No,,,,Yes,13,Yes,,not in CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAXDEG,Female,White,Hispanic or Latino,5416,Relapse,583,Alive,984,2015,2018,AAML1031,3.1,72,25,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWBUN,Female,White,Not Hispanic or Latino,660,Censored,1771,Alive,1771,2013,2018,AAML1031,17.1,78,26,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,"+6,+11",4,MLL,"48,XX,t(9;11)(p22;q23),+11,+mar[28]/49,idem,+6[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAULIY,Male,White,Not Hispanic or Latino,2075,Censored,2407,Alive,2407,2011,2018,AAML1031,8.7,84,26,Yes,No,,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"t(11;18)(p13;q21.3),del(3)(p13p21), der(6)t(6;9)(p23;q34),add(9)(q21)",4,Other,"46,XY,t(6;9)(p23;q34)[15]/46,idem,t(11;18)(p13;q21.3)[7]/46,idem,del(3)(p13p21)[4]/46,XY,der(6)t(6;9)(p23;q34),add(9)(q21)[4]",Yes,2.6,,No,No,,,,No,0,No,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(6;9)(p23;q34); DEK-NUP214
TARGET-20-PAXLBH,Male,Unknown,Hispanic or Latino,2045,Relapse,708,Alive,909,2015,2018,AAML1031,9.5,57,26,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"47,XY,t(8;21)(q22;q22),+mar?c16]/47,XY,+mar?c[4]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Low Risk,Yes,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWCJK,Female,White,Not Hispanic or Latino,6201,Relapse,260,Dead,353,2013,2014,AAML1031,121,40,26,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAWLUX,Female,White,Not Hispanic or Latino,7068,Censored,1338,Alive,1338,2014,2018,AAML1031,63.3,34,27,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.06,,Yes,No,,,,Yes,0.8,Yes,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAUXNH,Female,White,Not Hispanic or Latino,4967,Relapse,211,Dead,429,2012,2013,AAML1031,28.6,34,27,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,dup(1)(q21q32),2,t(8;21),"46,XX,dup(1)(q21q32),t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,No,0,,,CR,CR,Low Risk,No,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVEAF,Male,White,Hispanic or Latino,3225,Relapse,428,Alive,881,2012,2015,AAML1031,15.8,40,27,Yes,No,,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,,1,Other,"46,XY,del(5)(q23.3q35.1)[15]/46,XY[5]",No,N/A,,No,No,,,,Yes,7.4,No,0,not in CR,CR,High Risk,Yes,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAWCLC,Female,White,Not Hispanic or Latino,5369,Censored,723,Alive,723,2013,2015,AAML1031,6.7,66,27,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,-X,2,t(8;21),"45,X,-X,t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAXJSM,Female,Unknown,Unknown,778,Censored,912,Alive,912,2015,2018,AAML1031,14,78,27,Yes,No,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(11;19)(q23;p13.1)[19]/46,XX[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAVZCR,Male,White,Not Hispanic or Latino,4192,Censored,1631,Alive,1631,2013,2018,AAML1031,88.3,27,27,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,2,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,Yes,1.2,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAXHGG,Male,Unknown,Unknown,399,Relapse,146,Dead,213,2015,2016,AAML1031,13.9,24,28,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,Yes,No,No,"del(3)(p21.1p21.3),der(11)ins(11;10),+13,+14, +15,+20,+21,+21,+21,+22",>6,MLL,"54,XY,del(3)(p21.1p21.3),ins(11;10)(q23;p12p?11.2),der(11) ins(11;10),+13,+14,+15,+20,+21,+21,+21,+22[12]/46,XY[9]",No,N/A,,No,No,,,,Yes,4.9000000000000004,No,0,not in CR,CR,Standard Risk,No,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAXKXS,Female,Black or African American,Not Hispanic or Latino,8706,Censored,1145,Alive,1145,2015,2019,AAML1031,7.3,89,28,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,11,1,Other,"47,XX,+11[20]",Yes,0.02,,No,No,,,,Yes,79,,,not in CR,unevaluable,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAXHTS,Male,White,Not Hispanic or Latino,457,Relapse,199,Alive,929,2015,2018,AAML1031,108.9,89,28,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,ins(10;11)(p12;q23q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,Yes,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAUTWE,Male,White,Not Hispanic or Latino,664,Censored,2355,Alive,2355,2012,2018,AAML1031,15.3,62,28,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XY,inv(9)(p22q34)[19]/46,XY[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWNWV,Male,White,Not Hispanic or Latino,7526,Censored,1442,Alive,1442,2014,2018,AAML1031,20.9,24,29,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,t(11;20)(q23.1;q13.3)?C,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,,,,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAXLDJ,Female,White,Not Hispanic or Latino,4925,Death,658,Dead,658,2015,2017,AAML1031,40.8,27,29,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,Yes,33,,,not in CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAVPLL,Male,White,Not Hispanic or Latino,5260,Censored,1984,Alive,1984,2013,2018,AAML1031,9.8,64,29,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAVXME,Male,Black or African American,Not Hispanic or Latino,1375,Induction failure,87,Alive,1812,2013,2018,AAML1031,29.8,82,29,Yes,No,,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XY,t(6;9)(p23;q34)[20]",No,N/A,,No,No,,,,Yes,41,Yes,50,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(6;9)(p23;q34); DEK-NUP214
TARGET-20-PAVDAJ,Female,White,Not Hispanic or Latino,6518,Censored,2104,Alive,2104,2012,2018,AAML1031,5.3,0,30,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,Yes,,,,,,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWMJY,Male,White,Not Hispanic or Latino,4968,Censored,1484,Alive,1484,2014,2018,AAML1031,14.8,21,30,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"t(3;13)(p10;q10),r(16)(p12q22),add(4)(q31.3). Of note the 13q was not checked because it was a centromeric whole arm translocation.",3,Other,"46,XY,t(3;13)(p10;q10),r(16)(p12q22)[13]/46,idem,add(4)(q31.3)[6]/46,XY[1]",No,N/A,,No,No,,,,Yes,70,Yes,,not in CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAXJFS,Male,White,Not Hispanic or Latino,161,Relapse,237,Dead,503,2015,2017,AAML1031,14,26,30,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"+6,+6,t(11;17)(p15;q23),+21",4,Other,"47,XY,+6,t(11;17)(p15;q23)[2]/48,idem,+6[10]/49,idem,+6,+21[2]/46,XY[6]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAURII,Male,White,Not Hispanic or Latino,4929,Induction failure,67,Dead,256,2011,2012,AAML1031,4.7,50,30,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.72,,No,No,,,,Yes,64,Yes,,not in CR,not in CR,High Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVBIY,Male,White,Not Hispanic or Latino,4490,Death,213,Dead,213,2012,2013,AAML1031,71.6,35,31,Yes,No,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(11;19)(q23;p13.1)[16]/46,XY[4]+",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWBTJ,Female,White,Not Hispanic or Latino,310,Censored,1686,Alive,1686,2013,2018,AAML1031,21,48,31,Yes,No,,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,,2,Other,"46,XX,der(7)del(7)(q22q36)t(7;12)(q36;p13.3),der(12)t(7;12)(q36;p13.3)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAUZRY,Female,White,Hispanic or Latino,6512,Censored,2115,Alive,2115,2012,2018,AAML1031,17.1,53,32,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX.cryp ins(21)(8;21)(q22;q22q22)[?]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAXLHS,Female,Black or African American,Not Hispanic or Latino,2838,Relapse,956,Alive,956,2015,2018,AAML1031,7.6,81,32,Yes,No,,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,Yes,No,Yes,-X,2,MLL,"45,X,-X,der(7)(7pter->7q22::11q23->11qter),der(10)(7qter->7q22::11q13->11q23::10p12->10qter),der(11)t(10;11)(p12;q23)[19]/46,XX[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWNPG,Male,White,Not Hispanic or Latino,1431,Relapse,578,Alive,1357,2014,2018,AAML1031,18.8,45,33,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XY,t(8;21)(q22;q22)[12]/46,XY[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVLPL,Female,Black or African American,Not Hispanic or Latino,3465,Censored,1994,Alive,1994,2013,2018,AAML1031,5.7,57,33,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,-X,2,t(8;21),"46,XX,t(8;21)(q22;q22)[15]/45,idem,-X[3]/46,XX[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAUIPM,Male,White,Not Hispanic or Latino,3561,Censored,2721,Alive,2721,2011,2019,AAML1031,27.7,95,33,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,,No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXEBW,Female,Black or African American,Not Hispanic or Latino,5605,Relapse,139,Dead,368,2015,2016,AAML1031,15.5,38,34,Yes,No,,No,No,No,No,No,No,No,No,No,No,Yes,No,No,Yes,No,No,No,No,del(9)(q12q22),2,Other,"46,XX,del(9)(q12q22)[10]/47,idem,+8[10]",Yes,0.06,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAXDHL,Male,White,Not Hispanic or Latino,6606,Relapse,674,Alive,1356,2015,2019,AAML1031,11.2,57,34,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,-Y,1,Other,"45,X,-Y[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAVMED,Female,White,Not Hispanic or Latino,5558,Death,264,Dead,264,2013,2013,AAML1031,4.5,80,34,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,Yes,0.4,,,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAWKCU,Male,Black or African American,Not Hispanic or Latino,8608,Censored,456,Alive,456,2014,2015,AAML1031,2.9,,34,Yes,No,,Yes,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,,2,Other,"46,XY,der(6)t(6;9)(p23;q34),der(9)del(9)(q22q34)t(6;9) (p23;q34)",No,N/A,,No,No,,,,Yes,0.2,Yes,,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(6;9)(p23;q34); DEK-NUP214
TARGET-20-PAVPXS,Male,White,Not Hispanic or Latino,13,Relapse,58,Dead,178,2013,2013,AAML1031,301.4,,34,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,+X,2,MLL,"47,XY,+X,t(4;11)(q21;q23)[20]",No,N/A,,No,No,,,,No,0,Yes,15,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWYVR,Female,White,Not Hispanic or Latino,6049,Relapse,154,Dead,553,2015,2016,AAML1031,75.5,35,35,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.89,,No,No,,,,Yes,8,No,,not in CR,CR,High Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAUXNM,Female,White,Not Hispanic or Latino,3210,Relapse,553,Alive,2366,2012,2018,AAML1031,2.5,52,35,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XX,t(8;21)(q22;q22)[18]/46,XX[2]",No,N/A,,No,No,,,,Yes,0.6,,,CR,CR,Low Risk,No,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAUSCS,Female,White,Not Hispanic or Latino,6236,Relapse,398,Dead,818,2012,2014,AAML1031,4.5,61,35,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.36,,No,No,,,,Yes,0.5,,,CR,CR,Standard Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAVLZE,Male,Black or African American,Not Hispanic or Latino,2786,Relapse,106,Dead,1098,2013,2016,AAML1031,48,78,35,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[19]/46,XY[1]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Low Risk,No,No,Yes,No,No,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAXKES,Male,White,Not Hispanic or Latino,4220,Censored,1018,Alive,1018,2015,2018,AAML1031,189.1,80,35,Yes,No,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,,N/A,Unknown,,No,N/A,,No,No,,,,No,0,No,0,CR,CR,,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAUXYG,Male,White,Not Hispanic or Latino,6315,Censored,2153,Alive,2153,2012,2018,AAML1031,10.2,21,35,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[30]",Yes,0.1,,No,No,,,,Yes,0.6,Yes,,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAWTHU,Male,Black or African American,Not Hispanic or Latino,5402,Relapse,468,Alive,1317,2014,2018,AAML1031,54.7,37,36,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,Yes,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWSJC,Female,White,Hispanic or Latino,7057,Relapse,317,Dead,668,2014,2016,AAML1031,63.2,41,36,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,22,2,inv(16),"46,XX,inv(16)(p13.1q22)[8]/47,idem,+22[11]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAUZRT,Female,Unknown,Hispanic or Latino,4702,Relapse,548,Alive,1680,2012,2017,AAML1031,19.2,61,36,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,tetraploid from doubling of clone +4 in a hyperdiploid sideline,4,t(8;21),"46,XX,t(8;21)(q22;q22)[13]/47,idem,+4[5]/88,idemx2,-X,-1,-9,-11[1]/46,XX[1]",No,N/A,,No,No,,,,Yes,0.6,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWBVW,Male,White,Not Hispanic or Latino,393,Induction failure,46,Dead,85,2013,2014,AAML1031,131.5,65,36,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,Yes,No,No,"+6, +5, +15",5,MLL,"46,XY,t(9;11)(p22;q23)[2]/47,sl,+8[7]/48,sdl,+6[3]/50,sdl2,+5,+15[6]/46,XY[2]",No,N/A,,No,No,,,,Yes,7.9,,,not in CR,not in CR,Standard Risk,No,No,No,No,No,Yes,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVRUZ,Female,Black or African American,Not Hispanic or Latino,7660,Relapse,539,Dead,975,2013,2016,AAML1031,10.9,68,36,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAWUAE,Male,White,Not Hispanic or Latino,701,Relapse,214,Dead,427,2014,2016,AAML1031,51.2,88,36,Yes,No,,No,No,No,No,No,Yes,No,No,No,No,Yes,No,No,Yes,No,Yes,No,No,"add(8)(p21),der(8;12)(q10;q10),del(9)(q13q22)",5,MLL,"46,XY,add(8)(p21),der(10)t(10;11)(p12;q23)inv(11)(q14q23),der(11)t(10;11)(p12;q23)[7]/46,idem,del(9)(q13q22)[10]/46,idem,-add(8)(p21),+8,der(8;12)(q10;q10)[2]/46,XY[1]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVPMJ,Male,Black or African American,Not Hispanic or Latino,3421,Censored,696,Alive,696,2013,2015,AAML1031,6.7,90,36,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,Yes,No,,,,,,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAXKAL,Male,White,Not Hispanic or Latino,5302,Induction failure,63,Alive,132,2015,2016,AAML1031,13.4,93,36,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,"t(6;17)(q21;p13),der(7)t(7;7)(q36;p13),add(9)(p13),add(18)(q23),del(1)(q32),der(7)t(?4;7)(q21;q?32),der(7)del(7)(p13)t(7;7)(q36;p13),add(19)(q13.3)",>6,Other,"46,XY,t(6;17)(q21;p13),der(7)t(7;7)(q36;p13),add(9)(p13),add(18)(q23)[cp3]/46,sl,del(1)(q32)[2]/46,sl,der(7)t(?4;7)(q21;q?32)[3]/46,sdl2,der(7)del(7)(p13)t(7;7)(q36;p13),add(19)(q13.3)[9]/90,sdl3x2,-X,-21[cp2]",No,N/A,,No,No,,,,Yes,2.9,No,0,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWTBX,Male,Unknown,Not Hispanic or Latino,694,Censored,1581,Alive,1581,2014,2019,AAML1031,66.2,68,37,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,inv(2)(p13q14),2,Other,"45,XY,inv(2)(p13q14),-7[15]/46,XY[5]",No,N/A,,No,No,,,,No,0.06,No,0,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVRCS,Male,Unknown,Hispanic or Latino,3331,Relapse,126,Dead,191,2013,2013,AAML1031,4.3,,37,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,Yes,25,Yes,,not in CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAVDAB,Male,White,Hispanic or Latino,2846,Censored,2362,Alive,2362,2012,2019,AAML1031,5.8,77,38,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,2,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[18]/46,XY[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAULWG,Male,White,Not Hispanic or Latino,314,Relapse,145,Alive,2373,2011,2018,AAML1031,6.5,88,38,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(10;19;11)(p11.2;q13.1;q23)[14]/46,XY[6]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,No,No,Yes,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXGNI,Male,White,Not Hispanic or Latino,984,Death,424,Dead,424,2015,2016,AAML1031,22.4,68,38,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,ins(1;11)(q21;q13q23)[20]",Yes,0.41,,No,No,,,,No,0,No,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWIDI,Female,White,Hispanic or Latino,2400,Induction failure,61,Alive,1426,2014,2018,AAML1031,7.1,85,38,Yes,No,,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XX,t(6;9)(p22;q34)[20]",Yes,0.38,,No,No,,,,Yes,10,Yes,,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(6;9)(p23;q34); DEK-NUP214
TARGET-20-PAVRBA,Female,White,Not Hispanic or Latino,5691,Censored,1944,Alive,1944,2013,2018,AAML1031,61.1,15,39,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XX,t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,,,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAXFEX,Male,White,Not Hispanic or Latino,4982,Censored,1298,Alive,1298,2015,2019,AAML1031,5.9,57,39,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAWFVC,Female,White,Hispanic or Latino,6903,Censored,1612,Alive,1612,2014,2018,AAML1031,2.5,63,40,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,1,Other,"47,XX,+8[20]",Yes,0.71,,No,No,,,,No,0,No,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAXEKE,Female,White,Hispanic or Latino,5706,Censored,985,Alive,985,2015,2018,AAML1031,50.7,38,41,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAULDS,Female,American Indian or Alaska Native,Not Hispanic or Latino,5877,Censored,2502,Alive,2502,2011,2018,AAML1031,10.3,42,42,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,Yes,-Y,2,t(8;21),"45,X,-X,ins(21;8)(q22;q11.2q22)[13]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWWWM,Female,White,Not Hispanic or Latino,750,Relapse,454,Dead,661,2015,2016,AAML1031,13.3,43,42,Yes,No,,No,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"t(3;5)(q25.3;q35.1),del(6)(q15q25)",3,Other,"46,XX,der(13)del(13)(q14.11q14.13)del(13)(q14.2q14.3)[13]/46,idem,t(3;5)(q25.3;q35.1),del(6)(q15q25)[4]",No,N/A,,No,No,,,,Yes,0.5,,,CR,unevaluable,Standard Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAVHNV,Female,White,Not Hispanic or Latino,6655,Relapse,210,Dead,367,2012,2013,AAML1031,8,62,42,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[12]/46,XX[8]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,Unknown,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAWUEW,Male,White,Not Hispanic or Latino,802,Censored,1219,Alive,1219,2012,2018,AAML1031,107.5,64,42,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,13,2,t(8;21),"46,XY,t(8;21)(q22;q22)[18]/47,idem,+13[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVPZJ,Male,White,Not Hispanic or Latino,3291,Censored,2136,Alive,2136,2013,2019,AAML1031,5.1,71,42,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,1,Other,"45,X,-Y[22]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAWLEB,Male,White,Hispanic or Latino,2155,Relapse,119,Dead,131,2014,2014,AAML1031,23.3,87,42,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,i(17)(q10) which results in deletion of 17p. A +8 was not  observed cytogenetically but it was observed by FISH and  will show a discrepancy between the two methods.,3,MLL,"46,XY,t(9;11)(p22;q23)[11]/46,idem,i(17)(q10)[5]/46,XY[4]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,Yes,Yes,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVTXM,Male,White,Hispanic or Latino,2089,Death,299,Dead,299,2013,2014,AAML1031,17.2,91,42,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XY,add(19)(q13.1)[17]/46.XY[3]",No,N/A,,No,No,,,,Yes,1,No,0,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWDWA,Male,White,Not Hispanic or Latino,700,Relapse,773,Dead,879,2014,2016,AAML1031,37.9,43,43,Yes,No,,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,"ETV6 is deleted, not rearranged on the add(12) CBFB is deleted, not rearranged in this case. Cryptic deletion      inv(11) - NOT MLL",6,Other,"46,XY,del(7)(p15p22),del(8)(q22q24.1),der(11)inv(11)(p15q13.3)add(11)(q24),add(12)(p11.2)[3]/46,sl,del(9)(q21q33)[3]/46,SDL1,+mar[2]/46,XY[12]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML (megakaryoblastic) with  t(1;22)(p13;q13); RMB15-MKL1
TARGET-20-PAXAFS,Male,White,Hispanic or Latino,4957,Relapse,544,Dead,682,2015,2017,AAML1031,26.8,53,44,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,i(17)(q10),2,Other,"46,XY,t(7;11)(p15;p15)[5]/46,idem,i(17)(q10)[15]",No,N/A,,No,No,,,,,,,,CR,unevaluable,Standard Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAVMZL,Male,Unknown,Not Hispanic or Latino,4209,Censored,1931,Alive,1931,2013,2018,AAML1031,8.7,68,45,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,2,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[17]/46,XY[3]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAXGZB,Female,White,Not Hispanic or Latino,2703,Censored,1164,Alive,1164,2015,2018,AAML1031,34.8,,45,Yes,No,,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,Yes,No,No,,3,MLL,"46,XX,der(1)t(1;11)(p36.1;q13),t(10;11)(p12;q14),add(12) (p12)[14]/46,XX[6]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAURRC,Female,White,Hispanic or Latino,383,Relapse,173,Dead,181,2011,2012,AAML1031,39.9,57,46,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XX,ins(7;8)(p15;q21q22)[5]/46,XX[22]",No,N/A,,No,No,,,,Yes,0.7,No,0,not in CR,CR,Standard Risk,Yes,No,No,No,No,Yes,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAXLXJ,Male,White,Not Hispanic or Latino,4935,Censored,1120,Alive,1120,2015,2019,AAML1031,72.9,87,46,Yes,No,,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XY,t(6;9)(p23;q34)[20]",Yes,13.4,,No,No,,,,No,0,,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(6;9)(p23;q34); DEK-NUP214
TARGET-20-PAVGJG,Male,White,Not Hispanic or Latino,407,Relapse,298,Dead,392,2012,2013,AAML1031,268.3,9,47,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Low Risk,No,Yes,Yes,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWWWU,Female,Black or African American,Not Hispanic or Latino,1451,Censored,1500,Alive,1500,2015,2019,AAML1031,35.6,71,47,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(11;17)(q23;q12)[17]/46,XX[3]",No,N/A,,No,No,,,,Yes,0.1,,,CR,unevaluable,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXKKE,Female,Black or African American,Not Hispanic or Latino,4515,Censored,902,Alive,902,2015,2018,AAML1031,13.9,80,47,Yes,No,,No,No,No,No,No,No,No,Yes,No,Yes,No,No,No,No,No,No,No,No,,2,inv(16),"46,XX,der(7)t(7;8)((q31;q12),inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWTNN,Male,White,Not Hispanic or Latino,6488,Relapse,191,Dead,226,2014,2015,AAML1031,72.8,76,47,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[23]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAURAS,Male,White,Not Hispanic or Latino,5725,Censored,2344,Alive,2344,2011,2018,AAML1031,5.8,49,48,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,2,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[17]/46,XY[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAXEES,Female,White,Not Hispanic or Latino,7357,Censored,1215,Alive,1215,2015,2018,AAML1031,103.8,91,48,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[17]",Yes,0.47,,Yes,No,,,,Yes,0.1,No,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWSBW,Female,Black or African American,Not Hispanic or Latino,227,Censored,68,Alive,68,2014,2014,AAML1031,146.2,,48,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(11;17)(q23;q12)[19]/46,XX[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAVNWF,Male,White,Not Hispanic or Latino,5445,Relapse,99,Alive,1932,2013,2018,AAML1031,14.8,84,49,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,Yes,,,,Yes,7.4,,,not in CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAWIEM,Male,White,Not Hispanic or Latino,1915,Censored,1623,Alive,1623,2014,2018,AAML1031,12.7,90,49,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,"gain of 1q, loss of 16, loss of 13, loss of 12",6,MLL,"46,XY,del(1)(p13p36.1),+der(1)t(1;?21)(p22;?q11),-16,del(21)(q11.2)[14]/44,idem,der(2)t(2;12)(p13;q11),der(11)t(11;13)(q23;q12),-12,-13[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVXZH,Male,White,Not Hispanic or Latino,4443,Censored,1756,Alive,1756,2013,2018,AAML1031,4.8,61,50,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,Yes,,,,No,0,,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAXBXU,Male,White,Not Hispanic or Latino,6493,Censored,669,Alive,669,2015,2017,AAML1031,34.5,68,50,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,t(6;10)(p23;p14),1,Other,"46,XY,t(6;10)(p23;p14)[18]/46,XY[2]",Yes,2.94,,No,No,,,,No,0,No,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAWERN,Female,White,Not Hispanic or Latino,4957,Censored,1489,Alive,1489,2014,2018,AAML1031,96.5,70,50,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XX,inv(16)(p13.1q22)[17]/46,XX[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWPMA,Male,Asian,Not Hispanic or Latino,2638,Relapse,428,Alive,1302,2014,2018,AAML1031,3,80,50,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,Yes,No,No,No,"+10,+12,+13,+18,+21,+22",>6,Other,"51,XY,+10,+12,+13,+21,+22[12]/53,idem,+8,+18[3]/46,XY[5]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAUZMH,Female,White,Not Hispanic or Latino,5613,Relapse,222,Dead,315,2012,2013,AAML1031,42,95,50,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,duplication of 17q21-17qter,4,Other,"47,XX,+8[2]/47,idem,dup(17)(q21q25)[7]/47,idem,der(20)t(17;20)(q21;p13)[5]/47,idem,der(17)t(17;17)(p11.1;q21)[4]/47,idem,der(5)t(5;?9)(p15.1;?q13),t(17;17)[1]/47,idem,i(17)(q10)[1]",No,N/A,,Yes,No,,,,No,0,No,0,not in CR,CR,Low Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWSTK,Male,White,Not Hispanic or Latino,4841,Relapse,439,Dead,558,2014,2016,AAML1031,25.4,45,50,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,1,Other,"47,XY,+8[19]/46,XY[1]",No,N/A,,No,No,,,,Yes,4,No,0,not in CR,CR,Standard Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAUSXS,Female,White,Not Hispanic or Latino,6477,Censored,2012,Alive,2012,2012,2017,AAML1031,41.8,9,50,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XX,inv(16)(p13.1q22)[18]/46,XX[2]",No,N/A,,No,No,,,,No,0,,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWVNP,Male,White,Not Hispanic or Latino,3283,Censored,1216,Alive,1216,2015,2018,AAML1031,40.6,63,51,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,3,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[21]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVMBH,Male,Unknown,Hispanic or Latino,1845,Relapse,149,Dead,181,2013,2013,AAML1031,9.5,,52,Yes,No,,No,No,No,No,No,No,Yes,No,No,No,Yes,No,No,No,No,Yes,No,No,del(9)(q21.2q32),2,MLL,"46,XY,t(11;19)(q23;p13.1)[4]/46,idem,del(9)(q21.2q32)[26]",No,N/A,,No,No,,,,Yes,1.2,,,not in CR,CR,Standard Risk,Yes,No,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAWGPM,Male,White,Hispanic or Latino,5619,Relapse,394,Alive,1616,2014,2018,AAML1031,48.6,50,53,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,"loss of Y, doubling of the stem line with losses of 1,2,4,5,6,7,9,10,16,17",>6,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[16]/80,idem x 2,-1,-2,-4,-5,-6,-7,-9,-10,-16,-17[4]",No,N/A,,No,No,,,,Yes,1,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAVRGN,Male,Unknown,Not Hispanic or Latino,2406,Relapse,606,Alive,771,2013,2015,AAML1031,13.5,51,53,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,2,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[16]/46,XY[4]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVEEI,Female,White,Not Hispanic or Latino,5446,Relapse,209,Dead,248,2012,2013,AAML1031,2.2,67,53,Yes,No,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,"-21,der(14)t(1;14)(q12;p12)",4,MLL,"46,XX,t(11;19)(q23;p13.3),der(14)t(1;14)(q12;p12)[1]/45,idem,-21[4]/45,idem,del(13)(q21q33),-21[7]/46,XX[7]",No,N/A,,No,No,,,,No,0,,,CR,unevaluable,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXBLX,Male,Black or African American,Not Hispanic or Latino,886,Relapse,502,Alive,1308,2015,2018,AAML1031,5.6,86,53,Yes,No,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,Yes,No,Yes,No,No,"+Y,+9,extra der(19)",5,MLL,"50,XY,+Y,+8,+9,t(11;19)(q23;p13.1),+der(19)t(11;19)(q23;p13.1)[17]/46,XY[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWHIZ,Female,White,Not Hispanic or Latino,6372,Censored,350,Alive,350,2014,2015,AAML1031,5.1,,53,Yes,No,,No,No,No,No,No,Yes,No,No,No,No,Yes,No,No,No,No,Yes,No,No,"t(10;11)(p12.3;q14.2),del(12)(p11.2p13), add(17)(q25),del(9)(q22q32)",4,MLL,"46,XX,t(10;11)(p12.3;q14.2),del(12)(p11.2p13),add(17)(q25)[12]/46,idem,del(9)(q22q32)[8]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVDBK,Male,Black or African American,Not Hispanic or Latino,5696,Censored,2195,Alive,2195,2012,2018,AAML1031,32.3,90,54,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XY,t(8;21)(q22;q22)[20]/46,XY[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAUZRX,Male,Black or African American,Not Hispanic or Latino,6334,Censored,2393,Alive,2393,2012,2019,AAML1031,90.5,52,55,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,21,2,t(8;21),"46,XY,t(8;16;21)(q22;p11.2;q22)[16]/47,idem,+21[4]",No,N/A,,No,No,,,,Yes,2.2999999999999998,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAXKIB,Female,White,Hispanic or Latino,1781,Censored,1163,Alive,1163,2015,2019,AAML1031,20,70,55,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,3,t(8;21),"46,XX,t(1;18)(q42;q23),der(8)inv(8)(p11.2q21)t(8;21) (q22;q22),der(21)t(8;21)(p11.2;q22)[8]/45,idem,-X[12]",No,N/A,,No,No,,,,Yes,1.4,Yes,,unevaluable,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAVCHU,Male,White,Hispanic or Latino,5687,Censored,2311,Alive,2311,2012,2018,AAML1031,5.2,78,55,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,2,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,No,0,,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVJCJ,Male,White,Not Hispanic or Latino,5805,Relapse,28,Dead,575,2012,2014,AAML1031,46.2,82,55,Yes,No,,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,cryp ins(6;11)(q27;q23q23)[20]",No,N/A,,No,No,,,,No,0,,,not in CR,not in CR,Standard Risk,No,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAWFTV,Female,White,Not Hispanic or Latino,1331,Censored,1723,Alive,1723,2014,2018,AAML1031,291.5,,55,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,21,2,inv(16),"47,XX,t(16;16)(p13.1;q22),+21[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAUNVK,Male,White,Not Hispanic or Latino,1035,Censored,1981,Alive,1981,2011,2017,AAML1031,13.3,60,56,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,,3,t(8;21),"45,X,-Y,der(8)ins(21;8)(q22;q22q21)t(8;10)(q22;p11.2),der(10)t(8;10),der(21)ins(21;8)",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAXLEF,Female,White,Unknown,547,Relapse,98,Alive,908,2015,2018,AAML1031,218.4,79,56,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,Yes,No,No,No,No,Yes,No,No,del(9)(p11p22),3,MLL,"46,XX,der(9)t(9;11)(p22;q23)del(9)(p11p22),der(11)t(9;11)(p22;q23),add(20)(q13.3)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,No,No,No,No,Yes,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAXDEX,Female,White,Not Hispanic or Latino,3595,Censored,1198,Alive,1198,2015,2018,AAML1031,18.4,74,57,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.7,,Yes,No,,,,No,0,No,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWRUX,Female,Unknown,Not Hispanic or Latino,256,Censored,1323,Alive,1323,2014,2018,AAML1031,75.9,54,57,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,19,2,Other,"47,XX,t(1;22)(p13;q13),+19[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML (megakaryoblastic) with  t(1;22)(p13;q13); RMB15-MKL1
TARGET-20-PAUYUH,Female,Unknown,Not Hispanic or Latino,967,Death,322,Dead,322,2012,2013,AAML1031,17.8,64,58,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,21,2,Other,"48,XX,+8,+21[18]/46,XX[2]",No,N/A,,No,No,,,,No,0,No,0,CR,unevaluable,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAUUYJ,Female,White,Not Hispanic or Latino,5734,Relapse,650,Dead,1334,2012,2015,AAML1031,9,73,58,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAVNVF,Male,White,Not Hispanic or Latino,1870,Censored,1000,Alive,1000,2013,2015,AAML1031,18.9,83,58,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,"add(5)(q31), -Y",3,t(8;21),"45,X,-Y,cryp ins(8;21)(q22;q22q22)[8]/45,idem,add(5)(q31)[13]/46,XY[4]",No,N/A,,No,No,,,,No,0,,,CR,unevaluable,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVJVS,Female,White,Not Hispanic or Latino,6353,Induction failure,60,Alive,1914,2013,2018,AAML1031,27.5,91,58,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[23]",Yes,0.61,,No,No,,,,Yes,27,Yes,,not in CR,not in CR,High Risk,No,Yes,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAVBVA,Male,White,Not Hispanic or Latino,6396,Relapse,469,Dead,659,2012,2014,AAML1031,56.4,38,59,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,1,Other,"47,XY,+8[20]",Yes,0.78,,No,No,,,,Yes,0.7,Yes,,CR,CR,High Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWZKW,Male,White,Not Hispanic or Latino,1961,Censored,1234,Alive,1234,2015,2018,AAML1031,15.2,70,59,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,Yes,No,No,No,No,,2,inv(16),"47,XX,+8,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWGSX,Male,White,Not Hispanic or Latino,2511,Censored,1590,Alive,1590,2014,2018,AAML1031,10.5,79,59,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,del 9q,2,t(8;21),"46,XY,t(8;21)(q21;q21),del(9)(q12q21)[16]/46,XY[4]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWGEW,Male,Black or African American,Not Hispanic or Latino,2938,Censored,1677,Alive,1677,2014,2018,AAML1031,5.7,26,60,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,,3,Other,"45,XY,-7[17]/47,idem,+Y,+21[3]",No,N/A,,No,No,,,,No,0,,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAWAIG,Male,White,Hispanic or Latino,6449,Relapse,237,Dead,266,2013,2014,AAML1031,1.8,70,60,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,Yes,Yes,No,"MLL is NOT rearranged; however, MLL is amplified. There are four copies on the der(16), one on the Mar 1 in Clone 1, in addition to one on each of the normal #11 chromosomes. SCR-BH AGREED AT COG MEETING [4-14] THAT THE CASE IS NOT MLL REARRANGED, THUS É",>6,MLL,"59,X,-Y,+4,-5,+8,+8,+10,+11,der(11)cryp del(11)(q23q23)inv(11)p15q23),+13,+13,+14,der(16)hsr(p13.3),+17,del(17)(p11.2p13),+19,+20,+21,+22,+mar1,+mar2[cp4].ish der(16)(MLL++++).ish mar1 (MLL+). ish der(11)(MLL-)  This is one of three related clones, thiÉ",No,N/A,,No,No,,,,,,Yes,,not in CR,CR,Standard Risk,Yes,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAXMLW,Female,White,Hispanic or Latino,4248,Relapse,104,Alive,936,2016,2018,AAML1031,97,90,60,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,2.06,,No,No,,,,Yes,43,Yes,,not in CR,CR,High Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAUUWT,Female,White,Not Hispanic or Latino,4176,Relapse,295,Dead,1388,2012,2015,AAML1031,39.7,45,61,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAVYVR,Male,White,Hispanic or Latino,358,Censored,1539,Alive,1539,2014,2018,AAML1031,38.7,69,61,Yes,No,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(11;19)(q23;p13.1)[13]/46,XY[7]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAVWJK,Female,White,Hispanic or Latino,8223,Induction failure,74,Dead,505,2013,2014,AAML1031,12.8,87,61,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[18]/46,XX[2]",No,N/A,,No,No,,,,Yes,19,Yes,,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAXBZH,Female,White,Unknown,5333,Death,100,Dead,100,2015,2015,AAML1031,17.2,,61,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.3,,No,No,,,,No,0,No,0,unevaluable,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWTDZ,Male,White,Hispanic or Latino,6992,Censored,1245,Alive,1245,2014,2018,AAML1031,150.9,,61,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAWAAX,Male,White,Not Hispanic or Latino,1454,Censored,1931,Alive,1931,2013,2019,AAML1031,36.6,59,62,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,2,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,No,0,,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVCVD,Male,White,Hispanic or Latino,1784,Relapse,293,Dead,469,2012,2013,AAML1031,43.6,61,62,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(9;11)(p22;q23)[20]",No,N/A,,No,No,,,,Yes,3.9,Yes,,unevaluable,CR,Standard Risk,Yes,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAWYKA,Male,White,Hispanic or Latino,3073,Censored,1103,Alive,1103,2015,2018,AAML1031,23,65,62,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[30]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAXIFA,Male,White,Not Hispanic or Latino,2406,Induction failure,71,Dead,189,2015,2016,AAML1031,35.2,82,63,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,Yes,Yes,No,No,No,No,"+8,+8,+8,+8  six copies total of chromosome 8",5,Other,"45,XY,-7[13]/50,XY,+8,+8,+8,+8[7]",No,N/A,,No,No,,,,Yes,0.3,No,0,not in CR,not in CR,High Risk,No,No,No,No,No,Yes,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVZZC,Female,White,Not Hispanic or Latino,3373,Induction failure,32,Dead,480,2013,2015,AAML1031,219.8,,63,Yes,No,,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(6;11)(q27;q23)[20]",No,N/A,,No,No,,,,Yes,37,,,not in CR,not in CR,Standard Risk,No,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVMPA,Female,White,Not Hispanic or Latino,3348,Censored,1956,Alive,1956,2013,2018,AAML1031,40.7,98,64,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,extra copy der(9)t(9;11),2,MLL,"46,XX,t(9;11)(p22;q23)[24]/47,idem,+der(9)t(9;11)(p22;q23)[2]",No,N/A,,No,No,,,,Yes,8.5,No,0,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXCYN,Female,Unknown,Not Hispanic or Latino,745,Relapse,396,Alive,1232,2015,2018,AAML1031,73.5,80,65,Yes,No,,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(6;11)(q27;q23)[19]/46,XX[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVKNA,Female,Black or African American,Not Hispanic or Latino,5053,Censored,1968,Alive,1968,2013,2018,AAML1031,21.1,85,65,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,Yes,No,,,,No,0,No,0,not in CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAWUMM,Female,White,Not Hispanic or Latino,5792,Relapse,249,Dead,507,2014,2016,AAML1031,38.5,89,65,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVKPK,Male,White,Hispanic or Latino,2361,Censored,1980,Alive,1980,2013,2018,AAML1031,29.4,75,66,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAVZJM,Female,White,Not Hispanic or Latino,6144,Censored,1887,Alive,1887,2013,2018,AAML1031,57.4,83,66,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9*;11;9*)(p22;q23;q34)[22]/46,XX[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAUXKI,Male,White,Not Hispanic or Latino,6095,Relapse,351,Dead,721,2012,2014,AAML1031,11.8,53,68,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,"-Y,add(10)(p15),add(7)(q36)",5,t(8;21),"46,XY,der(5)t(5;13)(q11.2;q12),der(8)t(8;21)(q22;q22),der(13)t(5;13)(q11.2;q12)t(5;8)(q35;q22),der(21)t(?5;21)(q35;q22)[1]/45,sl,-Y[7]/45,sl1,add(10)(p15)[8]/46,sl,add(7)(q36)[7]",Yes,7.0000000000000007E-2,,No,No,,,,No,0,No,0,CR,CR,Low Risk,Unknown,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWJPN,Male,White,Not Hispanic or Latino,3811,Censored,1720,Alive,1720,2014,2019,AAML1031,83.1,84,68,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,11,1,Other,"47,XY,+11[15]",Yes,0.41,,No,No,,,,Yes,1.9,,,not in CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAUTJD,Male,White,Not Hispanic or Latino,884,Relapse,245,Dead,302,2012,2012,AAML1031,72.1,91,68,Yes,No,,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(10;11)(p12;q23)[19]/46,XY[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,Yes,Yes,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWSHR,Male,Unknown,Not Hispanic or Latino,2842,Relapse,425,Alive,1553,2014,2019,AAML1031,17.2,80,68,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"del(2q), add(8q) to the p of der(8)t(8;21).",2,t(8;21),"46,XY,del(2)(q33.1q36.1),der(8)(8qter->8q22.1::8p23->8q22::21q22->21qter),der(21)t(8;21)(q22;q22)/46,XY[1]",No,N/A,,No,No,,,,Yes,1.9,,,not in CR,unevaluable,Low Risk,No,Yes,No,No,No,Yes,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAVSFB,Male,White,Unknown,4439,Relapse,287,Dead,1383,2013,2017,AAML1031,232.6,41,69,Yes,No,,No,No,No,No,No,No,Yes,No,No,Yes,No,No,No,No,No,Yes,No,No,,2,Other,"46,XY,t(11;19)(q23;p13.3)[1]/46,idem,del(7)(q31q34)[10]",Yes,0.01,,No,No,,,,Yes,1,No,0,CR,CR,Standard Risk,Yes,Yes,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAVUAP,Male,White,Not Hispanic or Latino,5091,Relapse,329,Alive,1904,2013,2018,AAML1031,74.1,91,69,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,Yes,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWAMM,Male,Asian,Not Hispanic or Latino,6259,Relapse,263,Alive,1855,2013,2018,AAML1031,160,35,70,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAXCVR,Female,Black or African American,Not Hispanic or Latino,735,Censored,1232,Alive,1232,2015,2018,AAML1031,157.5,82,70,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAWACC,Female,White,Not Hispanic or Latino,1874,Censored,1924,Alive,1924,2013,2019,AAML1031,276.2,97,70,Yes,No,,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(6;11)(q27;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAUUSX,Male,Unknown,Not Hispanic or Latino,50,Induction failure,66,Dead,498,2012,2013,AAML1031,11.1,,70,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,12,2,MLL,"46,XY,t(2;11;17;6;10)(q35;q23;q21;p23;p11.2)[4}/47,idem,+12[14]/46,XY[3]",No,N/A,,No,No,,,,No,0,No,0,unevaluable,not in CR,Standard Risk,No,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXCLX,Male,White,Not Hispanic or Latino,144,Censored,1224,Alive,1224,2015,2018,AAML1031,332.1,,70,Unknown,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,t(7;16)(p22;p11.2),2,MLL,"46,XY,t(7;16)(p22;p11.2),t(11;17)(q23;q12)[20]/46,XY[5]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAVLBB,Male,White,Hispanic or Latino,5537,Death,281,Dead,281,2013,2013,AAML1031,18.9,70,71,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,Yes,1,,,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAXMIJ,Female,White,Not Hispanic or Latino,2280,Relapse,288,Alive,940,2016,2018,AAML1031,60.7,78,71,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,del 9q -X,3,t(8;21),"46,XX,t(8;21)(q22;q22)[2]/45,idem,-X[7]/46,idem,del(9)(q13q22)[5]/46,XX[6]",No,N/A,,No,No,,,,Yes,0.6,Yes,,CR,CR,Low Risk,No,Yes,No,Yes,No,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVFDW,Female,Unknown,Not Hispanic or Latino,6287,Relapse,811,Alive,879,2012,2015,AAML1031,15.8,79,71,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.02,,Yes,No,,,,No,0,,,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAVZBA,Male,White,Not Hispanic or Latino,5948,Death,82,Dead,82,2013,2013,AAML1031,212.4,50,72,Yes,No,,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(6;11)(q27;q23)[6]/46,XY[1]",No,N/A,,No,No,,,,Yes,54,,,not in CR,unevaluable,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAVVAB,Male,White,Not Hispanic or Latino,3182,Relapse,769,Dead,1349,2013,2017,AAML1031,51.6,91,72,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,+der(9)t(9;11)t(9;19) der(19)t(9;19),3,MLL,"46,XY,der(9)(11qter->11q23::9p22->9q13::19q13.4->19qter),der(11)t(9;11)(p22;q23),der(19)(19pter->19q13.4::9q13->9qter)[11]/47,idem,+der(9)(11qter->11q23::9p22->9q13::19q13.4->19qter)[12]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVYVH,Male,White,Hispanic or Latino,6105,Censored,1953,Alive,1953,2013,2019,AAML1031,19.9,,72,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAXANS,Male,White,Not Hispanic or Latino,4042,Censored,1414,Alive,1414,2015,2019,AAML1031,255.6,80,73,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,variant of the t(5;11)(q35;p15.4),1,Other,"46,XX,t(5;11;11)(q35.2;p15.4;q13.2)[20]",Yes,0.57999999999999996,,No,No,,,,Yes,16,No,,not in CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXETC,Male,White,Not Hispanic or Latino,6235,Relapse,100,Dead,149,2015,2015,AAML1031,84.1,85,73,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,"der(11)del(11)(p15)add(11)(q21),add(17)(q25), +der(?)t(?;11)(?;q23->q23::q23->q23;?)",4,Other,"48,XY,+8,der(11)del(11)(p15)add(11)(q21),add(17)(q25),+der(?)t(?;11)(?;q23->q23::q23->q23;?)[13]/46,XY[7]",No,N/A,,No,No,,,,Yes,37,No,0,not in CR,CR,Standard Risk,No,Yes,No,Yes,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAUVBZ,Male,Black or African American,Not Hispanic or Latino,3451,Relapse,455,Alive,2164,2012,2018,AAML1031,38.4,88,73,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,Yes,No,No,No,22,2,Other,"48,XY,+21,+22[26]/46,XY[1]",Yes,0.41,,No,No,,,,Yes,0.8,Yes,,CR,CR,High Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAXGTM,Male,White,Not Hispanic or Latino,4285,Death,191,Dead,191,2015,2016,AAML1031,54.5,89,73,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,dup(3)(q21q29) does not rearrange MECOM,1,Other,"46,XY,dup(3)(q21q29)[19]/46,XY[1]",Yes,1.1599999999999999,,No,No,,,,No,0,,,CR,CR,High Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWZUF,Male,White,Hispanic or Latino,4589,Relapse,196,Dead,532,2015,2016,AAML1031,214.7,,73,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.8,,No,No,,,,,,No,,CR,CR,High Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWCAW,Male,White,Not Hispanic or Latino,1871,Induction failure,96,Alive,1601,2013,2018,AAML1031,329.2,79,73,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,1.0900000000000001,,No,No,,,,Yes,16,Yes,,not in CR,not in CR,High Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAVJZU,Female,Unknown,Unknown,4872,Censored,1877,Alive,1877,2013,2018,AAML1031,34.6,74,74,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,Yes,No,,,,,,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWXCM,Male,Black or African American,Not Hispanic or Latino,6181,Censored,1474,Alive,1474,2015,2019,AAML1031,8.6,78,74,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,t(16;21)(q24;q22),2,Other,"47,XY,+8,t(16;21)(q24;q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAXFAG,Female,Black or African American,Not Hispanic or Latino,4060,Censored,1254,Alive,1254,2015,2019,AAML1031,39.8,85,75,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[15]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWFMF,Female,Black or African American,Not Hispanic or Latino,5510,Censored,1469,Alive,1469,2014,2018,AAML1031,29.7,90,76,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,Yes,,,,Yes,0.7,Yes,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAXEET,Female,Black or African American,Not Hispanic or Latino,3941,Induction failure,109,Dead,183,2015,2016,AAML1031,140,,76,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,1,Other,"47,XX,+8[20]",Yes,0.52,,No,No,,,,Yes,3.9,,,not in CR,not in CR,High Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAVWVT,Female,White,Not Hispanic or Latino,3156,Relapse,184,Alive,2019,2013,2019,AAML1031,64.3,86,77,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[30]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAVIDK,Male,White,Not Hispanic or Latino,2116,Censored,1994,Alive,2099,2012,2018,AAML1031,49,90,77,Yes,No,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,Yes,No,Yes,No,No,"+6,+9,+13,+18,+21 extra copy of der(19)t(11;19)",>6,MLL,"49,XY,+6,+8,t(11;19)(q23;p13.3),+der(19)t(11;19)[15]/53,idem,+9,+13,+18,-der(19),+19,+21[5]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVCMR,Female,White,Not Hispanic or Latino,6614,Relapse,526,Dead,675,2012,2014,AAML1031,27,49,77,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XX,t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,No,0,,,CR,unevaluable,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVUPX,Male,American Indian or Alaska Native,Not Hispanic or Latino,1051,Censored,2023,Alive,2023,2013,2019,AAML1031,280.1,86,78,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,2,MLL,"46,XY,t(9;11)(p22;q23),der(20)t(9;20)(q13;p13)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAWLTL,Female,White,Hispanic or Latino,526,Relapse,100,Alive,134,2014,2014,AAML1031,264.3,86,78,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,t(8;16)(q13;q24) +21,3,Other,"48,XX,+8,t(8;16)(q13;q24),+21[20]",No,N/A,,No,No,,,,Yes,1.7,,,not in CR,unevaluable,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAXCFI,Male,Black or African American,Not Hispanic or Latino,4328,Relapse,150,Dead,331,2015,2016,AAML1031,409.4,,78,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,1,Other,"47,XY,+8[20]",Yes,0.81,,No,No,,,,No,0,No,,CR,CR,High Risk,No,Yes,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAVBWL,Female,White,Not Hispanic or Latino,2438,Censored,2427,Alive,2427,2012,2019,AAML1031,130.9,79,78,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,,Yes,0.57999999999999996,,No,Yes,,,,No,0,No,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAWGRP,Male,White,Hispanic or Latino,4840,Relapse,365,Dead,662,2014,2016,AAML1031,12.4,68,79,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,Yes,No,No,,3,MLL,"47,XY,der(5)(5pter->5q33::11q23->?11qter),+8,der(9) t(9;10)(q32;q22),der(10)(5qter->5q33::11q2311q23::10p12- >10q22::9q32->9qter),der(11)(11pter->11q23::?)[15]/46,XY[5]  .ish der (5)ins(11)(q23)(3'MLL+),der(10)ins(11)(q23)(5'MLL+)[15]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWBSF,Female,White,Not Hispanic or Latino,2274,Relapse,238,Dead,316,2013,2014,AAML1031,51.4,70,79,Yes,No,,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,Yes,No,No,"+3,+18,+19,+21,+der(10)",6,MLL,"51,XX,+3,t(10;11)(p12;q23),+der(10)t(10;11),+18,+19,+21[19]/46,XX[1]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Yes,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAUZVP,Male,Black or African American,Not Hispanic or Latino,5593,Relapse,733,Dead,1044,2012,2015,AAML1031,1.5,79,79,Yes,No,,No,No,No,No,No,No,No,No,Yes,Yes,No,No,No,No,No,No,No,No,"+1,inv(1)(p36.1q44)x3,-2,+3,dic(7;13)(q10;q10)x2,-11,-17,-18,-21",>6,Other,"87(<4n),XXYY,+1,inv(1)(p36.1q44)x3,-2,+3,add(3)(q12)x2, del(5)(q13q33)x2,del(7)(q22q36)x2,dic(7;13)(q10;q10)x2,-11,-17,-18,-21[15]/86,idem,-9[3].ish cryp amp ABL1",No,N/A,,No,No,,,,Yes,5,,,not in CR,CR,High Risk,Yes,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVIZK,Male,Asian,Not Hispanic or Latino,4797,Censored,2070,Alive,2070,2012,2018,AAML1031,127.5,,79,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,Yes,,,,No,0,No,0,not in CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWNYX,Female,Black or African American,Not Hispanic or Latino,2726,Relapse,335,Dead,492,2014,2016,AAML1031,75.6,55,80,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVAYD,Male,Black or African American,Not Hispanic or Latino,2428,Death,154,Dead,154,2012,2012,AAML1031,316.4,82,80,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[19]/46,XY[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAVPFR,Male,White,Not Hispanic or Latino,3697,Relapse,317,Alive,2036,2013,2018,AAML1031,40.7,83,80,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,2,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[20]",No,N/A,,No,No,,,,Yes,3.2,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVHTL,Female,White,Not Hispanic or Latino,3629,Relapse,684,Alive,2170,2012,2018,AAML1031,58,90,80,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAVZEC,Female,White,Not Hispanic or Latino,5131,Relapse,759,Alive,1988,2013,2019,AAML1031,7.5,96,80,Yes,No,,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,"der(9)add(9)(q34)del(9)(q12q22),+10,t(12;13)(p12;q14),t(12;15)(p12;q21)/duplication clone",5,Other,"47,XX,der(9)add(9)(q34)del(9)(q12q22),+10,t(12;13)(p12;q14),t(12;15)(p12;q21)[17]/94,idemx2[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,Yes,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVGYA,Female,White,Hispanic or Latino,7853,Relapse,346,Dead,497,2012,2014,AAML1031,44.7,97,80,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,4,Other,"46,XX,t(1;2)(p34;p13),+4,del(12)(p11.2),+5[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,No,No,No,No,Yes,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVCNG,Male,White,Unknown,5386,Relapse,279,Alive,2196,2012,2018,AAML1031,186.5,,80,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWANV,Male,White,Not Hispanic or Latino,238,Relapse,915,Alive,1713,2013,2018,AAML1031,117.4,69,81,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[15]/46,XY[5]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,No,No,No,No,Yes,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWKLC,Male,Native Hawaiian or other Pacific Islander,Hispanic or Latino,4683,Censored,1507,Alive,1507,2014,2018,AAML1031,33.3,76,81,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XY,t(8;21)(q22;q22)[19]/46,XY[1]",No,N/A,,No,No,,,,No,0,,,not in CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWLAG,Male,White,Not Hispanic or Latino,729,Relapse,377,Dead,730,2014,2016,AAML1031,76.3,77,81,Yes,No,,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(10;11)(p12;q23)[14]/46,XY[7]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,Yes,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAXFEA,Male,Unknown,Not Hispanic or Latino,5205,Censored,1145,Alive,1145,2015,2018,AAML1031,170.2,78,81,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,+21 -Y,3,Other,"47,XY,t(9;17)(q32;q11.2),+12[5]/45,X,-Y[14]/46,XY[1]",Yes,0.28999999999999998,,No,Yes,,,,,,,,unevaluable,unevaluable,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAVNIX,Male,White,Not Hispanic or Latino,5803,Relapse,290,Dead,302,2013,2014,AAML1031,130.6,80,81,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,1.82,,Yes,No,,,,No,0,,,CR,unevaluable,High Risk,No,No,No,No,No,Yes,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAXMNG,Female,White,Not Hispanic or Latino,6128,Relapse,1161,Alive,1161,2016,2019,AAML1031,58.2,83,81,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,N/A,MLL,"46,XX,t(9;11)(p22;q23)[19]/46,XX[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAXGSJ,Male,White,Not Hispanic or Latino,1941,Censored,1251,Alive,1251,2015,2019,AAML1031,262,86,81,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"del(3)(q12q21)[MECOMX2, RPM1X1],t(5;11)(q32;q22),del(14)(q24q32)",3,Other,"46,XY,del(3)(q12q21),t(5;11)(q32;q22),del(14)(q24q32)[23]",Yes,0.47,,No,No,,,,Yes,1.2,,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAUPXH,Male,White,Not Hispanic or Latino,8168,Censored,2458,Alive,2458,2011,2018,AAML1031,39.4,87,81,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,Yes,No,,,,No,0,,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAWHPL,Male,White,Not Hispanic or Latino,964,Relapse,366,Alive,1712,2014,2018,AAML1031,200.1,,81,Yes,No,,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(6;11)(q27;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,Yes,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWMPH,Female,White,Not Hispanic or Latino,4452,Induction failure,24,Alive,1614,2014,2019,AAML1031,129.5,41,82,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XX,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,,,,,not in CR,not in CR,Low Risk,No,No,Yes,No,No,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAXHLD,Female,White,Not Hispanic or Latino,1726,Relapse,419,Alive,1239,2015,2019,AAML1031,42.3,78,82,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAVZHF,Male,White,Not Hispanic or Latino,6418,Death,355,Dead,355,2013,2014,AAML1031,27.3,81,82,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,4,1,Other,"47,XY,+4[35]/46,XY[7]",No,N/A,,No,No,,,,Yes,3.6,No,,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAUUHV,Female,White,Not Hispanic or Latino,5125,Relapse,102,Dead,217,2012,2012,AAML1031,247.8,81,82,Unknown,No,,No,No,No,Yes,No,No,No,No,No,No,Yes,No,No,Yes,No,Yes,No,No,"+4, +6, +12, del(9q)",6,MLL,"50,XX,+4,+6,cryp ins(6;11)(q27;q23q23),+8,del(9)(q13q32),+12[20]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAUJNJ,Female,White,Not Hispanic or Latino,837,Relapse,209,Alive,2523,2011,2018,AAML1031,141.7,87,82,Yes,No,,No,No,No,No,No,No,No,No,No,No,Yes,No,No,Yes,No,No,No,No,del(9q),2,Other,"47,XX,+8,del(9)(q13q22)[10]",No,N/A,,No,No,,,,Yes,31,Yes,,not in CR,CR,Standard Risk,Yes,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAUULL,Female,White,Hispanic or Latino,443,Relapse,114,Dead,243,2012,2012,AAML1031,155.2,88,82,Yes,No,,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,Yes,No,No,gain of 1q gain of 8q,5,MLL,"46,XY,t(10;11)(p11.2;q23)[3]/46,idem,i(8)(q10),der(8;12)(q10;q10)[14]/46,idem,der(14)t(1;14)(q11;p11.2)[3]/46,idem,der(10)t(1;10)(q11;p15)[1]",No,N/A,,No,No,,,,No,0,Yes,,CR,CR,Standard Risk,No,Yes,No,Yes,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXGRE,Male,White,Not Hispanic or Latino,1118,Censored,1268,Alive,1268,2015,2019,AAML1031,196.3,89,82,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,t(3;21)(q26.2;q22),2,Other,"45,XY,t(3;21)(q26.2;q22),-7[20]",No,N/A,,No,No,,,,Yes,0.1,Yes,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAXMFG,Female,White,Not Hispanic or Latino,4428,Censored,1069,Alive,1069,2016,2018,AAML1031,10.5,91,82,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,-X,2,t(8;21),"45,X,-X,t(8;21)(q22;q22)[19]/46,XX[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWHAX,Female,White,Not Hispanic or Latino,4484,Censored,1589,Alive,1589,2014,2018,AAML1031,29.5,89,82,Unknown,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAWLAJ,Male,White,Not Hispanic or Latino,4631,Censored,1483,Alive,1483,2014,2018,AAML1031,208.8,80,83,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,t(4;9)(p16;p13),2,inv(16),"46,XY,t(16;16)(p13.1;q22)[13]/46,idem,t(4;9)(p16;p13)[7]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWTWW,Male,White,Not Hispanic or Latino,6054,Relapse,481,Dead,570,2014,2016,AAML1031,206.9,86,83,Yes,No,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,Yes,No,Yes,No,No,10,3,MLL,"47,XY,+8,t(11;19)(q23;p13.1)[19]/48,idem,+10[2]",Yes,0.09,,No,No,,,,No,0,,,CR,unevaluable,Standard Risk,No,No,Yes,Yes,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVFPR,Female,White,Not Hispanic or Latino,5685,Censored,2012,Alive,2012,2012,2018,AAML1031,63.8,90,83,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XX,t(8;21)(q22;q22)[18]/46,XX[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAXEWS,Male,White,Not Hispanic or Latino,196,Censored,1257,Alive,1257,2015,2019,AAML1031,74.2,55,84,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,2,Other,"47,XY,t(7;12)(q36;p13),+19[20]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAXHCC,Male,White,Not Hispanic or Latino,4165,Censored,915,Alive,1154,2015,2018,AAML1031,89.3,60,84,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.1,,No,Yes,,,,No,0,,,CR,unevaluable,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAVVCS,Male,White,Not Hispanic or Latino,9732,Relapse,221,Alive,2035,2013,2019,AAML1031,176.3,64,84,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAXEFX,Male,White,Not Hispanic or Latino,5131,Relapse,269,Alive,1264,2015,2019,AAML1031,154.6,73,84,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,der(X)t(X;8)(q28;q13),2,Other,"47,XY,+8[4]/46,Y,der(X)t(X;8)(q28;q13)[13]/46,XY[2]",Yes,0.55000000000000004,,No,No,,,,Yes,45,Yes,,not in CR,unevaluable,High Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAXAXY,Male,White,Hispanic or Latino,6563,Relapse,349,Alive,1190,2015,2018,AAML1031,11.4,74,84,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,Yes,,,,No,0,No,0,not in CR,CR,Low Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAVHUF,Female,Black or African American,Not Hispanic or Latino,2514,Induction failure,74,Dead,477,2012,2014,AAML1031,400.2,82,84,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,Yes,57,,,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAVTRU,Male,White,Not Hispanic or Latino,5306,Relapse,270,Dead,780,2013,2015,AAML1031,157,86,84,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,1,Other,"47,XY,+8[4]/46,XY[20]",Yes,0.81,,No,No,,,,,,,,CR,unevaluable,High Risk,Yes,No,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVYYR,Male,White,Not Hispanic or Latino,5981,Relapse,211,Dead,248,2013,2014,AAML1031,101.7,95,84,Yes,No,,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(6;11)(q27;q23)[15]/46,XY[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWURP,Female,White,Hispanic or Latino,218,Censored,1216,Alive,1216,2014,2018,AAML1031,186.3,71,84,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,The reviewer believes this to be a variant of the t(X;6)  resulting in GATA1-MYB fusion.,2,Other,"46,X,ins(X;6)(p11.2;q23.3q25)[14]/47,idem,+13[6]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAXKZN,Female,White,Not Hispanic or Latino,2051,Censored,953,Alive,953,2015,2018,AAML1031,453.8,72,85,Yes,No,,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,3,3,MLL,"48,XX,+3,cryp ins(6;11)(q27;q23q23),+19[19]/46,XX[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAUVCL,Female,White,Not Hispanic or Latino,6328,Relapse,227,Dead,261,2012,2012,AAML1031,96.2,73,85,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,6.84,,Yes,No,,,,Yes,0.9,Yes,,CR,CR,High Risk,Unknown,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAWPBT,Male,White,Not Hispanic or Latino,3396,Relapse,629,Alive,1524,2014,2018,AAML1031,8.2,86,85,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[21]",No,N/A,,No,No,,,,Yes,49,No,,not in CR,CR,Standard Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWMDY,Male,White,Not Hispanic or Latino,6465,Death,249,Dead,249,2014,2015,AAML1031,21.8,88,85,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWIVB,Male,Black or African American,Not Hispanic or Latino,5171,Relapse,391,Alive,1729,2014,2019,AAML1031,246.7,95,85,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(9;11)(p22;q23)[20]",Yes,0.01,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,No,Yes,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAWMLK,Male,White,Not Hispanic or Latino,5836,Censored,1598,Alive,1598,2014,2018,AAML1031,50,75,86,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[60]",Yes,0.02,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAVNKI,Female,White,Not Hispanic or Latino,7663,Relapse,216,Alive,1726,2013,2017,AAML1031,85,80,86,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,22,2,inv(16),"46,XX,inv(16)(p13.1q22)[14]/47,idem,+22[6]",Yes,0.04,,No,No,,,,No,0,No,0,CR,CR,Low Risk,Unknown,Yes,Yes,No,No,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAXIJB,Male,White,Not Hispanic or Latino,2590,Relapse,407,Alive,1221,2015,2019,AAML1031,53,66,87,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,-Y,2,t(8;21),"45,X,-Y,t(8;21)(q22;q22)[18]/46,XY[2]",No,N/A,,No,No,,,,Yes,0.9,No,0,CR,CR,Low Risk,Unknown,Yes,Yes,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVAAS,Female,Black or African American,Not Hispanic or Latino,5402,Relapse,276,Dead,552,2012,2013,AAML1031,60.5,73,87,Unknown,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,4,2,t(8;21),"46,XX,t(8;21)(q22;q22)[4]/47,idem,+4[20]",No,N/A,,No,No,,,,No,0,,,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAVBUX,Male,American Indian or Alaska Native,Not Hispanic or Latino,6340,Relapse,162,Dead,426,2012,2013,AAML1031,143.7,79,87,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.05,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAVDYE,Female,White,Not Hispanic or Latino,2682,Relapse,630,Dead,1379,2012,2016,AAML1031,71.2,87,87,Yes,No,,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,Yes,No,No,"+21,+21",3,MLL,"46,XX,t(6;11)(q27;q23)[14]/48,idem,+21,+21[6]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAUWUZ,Male,Unknown,Not Hispanic or Latino,6011,Censored,2526,Alive,2526,2012,2019,AAML1031,49.3,90,87,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,-18,4,Other,"45,XY,-7[2]/44,idem,add(2)(q11/2),der(12)t(2;12)(q11.2;p12),-18[19]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAUVGD,Male,White,Not Hispanic or Latino,2928,Relapse,115,Alive,2321,2012,2018,AAML1031,92.4,90,87,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,2,Other,"46,XY,t(5;12)(q35;p13),add(17)(p11.2)[20]",Yes,0.78,,No,No,,,,Yes,12,No,,not in CR,CR,High Risk,No,No,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAXCWR,Male,White,Hispanic or Latino,5393,Censored,1145,Alive,1248,2015,2018,AAML1031,130.5,93,87,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,,1,Other,"47,XY,+8[20]",Yes,7.06,,No,No,,,,No,0,,,CR,unevaluable,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWKIW,Female,Black or African American,Not Hispanic or Latino,3249,Death without remission,35,Dead,35,2014,2014,AAML1031,172.8,,87,Unknown,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,,,,,death,death,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVDPF,Female,White,Hispanic or Latino,798,Relapse,294,Dead,449,2012,2013,AAML1031,185.3,85,88,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"47,XX,+19[2]/46,XX[2]",No,N/A,,No,No,,,,Yes,12,No,0,not in CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAVDXS,Male,White,Hispanic or Latino,5192,Relapse,711,Dead,985,2012,2015,AAML1031,155.4,90,88,Yes,No,,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,Yes,No,No,t(10;11)(p12;q14),1,MLL,"46,XY,t(10;11)(p12;q14)[20]",No,N/A,,No,No,,,,Yes,0.2,,,CR,unevaluable,Standard Risk,Yes,Yes,No,Yes,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAWMKP,Male,Black or African American,Not Hispanic or Latino,4968,Relapse,520,Alive,1596,2014,2018,AAML1031,82.1,91,88,Yes,No,,No,Yes,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,del(7)(q36) seen at time of relapse and retrospectively checked and it is there. just too subtle. SCR. 1-25-16.,2,t(8;21),"46,XY,del(7)(q36),t(8;21)(q22;q22)[10]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAUWYR,Female,White,Not Hispanic or Latino,5757,Censored,2400,Alive,2400,2012,2018,AAML1031,47.1,91,88,Yes,No,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,Yes,No,Yes,No,No,,2,MLL,"47,XX,+8,t(11;19)(q23;p13.3)[14]/46,XX[6]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVBZY,Female,White,Not Hispanic or Latino,3596,Censored,2398,Alive,2398,2012,2019,AAML1031,240,,88,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAUPPD,Male,White,Hispanic or Latino,2222,Relapse,302,Dead,914,2011,2014,AAML1031,308,,88,Unknown,No,,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(6;11)(q27;q23)[19]/46,XY[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,No,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWGCP,Male,Unknown,Unknown,3040,Censored,1694,Alive,1694,2014,2018,AAML1031,49.8,60,89,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[18]/46,XY[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWKPU,Male,White,Not Hispanic or Latino,3888,Death,345,Dead,345,2014,2015,AAML1031,61.7,83,89,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XY,ins(5;3)(q35;q12q25.3)[15]/46,XY[5]",Yes,15.8,,No,No,,,,No,0,,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWAKF,Male,White,Not Hispanic or Latino,4159,Relapse,358,Dead,1158,2013,2017,AAML1031,473.2,,89,Unknown,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XY,t(5;11)(q15;q14)[20]",No,N/A,,No,No,,,,Yes,59,No,0,not in CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAUSMT,Female,Unknown,Hispanic or Latino,3813,Relapse,262,Dead,413,2012,2013,AAML1031,455.4,94,89,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,t(16;21)(p11.2;q22),1,Other,"46,XX,t(16;21)(p11.2;q22)[16]/46,XX[5]",No,N/A,,No,No,,,,Yes,1.3,No,0,CR,CR,Standard Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAUVMN,Female,White,Not Hispanic or Latino,4744,Relapse,315,Alive,2240,2012,2018,AAML1031,307.5,90,90,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,Yes,,,,Yes,13,No,0,not in CR,CR,Low Risk,No,Yes,Yes,No,No,No,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAVPVK,Female,White,Not Hispanic or Latino,1560,Censored,1246,Alive,1246,2013,2016,AAML1031,106.9,95,90,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[18]/46,XX[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAUPDB,Female,White,Not Hispanic or Latino,5550,Induction failure,62,Dead,556,2011,2013,AAML1031,307.3,,90,Yes,No,,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,,N/A,Unknown,,Yes,0.7,,No,No,,,,Yes,86,,,not in CR,not in CR,High Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWCKH,Female,Black or African American,Not Hispanic or Latino,3083,Censored,1553,Alive,1553,2013,2018,AAML1031,218.4,64,91,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,Yes,,,,No,0,,,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAUWEW,Male,White,Not Hispanic or Latino,8026,Censored,494,Alive,494,2012,2013,AAML1031,55.2,85,91,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWICA,Male,White,Not Hispanic or Latino,146,Relapse,74,Alive,1694,2014,2018,AAML1031,550,,91,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(5;11)(p15.3;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,not in CR,Standard Risk,No,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAVKKI,Female,Unknown,Hispanic or Latino,1557,Relapse,419,Dead,632,2013,2014,AAML1031,165,,91,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.83,,No,No,,,,Yes,18,,,not in CR,CR,High Risk,Yes,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAVVAM,Female,Black or African American,Not Hispanic or Latino,4014,Relapse,441,Dead,651,2013,2015,AAML1031,16.2,76,92,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,add(7)(q32),3,t(8;21),"46,XX,add(7)(q32),t(5;21;8)(q22;q22;q22)[18]/47,idem,+8[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAUWNT,Female,Black or African American,Not Hispanic or Latino,4130,Death,2315,Dead,2315,2012,2018,AAML1031,68.3,88,92,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,del 11q,2,t(8;21),"46,XX,t(8;11;21)(q22;q13;q22),del(11)(q22)[18]/46,XX[2]",No,N/A,,No,No,,,,Yes,70,Yes,,not in CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAXLJV,Male,White,Unknown,5129,Censored,1050,Alive,1050,2015,2018,AAML1031,392,95,92,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.79,,No,Yes,,,,,,,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAVWBB,Male,White,Hispanic or Latino,7214,Censored,1960,Alive,1960,2013,2018,AAML1031,164.7,95,92,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.56999999999999995,,Yes,No,,,,No,0,No,,CR,CR,High Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAXLYJ,Female,White,Not Hispanic or Latino,2407,Censored,822,Alive,822,2016,2018,AAML1031,49.1,71,93,Yes,No,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,gain 1q del 9q,2,MLL,"46,XX,der(9)t(1;9)(q21;q12),t(11;19)(q23;p13.3) [19]/46,XX[1]",No,N/A,,No,No,,,,,,,,not in CR,unevaluable,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWTYD,Female,Black or African American,Not Hispanic or Latino,4683,Induction failure,54,Dead,294,2014,2015,AAML1031,438.3,,93,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,,2,Other,"45,XX,der(3)inv(3)(p22q21)inv(3)(q21q26),-7[20]",Yes,0.04,,No,No,,,,Yes,22,,,not in CR,not in CR,High Risk,No,No,Yes,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAXIIP,Female,Unknown,Not Hispanic or Latino,4879,Censored,1200,Alive,1200,2015,2019,AAML1031,174.8,89,94,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"46,XX,t(8;22)(p11.1;q13)[19]/46,XX[1]",1,Other,"46,XX,t(8;22)(p11.1;q13)[15]/46,XX[5]",No,N/A,,No,No,,,,No,0,No,0,CR,unevaluable,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAWUWJ,Male,White,Not Hispanic or Latino,3132,Relapse,360,Alive,1308,2014,2018,AAML1031,185.1,95,94,Yes,No,,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,"del 9q, +21",2,Other,"47,XY,del(9)(q12q22),+21[2]/46,XY[18]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXGYZ,Male,White,Not Hispanic or Latino,2578,Death without remission,3,Dead,3,2015,2015,AAML1031,478.5,,94,Unknown,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,der(X)t(X;16)(q22;q22),2,inv(16),"46,Y,der(X)t(X;16)(q22;q22),der(16)inv(16)(p13.1q22)t(X;16)(q22;q22)[20]",No,N/A,,No,No,,,,,,,,death,death,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAVESI,Female,White,Not Hispanic or Latino,1749,Induction failure,76,Alive,275,2012,2013,AAML1031,407.6,,94,Unknown,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.87,,No,No,,,,Yes,0.2,Yes,,not in CR,not in CR,High Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAUYCA,Male,White,Not Hispanic or Latino,5304,Censored,864,Alive,864,2012,2014,AAML1031,209.6,93,94,Unknown,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWSJZ,Male,White,Not Hispanic or Latino,7484,Death,179,Dead,179,2014,2015,AAML1031,12.2,26,95,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,22,2,inv(16),"46,XY,inv(16)(p13.1q22)[16]/47,idem,+22[8]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWBVL,Female,Black or African American,Not Hispanic or Latino,4693,Induction failure,77,Alive,1635,2013,2018,AAML1031,211.1,77,95,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,6,1,Other,"47,XX,+6[14]/46,XX[5]",Yes,0.81,,No,No,,,,Yes,35,Yes,,not in CR,not in CR,High Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAUUTI,Male,White,Not Hispanic or Latino,4138,Censored,2546,Alive,2546,2012,2019,AAML1031,96.2,85,95,Unknown,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAURJZ,Male,White,Not Hispanic or Latino,764,Relapse,393,Alive,2301,2011,2018,AAML1031,257.6,87,95,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,likely variant of the t(16;21),2,Other,"47,XY,t(7;8;21;16)(p15;q24;q22;q24),+der(8)t(7;8;21;16)[17]/46,XY[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,Yes,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWUUE,Female,Asian,Not Hispanic or Latino,3452,Censored,1270,Alive,1270,2014,2018,AAML1031,171.7,89,95,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[21]",Yes,1.29,,Yes,No,,,,No,0,No,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAVHFP,Female,White,Hispanic or Latino,5339,Relapse,385,Alive,2319,2012,2019,AAML1031,523.7,92,95,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,,Yes,0.56999999999999995,,No,Yes,,,,No,0,No,,CR,CR,High Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAVTRM,Female,White,Not Hispanic or Latino,4575,Relapse,476,Alive,1858,2013,2018,AAML1031,160,94,95,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAVALK,Female,White,Hispanic or Latino,146,Relapse,543,Alive,2205,2012,2018,AAML1031,712.7,95,95,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[10]/46,XX[10]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXBHX,Female,White,Not Hispanic or Latino,1518,Induction failure,13,Alive,1312,2015,2018,AAML1031,206.4,,95,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[16]",Yes,0.92,,No,No,,,,,,,,not in CR,not in CR,High Risk,No,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWSWU,Male,White,Not Hispanic or Latino,211,Death without remission,11,Dead,11,2014,2014,AAML1031,542.5,,95,Unknown,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(9;11)(p22;q23)[20]",No,N/A,,No,No,,,,,,,,death,death,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAWRGZ,Female,White,Not Hispanic or Latino,3283,Censored,1402,Alive,1402,2014,2018,AAML1031,195,92,95,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20} on bone marrow 46,XX[20} on blood",Yes,0.67,,Yes,No,,,,No,0,No,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAVSYK,Female,White,Not Hispanic or Latino,1683,Death,284,Dead,284,2013,2014,AAML1031,918.5,,95,Unknown,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,der(21)t(16;21)(p11.2;q22.3),6,Other,"46,XX,der(2)t(2;19)(q37.1;q13.3),del(12)(p11.2p13),+r(12)(p?12?q11),-16,r(19)(p13.3q13.3)der(21)t(16;21)(p11.2;q22.3)[20]",No,N/A,,No,No,,,,Yes,0.1,No,,not in CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWEAD,Female,White,Not Hispanic or Latino,2816,Relapse,531,Alive,1566,2014,2018,AAML1031,322.4,75,96,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",Yes,0.84,,No,No,,,,Yes,0.2,No,,not in CR,CR,High Risk,Yes,No,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAVNHN,Female,Asian,Not Hispanic or Latino,1378,Relapse,137,Dead,209,2013,2013,AAML1031,217.1,84,96,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,Yes,No,No,"+1,i(1)(q10),del(4)(p14p16),+22",6,MLL,"49,XX,+1,i(1)(q10),del(4)(p14p16),+8,t(9;11)(p21;q23),+22[4]/46,XX[16]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAVWEA,Female,White,Not Hispanic or Latino,187,Censored,1918,Alive,1918,2013,2018,AAML1031,355.6,,97,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11)(p22;q23)[22]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVLYV,Male,White,Hispanic or Latino,4058,Relapse,253,Alive,1870,2013,2018,AAML1031,357.9,,97,Unknown,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,Yes,No,No,,2,MLL,"46,XY,t(9;11)(p22;q23)[14]/47,idem,+8[6]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,Yes,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAWGTG,Male,White,Not Hispanic or Latino,1858,Induction failure,101,Dead,224,2014,2014,AAML1031,55,97,98,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"t(X;7)(p11.4;p15),del(11)(q21),der(1)t(1;1)(p36.1;q21)",3,Other,"46,XY,t(X;7)(p11.4;p15),del(11)(q21)[2]/46,idem,der(1)t(1;1)(p36.1;q21)[18]",No,N/A,,No,No,,,,Yes,1.6,Yes,24,CR,not in CR,Standard Risk,No,Yes,No,Yes,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAUUKZ,Male,White,Not Hispanic or Latino,124,Relapse,302,Alive,2242,2012,2018,AAML1031,310,98,99,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,t(9;11)(p22;q23)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,Yes,Yes,No,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAWUUY,Female,White,Hispanic or Latino,2417,Relapse,494,Alive,1235,2014,2018,AAML1031,22.1,17,26,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,loss of X,2,t(8;21),"45,X,-X,t(8;21)(q22;q22)[19]/46,XX[1]",No,N/A,,No,No,,,,Yes,6.2,No,0,CR,CR,Low Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAXIEG,Female,White,Hispanic or Latino,5411,Relapse,153,Alive,916,2015,2018,AAML1031,79.8,18,17,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,"+4,+13,+15,+18,+19,+20,+der(21),+21  ?del(9)(q13;q21.2)",>6,t(8;21),"46,XX,t(8;21)(q22q22),?del(9)(q13q21.2) [17]/49,idem,+4,+15,+der(21)t(8;21) [2]/53,idem,+13,+15,+18,+19,+20,+21,+der(21)[4]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,No,Yes,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAXIPM,Female,White,Hispanic or Latino,5324,Censored,892,Alive,892,2015,2018,AAML1031,5.5,24,4,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAVFKS,Male,White,Not Hispanic or Latino,6467,Censored,1638,Alive,1638,2012,2017,AAML1031,1.5,25,7,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAUYKH,Male,White,Not Hispanic or Latino,768,Relapse,284,Alive,2261,2012,2018,AAML1031,7.2,28,10,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,>6,Other,"47,XY,+21[2]/47,sl,Y,t(X;4)(q12;q31.2),del(3)(q24;q26.3),add(9)(q34),del(13)(q12q14.3)[3]/47,sl1,inv(3)(p14q25)[2]/47,sl2,der(X)t(X;7)(q12;q11.2),r(7)(p11.2q11.2)[4]/46,XY[9]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAXGDZ,Female,White,Not Hispanic or Latino,141,Censored,1244,Alive,1244,2015,2019,AAML1031,110.2,29,20,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAWGAZ,Male,Black or African American,Not Hispanic or Latino,5267,Censored,203,Alive,203,2014,2014,AAML1031,2.8,30,1,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,12,1,Other,"47,XY,+12[2]/46,XY[100]",No,N/A,,No,No,,,,Yes,0.3,Yes,,CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAVSAN,Male,Asian,Not Hispanic or Latino,1951,Relapse,451,Alive,1840,2013,2018,AAML1031,81.6,30,29,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13q22)[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,Unknown,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAXKUA,Male,White,Not Hispanic or Latino,3501,Censored,874,Alive,874,2015,2018,AAML1031,21.9,35,,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[30]",Yes,0.02,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAXIPJ,Female,White,Not Hispanic or Latino,4970,Censored,1236,Alive,1236,2015,2019,AAML1031,8.1,36,10,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,2,inv(16),"46,XX,inv(2)(p11.2q14.2),inv(16)(p13.1;q22)[9]/46,XX[11]",No,N/A,,No,No,,,,No,0.05,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAWKJC,Male,Asian,Not Hispanic or Latino,3551,Relapse,876,Dead,939,2014,2017,AAML1031,4.6,36,18,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.23,,No,No,,,,Yes,13,,,CR,CR,Standard Risk,Yes,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAUNYL,Male,White,Not Hispanic or Latino,5082,Relapse,296,Dead,495,2011,2013,AAML1031,0.9,37,,Yes,No,,No,No,No,No,No,No,Yes,No,No,No,No,No,No,Yes,No,Yes,No,No,,2,MLL,"47,XY,+8,t(11;19)(q23;p13.3)[20]",No,N/A,,No,No,,,,No,0,No,0,unevaluable,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWJVZ,Female,White,Not Hispanic or Latino,3000,Relapse,142,Dead,339,2014,2015,AAML1031,18.4,60,,Yes,No,,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,,1,Other,"46,XX,r(7)(p12q21)[11]",No,N/A,,No,No,,,,Yes,1.1000000000000001,Yes,,CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAVTBA,Female,White,Not Hispanic or Latino,2717,Induction failure,57,Dead,210,2013,2013,AAML1031,15.9,60,57,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,"t(3;3)(q21;q26.2),t(5;12)(q33;p13)",3,Other,"45,XX,t(3;3)(q21;q26.2),-7[14]/45,idem,t(5;12)(q33;p13)[6]",No,N/A,,No,No,,,,Yes,61,Yes,49,not in CR,not in CR,High Risk,No,Yes,No,No,No,Yes,,,,WHO Classification (final: path then study entry): AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1
TARGET-20-PAURDN,Male,Unknown,Not Hispanic or Latino,1064,Induction failure,79,Dead,431,2011,2013,AAML1031,197.5,60,84,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[25]",Yes,0.17,,No,No,,,,Yes,63,Yes,58,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML with maturation"
TARGET-20-PAXBAZ,Female,White,Hispanic or Latino,4626,Relapse,599,Alive,1300,2015,2018,AAML1031,8.8,71,11,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,3,Other,"47,XX,t(3;22)(p25;q13),psu dic(4;10)(p14;p11.2),del(6) (q15q23),der?(10pter-->10p?::4p?::?)x2[12]/46,XX[8]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,Unknown,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAVWBW,Female,Unknown,Not Hispanic or Latino,108,Relapse,615,Dead,706,2013,2015,AAML1031,58,75,53,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,t(9;11;18)(p22;q23;q21)[20]",No,N/A,,No,No,,,,No,0,,,CR,CR,Standard Risk,No,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAWUEX,Male,Unknown,Hispanic or Latino,4562,Induction failure,85,Dead,299,2014,2015,AAML1031,39.6,76,82,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,"del(9)(q22q34),del(13)(q14q22)",3,t(8;21),"46,XY,t(8;21)(q22;q22)[12]/46,idem,del(9)(q22q34),del(13)(q14q22)[6]/46,XY[2]",No,N/A,,No,No,,,,Yes,12,Yes,,CR,not in CR,Low Risk,No,Yes,No,No,No,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWRGN,Male,White,Hispanic or Latino,5948,Censored,1358,Alive,1358,2014,2018,AAML1031,7.5,82,27,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,6,Other,"48,XY,+4,dup(5)(q31q22),inv(7) (p13q32),+14[2]/48.idem,-14,dup(14)(q24q32.3) [5]/48,idem,i(17)(q10)[4]/46,XY[9]",No,N/A,,No,No,,,,Yes,54,Yes,,not in CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with myelodysplasia-related changes
TARGET-20-PAXGNZ,Female,White,Not Hispanic or Latino,636,Relapse,103,Alive,105,2015,2015,AAML1031,14.3,85,,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,3,1,Other,"47,XX,+3[4]/46,XX[15]",No,N/A,,No,No,,,,Yes,0.7,Yes,,not in CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAWNHU,Male,White,Hispanic or Latino,5717,Censored,1480,Alive,1480,2014,2018,AAML1031,147.7,87,90,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,2,Other,"48,XY,+10,+19[17]/46,XY[3]",Yes,0.78,,No,No,,,,No,0,No,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAUSZL,Female,White,Not Hispanic or Latino,5108,Death without remission,16,Dead,16,2012,2012,AAML1031,171.8,89,85,Unknown,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,2,MLL,"46,XX,t(9;11)(p22;q23)[5]/47,idem,+19[15]",No,N/A,,No,No,,,,,,,,death,death,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAXBNE,Male,White,Not Hispanic or Latino,5504,Censored,1272,Alive,1272,2015,2018,AAML1031,135.4,92,,Yes,No,,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XY,ins(9;11)(p22;q23q24)[13]/46,XY[7]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(9;11)(p22;q23); MLLT3-MLL
TARGET-20-PAXKAX,Female,White,Not Hispanic or Latino,6480,Censored,899,Alive,899,2015,2018,AAML1031,106.7,93,88,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,,Yes,0.7,,Yes,No,,,,No,0,No,,CR,CR,High Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  AML without maturation"
TARGET-20-PAWVVR,Female,White,Not Hispanic or Latino,5093,Censored,1256,Alive,1256,2015,2018,AAML1031,109.8,94,96,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,No,Yes,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated CEBPA
TARGET-20-PAXCZX,Female,Native Hawaiian or other Pacific Islander,Not Hispanic or Latino,1218,Relapse,474,Dead,727,2015,2017,AAML1031,8.5,95,84,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XX[20]",No,N/A,,Yes,No,,,,No,0,,,CR,CR,Low Risk,No,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAVLWY,Female,White,Not Hispanic or Latino,502,Induction failure,30,Dead,171,2013,2013,AAML1031,245.9,95,,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,No,No,,2,MLL,"46,XX,der(3)t(3;20)(p21.31;q11.2)cryp del(3)(p21.3p21.3),inv(11)(q23.3q24.1),der(20)t(3;20)(p21.31;q11.2)cryp del(20)(q11.2q11.2)[22]/46,XX[1}",No,N/A,,No,No,,,,No,0,,,not in CR,not in CR,Standard Risk,No,No,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAXIWR,Male,White,Not Hispanic or Latino,567,Death,247,Dead,247,2015,2016,AAML1031,264.3,31,33,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.04,,No,No,,,,Yes,23,No,0,not in CR,CR,Standard Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAXGES,Male,White,Not Hispanic or Latino,3127,Induction failure,82,Dead,159,2015,2016,AAML1031,315.2,78,,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",No,N/A,,No,No,,,,Yes,0.6,,,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute megakaryoblastic leukemia"
TARGET-20-PAWZAX,Female,White,Not Hispanic or Latino,1049,Relapse,248,Dead,577,2015,2016,AAML1031,2.7,72,,Yes,No,,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,Yes,No,No,,1,MLL,"46,XX,der(10)t(10;11)(p12;q23)inv(11)(q14q23),der(11)t(10;11)(p12;q23)[12]/46,XX[2]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Yes,No,No,Yes,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute monoblastic/acute monocytic leukemia"
TARGET-20-PAWZAW,Male,Asian,Not Hispanic or Latino,5433,Relapse,134,Dead,275,2015,2015,AAML1031,12.2,68,38,Unknown,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,2,t(8;21),"46,XY,der(8)t(8;21)(q22;q22),der(11)t(8;11) (q22;p15),der(21)cryp t(8;21)(q22;q22)t(8;11)(q22;p15)[20]",No,N/A,,No,No,,,,Yes,16,Yes,,CR,CR,Low Risk,No,Yes,No,No,Yes,No,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWUTL,Female,White,Hispanic or Latino,1553,Relapse,320,Alive,1460,2014,2018,AAML1031,74.1,94,99,Yes,No,,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,"+6,del(7)(q22),add(12)(p13.3),+19,+22",5,Other,"49,XX,+6,del(7)(q22),add(12)(p13.3),+19,+22[19]/46,XX[1]",No,N/A,,No,No,,,,No,0,No,0,not in CR,CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized: AML, with minimal differentiation"
TARGET-20-PAWSZL,Male,White,Not Hispanic or Latino,1681,Censored,1365,Alive,1365,2014,2018,AAML1031,44.3,95,76,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.77,,Yes,No,,,,No,0,No,,CR,CR,High Risk,Yes,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): Provisional entity: AML with mutated NPM1
TARGET-20-PAWIAT,Female,White,Not Hispanic or Latino,5510,Censored,1555,Alive,1555,2014,2018,AAML1031,10.8,62,,Yes,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,t(8;21),"46,XX,t(8;21)(q22;q22)[21]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
TARGET-20-PAWHUX,Female,White,Not Hispanic or Latino,774,Censored,1560,Alive,1560,2014,2018,AAML1031,16.2,58,12,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"t(16;21)(q24;q22),+2,+21,der(1)t(1;3)(p31;p13)",4,Other,"46,XX,t(16;21)(q24;q22)[2]/47,idem,+2[12]/48,idem,+2,+21[2]/ 46,idem,der(1)t(1;3)(p31;p13)[3]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAWHSM,Male,White,Not Hispanic or Latino,6847,Censored,902,Alive,902,2014,2016,AAML1031,9.6,69,,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,0,Normal,"46,XY[20]",Yes,0.2,,Yes,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAWHRB,Female,White,Not Hispanic or Latino,6382,Censored,967,Alive,967,2014,2016,AAML1031,58.2,,96,Unknown,No,,No,Yes,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,Yes,-X,2,t(8;21),"45,X,-X,t(8;21)(q22;q22)[38]",No,N/A,,No,No,,,,,,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized"
TARGET-20-PAWAXV,Male,White,Hispanic or Latino,330,Relapse,245,Dead,584,2013,2015,AAML1031,10.4,,,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[3]/46,XY[20]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Yes,Yes,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAVIDJ,Male,White,Not Hispanic or Latino,281,Censored,2190,Alive,2190,2012,2018,AAML1031,118.1,53,6,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,,1,inv(16),"46,XY,inv(16)(p13.1q22)[15]/46,XY[5]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PAUSTZ,Female,American Indian or Alaska Native,Hispanic or Latino,6468,Induction failure,75,Dead,205,2012,2012,AAML1031,79.3,25,25,Yes,No,,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,,1,Other,"46,XX,t(6;12)(p21.3;p13)[12]/46,XX[8]",Yes,0.04,,No,No,,,,Yes,43,Yes,74,not in CR,not in CR,Standard Risk,No,Yes,No,No,No,No,,,,"WHO Classification (final: path then study entry): AML, not otherwise categorized:  Acute myelomonocytic leukemia"
TARGET-20-PAWXZJ,Female,White,Hispanic or Latino,4587,Censored,1278,Alive,1278,2015,2018,AAML1031,42.4,45,,Yes,No,,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No,No,No,No,22,2,inv(16),"46,XX,inv(16)(p13.1q22)[17]/47,idem,+22[2]/46,XX[1]",No,N/A,,No,No,,,,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,,,,WHO Classification (final: path then study entry): AML with inv(16)(p13q22) or t(16;16)(p13;q22); CBFB-MYH11
TARGET-20-PANVMR,Female,White,Not Hispanic or Latino,1222,Induction failure,45,Alive,2738,NA,2013,AAML03P1,19.6,51,0,No,No,M7,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,3,1,Other,"47,XX,+3[7]/46,XX[13] ",No,N/A,No,No,No,No,,,Yes,4.4,,,not in CR,not in CR,Standard Risk,Unknown,,,NA,,NA,CBFA2T3-GLIS2,NA,,NA
TARGET-20-PANRBV,Male,White,Not Hispanic or Latino,130,Induction failure,49,Dead,264,NA,2005,AAML03P1,69.7,NA,25,No,No,M5,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,"t(3;6)(q25;q23), t(8;16)(p11.2;p13.3)",2,Other,"46,XY,t(3;6)(q25;q23),t(8;16)(p11.2;p13.3)[14]/46,XY[5] ",No,N/A,No,No,No,No,,,,,,,CR,not in CR,Standard Risk,No,,,NA,,NA,KAT6A-CREBBP,NA,,NA
TARGET-20-PANXVZ,Male,White,Hispanic or Latino,725,Censored,1624,Alive,1624,NA,2010,AAML03P1,4.1,74,0,No,No,M5,No,No,No,No,Yes,No,No,No,No,No,No,No,No,Yes,No,Yes,No,No,,2,MLL,"46,XY,t(9;11)(p22;q23)[5]/47,idem,+8[15] ",No,N/A,No,No,No,No,,,No,0,,,not in CR,CR,Standard Risk,No,,,NA,,NA,KMT2A-MLLT3,NA,,NA
TARGET-20-PARVSF,Male,White,Not Hispanic or Latino,2330,Relapse,221,Alive,2192,2008,2014,AAML0531,86.9,46.5,18.5,No,No,M6,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No, ,0,Normal,"46,XY[20] ",No,NA,No,No,No,Yes,Not done,Not done,,NA,No,0,CR,CR,Standard Risk,No,Yes,No,No,Yes,No,NUP98-NSD1,Gentuzumab ozogamicin treatment,,"Validation,TMA"
TARGET-20-PASIEJ,Female,Asian,Not Hispanic or Latino,2686,Relapse,419,Dead,1118,2008,2011,AAML0531,5.4,30,19.1,No,No,M2,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No, ,0,Normal,"46,XX[20]",Yes,0.54,No,No,No,No,Not done,Not done,Yes,2.7,Yes,0.9,CR,CR,High Risk,No,Yes,No,No,No,No,CBFA2T3-GLIS2,Gentuzumab ozogamicin treatment,,"Discovery,Validation,TMA"
TARGET-20-PASLTF,Male,White,Hispanic or Latino,6157,Censored,1891,Alive,1891,2009,2014,AAML0531,49.2,81,67,No,No,Unknown,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No, ,0,Normal,"46,XY[20]",No,NA,No,No,Yes,No,Not done,Not done,No,0,No,0,CR,CR,Low Risk,No,Not done,Not done,Not done,Not done,Not done,NA,Gentuzumab ozogamicin treatment,,"Validation,TMA"
TARGET-20-PASRLS,Female,White,Not Hispanic or Latino,298,Censored,1778,Alive,1778,2009,2014,AAML0531,11.7,3,0,No,Yes,M7,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No,No, ,0,Normal,"46,XX[20] ",No,NA,No,No,No,No,Not done,Not done,Yes,0.02,Yes,4.7,not in CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,CBFA2T3-GLIS2,Gentuzumab ozogamicin treatment,,"Discovery,Validation"
TARGET-20-PATESX,Female,Asian,Not Hispanic or Latino,854,Censored,1822,Alive,1822,2010,2015,AAML0531,21.1,24,36,No,No,M6,No,No,No,No,No,No,No,No,No,No,Yes,No,No,No,No,No,No,No, ,More than 6,Other,"45,XX,del(9)(q13),add(11)(p11.2),-18,add(19)(p13.3)[6]/45,idem,- del(9),del(13)(q12q22)[2]/45,idem,del(1)(p22p32),add(12)(p11.2)[4]/46,XX[8]",No,N/A,No,No,No,No,Not done,Not done,No,0,No,0,not in CR,CR,Standard Risk,No,Not done,Not done,Not done,Not done,Not done,NA,NO Gentuzumab ozogamicin treatment,,"Validation,TMA"